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SUMMARY
HERPES SIMPLEX VIRUS LATENCY IN CULTURED CELLS
The molecular basis of herpes simplex virus (HSV) 
latency has been investigated by analysis of a latent 
interaction between HSV and cells in culture.
An in vitro latency system for HSV, based on previous 
work by E. Notarianni and C.M. Preston, has been 
characterised, in which incubation at a supraoptimal 
temperature converts HSV to a latent state within tissue 
culture cells. Human foetal lung (HFL) cells were infected 
at low multiplicity with HSV and, following adsorption, the 
cultures were shifted to 42°C for 6 days, then downshifted 
to a temperature permissive for HSV replication for a 
further 4 to 6 days. During the latter incubation period no 
virus was usually detectable and the HSV was considered to 
be in a latent state. HSV could be reactivated from this 
latent state at high efficiency by intertypic superinfection 
of the cultures with HSV mutants or with human 
cytomegalovirus.
To define the HSV gene products involved in latency, 
the behaviour of various temperature-sensitive (ts), 
insertion (_in) and deletion (dl) mutants of HSV in the in 
vitro latency system was examined. The rationale behind this 
approach is that mutants which fail to become established in 
a latent state, or which fail to reactivate latent HSV, must 
lack functions involved in establishment or reactivation, 
respectively. Two mutants of HSV type 1 (HSV-1) used in 
these studies, tsK and in!411, do not synthesise active 
immediate early (IE) polypeptide Vmwl75 and are blocked at a 
very early stage of the virus replication cycle, and a third 
mutant of HSV-1, d!14Q3, does not produce IE polypeptide 
VftiwllO, but otherwise exhibits a pattern of protein 
synthesis indistinguishable from that of wt HSV-1. All 
mutants tested were able to establish latency in HFL 
fibroblasts and could be reactivated by intertypic 
superinfection with HSV or with human cytomegalovirus, 
showing that no viral DNA synthesis and little or no viral
gene expression is necessary for the establishment of 
latency in vitro, and that at most the viral proteins 
involved are IE polypeptides Vmwl2, Vmw6 3, Vftiw6 8, Vftiwl75 or 
VftiwllO, the early polypeptide Vmwl36, and, possibly, 
components of the input virion. Reactivation of latent HSV-2 
v/as achieved by superinf ection with tsK or in!411. However, 
superinfection with d!1403 failed to reactivate latent HSV-2 
as a consequence of a deletion in the region of the genome 
encoding VftiwllO, strongly suggesting that VftiwllO, which is 
known to regulate gene expression by trans-activation, is 
required for reactivation in the in vitro latency system. 
The results presented do not indicate whether VftiwllO acts 
alone or in conjunction with one or more of the virion 
components and/or the other IE polypeptides, excluding 
Vmwl75. Harris et al. (19 89) have recently shown that VmwllO 
alone can reactivate latent HSV in vitro. One possibility is 
that a block in viral gene expression occurs at a very early 
stage in the viral cycle, either as the direct cause or as a 
consequence of establishment of latency, and that the block 
can be released by the VftiwllO gene product, thereby allowing 
HSV to continue into the lytic cycle.
The latent state of HSV DNA in vivo appears to be 
Endless' and is therefore either circular, concatemeric or 
integrated via regions of the genome other than the termini. 
A recent report shows that the majority of latent HSV DNA in 
vivo is extrachromosomal, suggesting that latent HSV DNA in 
vivo is not likely to be integrated into cellular DNA. The 
physical nature of the HSV DNA in the in vitro latency 
system described has been determined. The relative 
proportion of latent HSV genomes, initially present in vitro 
at 0.03-0.1 copies per cell, was selectively increased and 
the presence of joint and terminal fragments of HSV in 
latent HSV DNA was investigated by the use of a modified 
Southern hybridisation procedure. During the 4 2°C incubation 
period the HSV DNA is present in an 'endless' configuration, 
suggesting that the state of the latent HSV genome is 
'endless' in vitro.
These findings are discussed in terms of relevance to 
HSV latency in vivo, and of possible molecular mechanisms 
involved in HSV latency.
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11. INTRODUCTION
The research presented in this thesis concerns the 
characterisation of a latency system for herpes simplex 
virus (HSV) in cultured cells and the analysis of molecular 
aspects of HSV latency in the system. The biology and 
genomic structures of the human herpesviruses are described 
in INTRODUCTION Section 1.1.; Sections 1.2. and 1.3. of the 
INTRODUCTION deal with the biological and molecular features 
of lytic and latent interactions of HSV with the host cell.
1.1. THE HUMAN HERPESVIRUSES
1.1.1. Herpesviruses - Description and Classification
Members of the animal virus family Herpesviridae are 
structurally similar and possess a double-stranded linear 
DNA genome of relative molecular weight (MR ) ranging between 
80-150xl06 .
In terms of the structural components of the virion, 
herpesviruses can be identified by the presence of an 
envelope, tegument, capsid and core (DNA-protein complex) 
(Wildy et al., 1960; Epstein, 1962b). The envelope, the
outermost structure of the herpesvirion, is derived from 
nuclear and other cellular membranes (Morgan et al., 1959; 
Epstein, 1962a; Siminoff and Menefee, 1966; Shipkey et al., 
1967; Nii et al., 1968). It has a typical trilaminar 
appearance (Epstein, 1962b), and contains surface 
projections approximately 8nm in length (Wildy and Watson, 
1963). The tegument is defined as the structure located 
between the capsid and the envelope, and electron microscopy 
reveals it as a layer of amorphous material in thin section 
(Epstein, 1962b; Roizman and Furlong, 1974; Spear, 1980) and 
sometimes as a fibrous structure in negatively stained 
virions (Wildy et al., 1960). The amount of tegument can 
vary from virion to virion, even in the same cell (Fong et 
al. , 1973 ) and appears, at least in part, to be determined
by the virus strain (McCombs, 1971). The icosadeltahedral 
capsid, which has been characterised in most detail for 
herpes simplex virus type 1, is 100-110nm in diameter.
aIt contains 12 pentameric capsomeres and 150 hexameric 
capsomeres of 12nm diameter and 14nm length with a deep 
central indentation approximately 4nm wide tapering from 
the outer surface towards the capsomere base (Wildy et al., 
1960). The herpesvirus core is situated within the capsid 
and contains the deoxyribonucleic acid (Epstein, 1962b; 
Zambernand and Vatter, 1966). The core is of toroidal 
conformation with a central cylindrical structure (Furlong 
et al., 1972). Several models have been proposed to account 
for the electron microscopic appearance of the core, the 
most favoured of which is that proposed by Furlong and 
coworkers (1972) in which the viral DNA, in a 4-5nm thick 
nucleoprotein filament, is wound around the cylindrical 
structure.
The classification of the 80 or so herpes viruses 
comprising the family Herpesviridae into the Subfamilies 
Alpha-, Beta-, and Gamma-herpesvirinae, was conducted by the 
Herpes Study Group appointed by the International Committee 
on Taxonomy of Viruses (Roizman et al., 1981), and is based 
upon the biological properties of the viruses, including 
duration of reproductive cycle, cytopathology, 
characteristics of latent infection and host range. A 
summary of the characteristics of the herpesvirus 
Subfamilies, and designation, to these Subfamilies, of the 
human herpesviruses, with which this thesis is mainly 
concerned, is shown in Table 1.1. Note that the newly 
isolated human B lymphotropic virus (human herpes virus 6) 
has not yet been unequivocally designated to a Subfamily, 
but recent evidence suggests that it is a member of the 
betaherpesvirinae.
1.1.2. Human Herpesviruses and Disease
Herpes simplex virus (HSV) primary infection, which 
may produce clinical or sub-clinical infection in children, 
is thought to be responsible for the presence of antibodies 
to HSV type 1 (HSV-1) in 9 0% of the adult population. A 
significant proportion of adults also have antibodies to HSV 
type 2 (HSV-2) and a correlation exists between increased 
sexual activity and the incidence of HSV-2 primary infection 
(Whitley, 1985). Both HSV-1 and HSV-2 are spread by direct
TABLE 1.1. CHARACTERISATION OF HERPESVIRUS SUBFAMILIES;
DESIGNATION OF HUMAN HERPESVIRUSES TO SUBFAMILIES
SUBFAMILY 1 ALPHAHERPESVIRINAE
Relatively short reproductive cycle; in vitro 
rapid spread of infection.
Cytolytic - destruction of susceptible cells. 
Latent infections established primarily in 
ganglia.
Examples: Herpes simplex virus type 1 (human herpes virus 1)
Herpes simplex virus type 2 (human herpes virus 2)
Varicella zoster virus (human herpes virus 3)
SUBFAMILY 2 BETAHERPESVIRINAE
Restricted host range.
Relatively short reproductive cycle; in vitro 
slowly progressing infection.
Cytomegalic - frequent enlargement of infected 
cells.
Latent infections established in secretory 
glands, lymphoreticular cells, kidneys and other 
tissues.
Example: Human Cytomegalovirus (human herpes virus 5)
SUBFAMILY 3 GAMMAHERPESVIRINAE
Host range restricted to family or order of 
natural host.
In vitro replication in lymphoblastoid cells; 
some cause lytic infections in epitheloid and 
fibroblastic cells.
Latent infection established frequently in 
lymphoid tissue.
Example: Epstein-Barr Virus (human herpes virus 4)
3contact. Following primary infection HSV can establish a 
latent infection in the neurons of sensory ganglia or brain 
tissue (Baringer and Swoveland, 1973; Fraser et al., 1981). 
Reactivation may result in asymptomatic infection or in 
periodic muco-cutaneous infections; in general, HSV-1 
infection is associated with cold sore lesions of the lips 
(herpes labialis) and the eyes (herpes keratitis), while 
HSV-2 is more usually associated with genital lesions 
(herpes genitalis) (Whitley, 1985). The possibility of a 
causal relationship between HSV-2 and cervical neoplasia 
stemmed from epidemiological studies, which suggested a 
higher prevalence of HSV-2 antibodies among women suffering 
from cervical neoplasia than in matched controls, and, 
indirectly, from the demonstration of oncogenic potential of 
HSV for rodents. However, the serological results of a 
prospective study carried out by Vonka and associates 
(19 86a) on more than 10,000 women aged 25 to 45 years do not 
lend support to the hypothesis that HSV-2 is involved in the 
pathogenesis of cervical neoplasia. HSV has, rarely, been 
associated with serious generalised infections in newborns 
or meningitis, myelitis or a fatal non-epidemic encephalitis 
of adults (Whitley, 1985).
A primary infection with varicella zoster virus (VZV) 
usually results in the childhood disease known as chicken 
pox, which is a generalised infection at the skin surface; 
the disease can be spread by the respiratory route and 
direct contact. VZV can become established in a latent state 
in dorsal root ganglia and the spinal cord during primary 
infection. Upon reactivation of latent VZV, the cutaneous 
disease herpes zoster (shingles), a disease primarily of 
adults, may be produced. In adults and in a small percentage 
of children, VZV infection may cause herpes zoster 
encephalitis or meningitis (Kennedy, 1987).
Human cytomegalovirus (HCMV) infection normally 
results in a benign asymptomatic disease, although 
congenital HCMV infections may result in mental retardation. 
Infectious virus can be reactivated from transfused blood or 
transplanted organs in recipient immunosuppressed patients 
in which, therefore, clinically apparent infections occur 
frequently. The consequences of active infection are
4variable but generally include fever, pneumonia, 
mononucleosis and hepatitis, or combinations of these
(Hamilton, 1982).
Epstein-Barr virus (EBV) has been detected in African 
Burkitts lymphoma (BL) and nasopharyngeal carcinoma (NPC) 
tissues, although its role in the production of these 
neoplasms has not been resolved. Although EBV infection is 
often asymptomatic, the virus is the causative agent of 
infectious mononucleosis, otherwise known as glandular 
fever. EBV is able to establish a latent infection in the 
lymphocytes of patients with infectious mononucleosis, and 
reactivation may produce recurrences of the disease symptoms 
(Epstein and Achong, 1986; Dambaugh et al., 1986).
The human B-lymphotropic virus (HBLV), or human 
herpes virus 6, has been isolated from patients with 
lymphoproliferative diseases and infants with roseola
infantum; some of these patients were also seropositive for 
human immunodeficiency virus type 1 (Salahuddin et al., 
1986; Downing et al., 1987; Tedder et al., 1987; Yamanishi 
et al., 19 88).
1.1.3. Human Herpesviruses and Cellular Transformation
Analysis of the transforming abilities of HSV and 
HCMV was initiated because of sero-epidemiological studies 
which suggested a link between these herpesviruses and 
cervical carcinomas. HSV in which the normal capacity to 
grow and kill infected host cells is eliminated can induce 
morphological transformation of rodent cells (Duff and Rapp, 
1971). The viral DNA is successively lost on passage of 
transformed cells (Minson et al., 1976), suggesting a 'hit 
and run' mechanism for transformation (Skinner, 1976). 
Specific DNA fragments of HSV-1, HSV-2 and HCMV have been 
identified which have transforming ability but are not 
necessarily retained within the transformed cell: MTRI
(morphological transformation region 1) (Xbal f [0.29 to 
0.45mu] and Bglll i [0.311 to 0.415mu]) of HSV-1 DNA (Reyes 
et al. , 1979 ); MTRII (Bglll n [0.58 to 0.62mu]) of HSV-2 DNA 
(Reyes et al., 1979; Macnab and McDougall, 1980; Galloway 
and McDougall, 1981; Cameron et al., 1985); MTRIII (Bglll c
[0.54 to 0.58mu]) of HSV-2 DNA (Peden et_al., 1982; 
Jariwalla et al., 1983); and, HCMV MTR (HindiII E
subfragment [0.123 to 0.14]) of HCMV DNA (Galloway et al., 
1984; Nelson et al., 1984). The transforming regions of 
HSV-1, HSV-2 and HCMV DNA are not homologous. There is no 
evidence for the existence of an HSV-coded transforming 
protein (Cameron et al., 1985); specific subfragments from 
the transforming regions of HSV and HCMV are sufficient for 
transformation and yet too small to code for proteins 
(Galloway et al., 1984; Jones et al., 1986). The mechanism 
of transformation is likely to be complex; cis or trans 
activation or alteration of expression of cellular genes, 
oncogenes or endogenous retrovirus genes might occur via 
enhancement, mutagenesis or gene amplification (Sugden, 
1986; Macnab, 1987). Interestingly, the transformed cells 
are oncogenic in the host animal and immunocompetent mice.
EBV infection, which has been associated with NPC and 
BL, immortalises infected B lymphocytes in vitro as it does 
in vivo. In contrast to the situation with HSV and HCMV, the 
immortalised cells contain the complete viral genome and 
multiple viral functions appear to be required for induction 
and maintenance of cell proliferation. 20 to 25% of the 
genome is required to initiate and maintain immortalisation 
(Mark and Sugden, 1982). Several virally encoded proteins, 
or candidates for virally encoded proteins, have been 
identified in transformed cells, at least 2 of which, 
Epstein-Barr virus nuclear antigen I (EBNAI) and EBNA2, have 
been assigned putative functions in immortalisation (Section
1.3.5.2.).
1.1.4. Genome Structures of Human Herpesviruses
Herpesviruses have also been classified on the basis 
of gross characteristics of the genome (Roizman et al., 
1981). The structures of the double-stranded linear DNA 
genomes of HSV and other human herpesviruses are illustrated 
in Figure 1.1.
The HSV genome, which consists of double-stranded DNA 
containing random single strand breaks, has a molecular 
weight of about lOOxlO6 (Becker et al., 1968; Kieff et al.,
Figure 1.1. STRUCTURES OF THE GENOMES 
OF THE HUMAN HERPESVIRUSES
The genomes are represented as linear molecules. 
The bold lines represent unique sequences and the boxes 
represent repeat sequences, with arrows indicative of the 
relative sequence orientations. The genomes are described in 
Section 1.1.4.
ABBREVIATIONS:
°L - unique, long
us - unique, short
I / T R l  - internal/terminal repeat, long
I/TRS - internal/terminal repeat, short
MIR major internal repeat
d l - direct repeat, left
dr - direct repeat, right
ori origin of DNA replication
This figure was adapted from McGeoch (19 89), with 
the permission of D. McGeoch.
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61971; Wilkie, 1973; Wilkie et al., 1974; Clements et al.,
1976). HSV-1 (strain 17) DNA contains 152,260 base pairs
(bp). The overall base composition of HSV-1 DNA is 68.3% G+C
(McGeoch et al., 1988), whilst that of HSV-2 DNA is 69% G+C
as determined by buoyant density centrifugation (Goodheart
et al. , 1968; Kieff et al., 1971). The HSV-1 genome consists
of 2 covalently linked segments L (long) and S (short) each
comprising a unique DNA sequence (UT and UG ) bounded by
Li O
inverted repeats (R and Rc ) (Sheldrick and Berthelot,
Lj O
1974). The inverted repeats of L are designated ab and a'b',
each of approximately 9200bp (HSV-1), while those of S are
designated a'c1 and ac, and are each 6600bp (HSV-1)
(Wadsworth et al., 1975; Perry and McGeoch, 1988; McGeoch et
al. , 1986; Figure 1.2.). The 'a' sequence, of 400bp in HSV-1
(17) and 250bp in HSV-2 (333) (Davison and Wilkie, 1981), is
present as a direct repeat at the termini of the genome and,
also, in inverted orientation at the L-S junction (Grafstrom
et al. , 1974, 1975; Sheldrick and Berthelot, 1974; Wadsworth
et al., 1975, 1976). Several copies of this sequence may
occur at the L terminus and at the L-S junction (Wagner and
Summers, 1978). The L and S segments invert relative to each
other about the mutual joint region during infection.
Consequently, there are 4 types of HSV DNA molecule, present
in equimolar amounts in populations of virion DNA (Sheldrick
and Berthelot, 19 74; Hayward et al., 19 75; Clements et al.,
1976; Delius and Clements, 1976; Wilkie and Cortini, 1976;
Skare and Summers, 1977; Roizman, 1979), which appear to be
functionally equivalent (Davison and Wilkie, 1983a;
Longnecker and Roizman, 1986).
The HCMV genome, of MD 150-155xl06, consists of someK
235,000bp (Geelen et al., 1978; Lakeman and Osborn, 1979) 
with a base composition of 57-58% G+C (Crawford and Lee, 
1964; Plummer et al., 1969). The gross structure of the HCMV 
genome is similar to that of HSV, with 2 unique regions (U1j
and □ ) flanked by 2 pairs of dissimilar inverted repeats
u
(R^ and Rg ). Furthermore, an 800bp sequence similar to the 
HSV 'a' sequence is present at the L-S joint and in variable 
copy number at the S segment termini (LaFemina and Hayward, 
1980; Tamashiro et al, 1984; Spaete and Mocarski, 1985), and 
4 isomers of the HCMV genome are present in equimolar
Figure 1.2. THE RELATIVE POSITIONS OF THE a, b and c 
SEQUENCES IN THE LONG AND SHORT REGIONS 
OF THE HSV GENOME.
The positions of a, b and c sequences in the 
genome are shown. Note that a', b' and c1 sequences are 
equivalent to a, b and c sequences, respectively, in 
inverted orientation. One or more copies of the a sequences 
are present at the termini of the L and S components of the 
HSV genome (Figure 1.1.).
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amounts in virion populations (Kilpatrick and Huang, 1977;
LaFemina and Hayward, 1980).
The genome of VZV, of M^ 80x10^ (Dumas et al., 1980;K
Ecker and Hyman, 1982), is composed of 124,884bp (Davison
and Scott, 1986) of overall base composition 46% G+C (Ludwig
et al. , 1972; Davison and Scott, 1986). Its gross structure
is similar to that of HSV and HCMV, except that the inverted
repeat sequences flanking U are only 88.5bp (compared to
jL
9200bp in HSV-1), there is no proper terminal redundancy, 
and only 5% of VZV virion DNA contains L in inverted 
orientation (Davison, 1984), the remainder consisting of 
equimolar amounts of 2 isomeric genome arrangements which 
differ only with respect to the relative orientation of S 
(Dumas et al., 1981; Ecker and Hyman, 1982).
£
EBV, which has a genome of M 115x10 (Given and 
Kieff, 1978) and of 172,282bp with 60% G+C content (strain 
B95-8; Baer et al., 1984), has a different genomic
organisation, consisting of a short and a long unique region 
(Uc and U ), which are maintained in a unique orientationO lj
relative to each other (Given and Kieff, 1978; Skare and 
Strominger, 1980), and, which are divided by up to 12 direct 
sequence repeats of about 3000bp (MIR) (Rymo and Forsbloom, 
1978; Given and Kieff, 1979; Hayward et al., 1980). The EBV 
genome is terminally redundant with up to 5 copies of a 
550bp sequence, randomly distributed across both termini in 
linear virion DNA (Given et al., 1979; Kintner and Sugden, 
1979).
The genomes of HSV, HCMV, VZV and EBV are alike in 
possessing families of multiple copies of short, directly 
repeated sequences. Each group of repeats has a distinct 
sequence, and the repeats vary in copy number and size, for 
example, from the 12bp direct repeat which occurs 18 times 
within the HSV-1 (17) 'a1 sequence (Davison and Wilkie,
1981), to the 125bp Not I repeats in EBV (Jones and Griffin,
1983). In HSV, short direct repeats, which have been 
observed in U0 , Rc and Rr , are generally GC rich, with an
O  O Li
asymmetry of purine versus pyrimidine content of the 
strands, and a tendancy towards strings of G on 1 strand 
(McGeoch et al., 1985; Davison and Wilkie, 1981: Rixon et 
al. , 1984; Perry and McGeoch, 1988).
8Complete nucleotide sequences are known for HSV-1 
(McGeoch et al., 1985; McGeoch et_al., 1986; McGeoch et al., 
1988, Perry and McGeoch, 1988), EBV (Baer et al., 1984) and 
VZV (Davison and Scott, 1986). The sequence of the S segment 
and parts of the L segment unique and repeat regions of HCMV 
have been reported (Weston and Barrell, 1986; Kouzarides et 
al. , 1987), and most of the Ug region of the HSV-2 genome
has also been sequenced (McGeoch et al., 19 87).
The genome of HSV-1 is predicted to possess 72 genes, 
densely arranged and encoding 70 distinct proteins. There 
are 12 genes in U„ and 56 in U , while Rc and R each
O  Li O  Li
contain 1 well-characterised gene encoding the 
transcriptional control proteins IE Vfttwl75 and IE vmwllO 
respectively, as shown in Figure 1.3. (Easton and Clements, 
1980; McGeoch et al. , 1986; McGeoch et al. , 1988; McGeoch;
1989). The genomes of HSV-1 and HSV-2 share extensive 
sequence homology in approximately 5 0% of sequences, as 
shown by DNA hybridisation analysis (Kieff et al., 1972) and 
electron microscope studies (Kudler et al., 1983) and are 
very similar in physical structure, although Ug of HSV-2 is 
1500-3000bp longer than that of HSV-1 (Davison, 1981). The 
least homologous regions include the repeat sequences of L 
and most of S (Wilkie et al., 1979; Peden et al., 1982), 
Evidence that the genomes are coll inear comes from 
experiments utilising intertypic recombinants in which 
certain functions such as thymidine kinase (Halliburton et 
al. , 1980 ), DNA polymerase (Chartrand et al., 1979 ) and the 
IE genes (Easton and Clements, 1980) were shown to map in 
equivalent locations in HSV-1 and HSV-2, and, from molecular 
hybridisation analysis which identified regions of homology 
in the HSV-1 and HSV-2 genomes (Davison and Wilkie, 1983b), 
as well as from sequence data (McGeoch et al., 1987).
The other human herpesviruses show only 5% homology 
to each other at the DNA level (Huang and Pagano, 1974). 
However, regions of homology, as reflected in the sequence 
of the proteins encoded and the relative organisation of the 
genes, have been identified for HSV-1, VZV, EBV and HCMV. 
Homology of amino acid sequences, predicted by computer 
analysis of the nucleotide sequence (Taylor, 1986), occurs 
to varying degrees within the L segments of all these
Figure 1.3. THE LOCATION OF GENES IN THE HSV-1 GENOME
The locations of reading frames (shown by arrows) 
in the HSV-1 genome (represented on 4 lines, 40kbp per 
line), and reproduced from McGeoch (19 89) with the kind 
permission of the author. Reports concerning the functions 
of the HSV-1 genes are referenced in McGeoch et al. (19 88a)
McGeoch (1989) and in relevant sections of the thesis.
IE110/IE-l - IE transcriptional regulator, 
VinwllO; UL2 - Uracil-DNA glycosylase; UL3,4 - Unknown; UL5 - 
DNA helicase component, DNA replication; UL6 - Presumed 
virion component; UL7 - Unknown; UL8 - DNA replication, 
function unknown; UL9 - DNA replication, ori-binding 
protein; UL10 - Unknown, possible membrane-inserted protein; 
ULll - Unknown; UL12 - Deoxyribonuclease; UL13 - Predicted 
protein kinase; UL14,15,16,17,18 - Unknown; UL19 - Major 
capsid protein (ICP5, VP5); UL20, 21 - Unknown; UL22 - 
Glycoprotein H; UL23 - TK; UL24 - Unknown; UL25 - Virion 
protein; UL26 - DNA packaging; UL27 - Glycoprotein B; UL28 - 
Probably structural; UL29 - ssDNA binding protein required 
for replication (DBP); UL30 - Replicative DNA polymerase; 
UL31 - Unknown; UL32 - Probably structural UL3 3 - 
Structural, packaging; UL34 - Possible virion protein; UL35 
- Unknown; UL36 - Very large tegument protein; UL37 - 
Unknown; UL38 - Capsid assembly; UL39 - RR large subunit; 
UL40 - RR small subunit; UL41 - Presumed virion protein; 
UL42 - DNA binding protein, replication;®UL44 - Glycoprotein 
C; UL45,46,47 - Unknown; UL48 - Major tegument protein,
transactivates IE genes; UL49 - Unknown; UL50 - Deoxyuridine 
triphosphate; UL51 - Unknown; UL52 - DNA replication, 
function unknown; UL53 - Possible membrane protein; 
UL54/IE-2 - IE transcriptional regulatory protein, Vmw63;©
IE175/IE-3 - IE transcriptional regulatory protein, Vmwl75; 
US1/IE4 - IE protein Vmw6 8, function unknown; US2 - Unknown; 
US3 - Protein kinase; US4 - Glycoprotein G; US5 - Unknown, 
possible glycoprotein; US6 - Glycoprotein D; US7 - 
Glycoprotein I; US8 - Glycoprotein E; US9 - Virion protein; 
US10 - Virion protein; US11 - Unknown: US12/IE-5 - IE 
protein, Vmwl2, unknown.
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9genomes. There are no similarities in the predicted coding 
capacity and organisations of the Ug regions of VZV, HCMV 
and EBV, HSV-1 and HCMV, or, HSV-1 and EBV (Baer et al., 
1984; Weston and Barrell, 1986; Davison and Scott, 1986; 
McGeoch et al., 1986; Davison and McGeoch, 1986; Davison and 
Taylor, 1987; McGeoch et al., 1988). However, despite large 
differences in % G+C content, the genomes of HSV-1 and VZV, 
which are both alphaherpesviruses, contain homologies in 
both S and L. There is considerable reorganisation of the 
genes in the S segment relative to each other in HSV-1 and 
VZV, while the' gene arrangement in VZV L corresponds well to 
that of HSV-1 L from the HSV-1 isomer in which the long 
region is inverted compared to the accepted prototype isomer 
(Davison and Scott, 1986; McGeoch et al., 1986; Davison and 
McGeoch, 19 86; McGeoch et al., 19 88).
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1.2. HERPES SIMPLEX VIRUS - THE LYTIC CYCLE
1.2.1. Initial Stages of Infection
HSV infection is initiated upon adsorption of the 
virus to the host cell and penetration of the virions 
through the cell membrane. Adsorption to the host cell is 
presumably brought about by an interaction between cellular 
receptors and viral glycoproteins exposed at the virion 
surface, and there is evidence to suggest the involvement of 
glycoproteins gB, gC, gD and gE in this event (Para et al., 
1982; Johnson et al., 1984; Fuller and Spear, 1985).
Penetration occurs predominantly by fusion of the viral 
envelope with the plasma membrane (Morgan et al., 1968; Para 
et al., 1980) and experiments utilising HSV temperature
sensitive (ts) mutants tsB5 and tsj!2, which fail to process 
gB to its mature forms at the non-permissive temperature 
(NPT), have implicated this glycoprotein in the membrane 
fusion process (Sarmiento et al., 1979; Little et al., 1981; 
DeLuca et al., 1982). The occurrence of penetration
defective mutants with ts lesions in a region of the genome 
outwith gB coding sequences suggests the involvement of 
other viral polypeptides in penetration (Addison et al.,
1984). Internalised capsids are transported to the nuclear 
pores. Release of the HSV genome from the capsid into the 
nucleus requires a viral function but not de novo RNA and 
protein synthesis, suggesting involvement of viral 
structural component(s) and/or host cell factors (Hochberg 
and Becker, 1968). Characterisation of a ts mutant defective 
in release of viral DNA indicated a role for a virion 
component in the release of HSV DNA (Batterson et al., 
1983 ) .
1.2.2. Effect on Host Macromolecular Synthesis
Infection of cells with HSV has an inhibitory effect 
on the synthesis of cellular DNA, RNA and protein (Fenwick,
1984) which is generally more pronounced in cells infected 
with HSV-2 than with HSV-1 (Powell and Courtney, 1975; 
Pereira* 1977; Fenwick et al., 1979; Schek and Bachenheimer,
11
1985), although HSV-2 strain HG52 is an exception (Marsden 
et al. , 1978 ). Protein synthesis inhibition is mediated by
at least two factors; a virion-associated component, which 
is non-essential for growth of virus in tissue culture, and 
a protein synthesised later in infection, which can function 
in the absence of a functional virion component and is 
essential for the full inhibitory effect on host protein 
synthesis (Honess and Roizman, 1975; Fenwick and Clark, 
1982; Read and Frenkel, 1983). Disaggregation of
polyribosomes, degradation of cellular mRNA and inhibition 
of RNA synthesis accompany the suppression of cellular 
protein synthesis (Fenwick and McMenamin, 1984) and are also 
mediated by a component of the virion, although protein 
synthesis is also required for host mRNA degradation in some
cell types (Fenwick and Clark, 1982; Nishioka and
Silverstein, 1977, 1978; Schek and Bachenheimer, 1985). The
virion-associated inhibition of host protein synthesis is 
clearly non-essential for virus replication since viable 
mutants with mutations affecting host shut-off have been 
isolated (Read and Frenkel, 19 83); the mutation of one 
mutant mapped to a 2 65bp fragment within a region of the 
genome including gene UL41. It is not yet clear whether the 
UL41 gene is involved directly in host shut-off (Kwong et 
al., 1988) or is involved in mRNA stabilisation (Fenwick and 
Owen, 19 8 8).
In addition to the HSV-induced host shutoff effect, 
certain cellular genes are activated during HSV infection. 
Expression of some cellular genes is reported to be enhanced 
during normal HSV infection (LaThangue et al., 1984; MacNab 
et al., 1985; Patel et al., 1986; Kemp et al., 1986), while 
overexpression of an abnormal form of Vmwl75 activates the 
expression of cellular stress genes (Notarianni and Preston, 
1982; Russell et al., 1987). In this regard it is of
interest that HSV immediate early gene products (Section
1.2.3.) have been shown to activate certain cellular 
promoters, such as the rabbit B globin gene promoter 
(Everett, 1984a, 1985).
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1.2.3. Transcription and Gene Products
Transcription of HSV genes is directed by eukaryotic 
cellular RNA polymerase II (Alwine et al., 1974; Ben-Zeev 
and Becker, 1977) and other cellular factors, as well as 
viral factors. Therefore, HSV mRNAs have some features in 
common with eukaryotic cellular mRNAs and also with mRNAs of 
other nuclear-replieating DNA viruses (Wagner, 1984, 1985; 
McGeoch, 1986, 1988a): a cap at the 5' end; polyadenylation 
at the 3' end, signalled by AATAAA in the gene (Silverstein 
et al. , 19 76 ); and a leader sequence between the cap and the 
translation initiation site. Methylation of HSV mRNA, by a 
mechanism resembling that of the host cell, may also occur 
(Bartoski and Roizman, 1976).
In terms of the transcriptional organisation of the
HSV genome, genes are found in both orientations on the
genome, each with its own promoter (McGeoch et al., 1988a;
McGeoch, 19 89; Figure 1.3.). Gene overlap is a common
feature, for example, RNA mapping data has identified
families of transcripts with identical 3 1 ends (Rixon and
McGeoch, 1984; Draper et al., 1986), and transcripts with
overlapping 5' ends on opposite strands (Wilkie et al.,
1980). Splicing, although relatively uncommon, occurs within
some HSV transcripts, notably those of IEs VmwllO (Perry et
al., 1986) Vmw68 and Vmwl2 (Watson et al., 1981; Rixon and
Clements, 1982) and Ur15 (McGeoch et al., 1988a). Expression
Li
of the HSV genome during lytic infection occurs in a 
coordinate and sequential manner to produce three main 
temporal classes of transcripts,- immediate early (IE), early 
(E) and late (L). There is no obvious clustering of genes 
along the genome on the basis of class (McGeoch et al., 
1986; McGeoch et al., 1988a).
The viral genes transcribed initially in a lytic HSV 
infection, designated IE or alpha genes, have been
defined as those genes expressed in the absence of prior (de 
novo) viral protein synthesis (Kozak and Roizman, 1974; 
Clements et al., 1977; Jones and Roizman, 1979). Although 
under such conditions the IE mRNAs accumulate in relatively 
large amounts, they are normally expressed only transiently 
in a lytic infection (Clements et al., 1977; Watson et al.,
13
1979; Anderson et al., 1980). Functional IE gene products 
are required for progression to the E and L phases of gene 
expression (Honess and Roizman, 1974, 1975; Preston, 
1979a,b; Everett, 1984a; O'Hare and Hayward, 1985); L genes 
also require viral DNA synthesis for maximal expression 
(Swanstrom and Wagner, 1974; Powell et al., 1975; Jones and 
Roizman, 1979; Holland et al., 1980; Conley et al., 1981; 
Pederson et al., 1981). The absence of viral DNA synthesis 
affects two classes of HSV genes, the E/L genes (also known 
as &  ir and "leaky" late) and the "true" late genes
or ^ 2  ^ (Roizman and Batterson, 1985; Wagner, 1985;
Harris-Hamilton and Bachenheimer, 1985). Although viral DNA 
synthesis is required for maximum expression of E/L genes, 
expression is detected early in infection and occurs at 
moderately high levels in the absence of DNA synthesis 
(Gibson and Spear, 1983; Johnson et al., 1986). In contrast,
"true" late gene expression is severely reduced in the
absence of viral DNA synthesis (Jones and Roizman, 1979:
Holland et al., 1980; Hall et al., 1982), but is,
nevertheless, detectable with sensitive assays (Godowski and 
Knipe, 1985; Johnson et al., 1986). HSV gene expression is 
generally controlled at the level of transcription 
initiation, and certain HSV gene products, notably the IE 
polypeptides, are involved in transactivation, repression 
and autoregulation of transcription (Everett, 1987a).
The control of transcription of the HSV IE, E and L 
genes, the promoter elements required for efficient 
expression of genes in IE, E (including E/L) and L kinetic 
classes, diagrammed in Figure 1.4., and the functions of HSV 
gene products, are considered in the following sections.
1.2.3.1. Regulation of Immediate Early Gene Expression
There are 5 major IE genes of HSV-1 designated IE-1 
to IE-5, or, o(. 0 , 27 , 0C 4 , 0(22 and^47. The IE genes code for
polypeptides VmwllO, Vmw6 3, Vmwl75, Vmw6 8 and Vmwl2, named 
on the basis of apparent molecular weight as estimated by 
SDS-PAGE, and also known as ICPO, ICP2 7, ICP4, ICP2 2 and 
ICP47, respectively. The IE polypeptides were initially 
mapped by analyses of virus genomes and polypeptides
Figure 1.4. DNA SEQUENCE REQUIREMENTS FOR IE, E AND L 
PROMOTER ACTIVITY.
IE promoter regions contain a capsite, a TATA 
box, distal promoter elements, including GC- and GA- rich 
motifs, and a far-upstream element required for activation 
by the virion component, Vmw65, which includes the consensus 
sequence TAATGARATTC. E promoters include only the distal 
and proximal promoter sequences. Late promoters may include 
only a TATA box and capsite region on a replicating 
template. This figure was reproduced from Johnson and 
Everett (1986) with the kind permission of Dr. R.D. Everett.
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expressed by HSV-l/HSV-2 intertypic recombinants (Preston et 
al. , 1978). The locations of the genes for the IE
polypeptides were confirmed by RNA mapping and in vitro 
translation of IE mRNAs (Watson et al., 1979) as well as by 
hybridisation studies which, in addition, established the 
transcriptional orientation of the IE genes (Clements et 
al., 1979; Mackem and Roizman, 1980). Four of the IE genes
are associated with the repeat regions of the HSV genome, as 
illustrated in Figure 1.5. IE-1 and IE-3 are diploid due to 
their respective positions in the repeat regions flanking UJL
and Ug. The coding sequences of IE-4 and IE-5 lie at either 
end of Ug, but the promoter and regulatory regions of these 
genes are identical and are located in Rg . IE-1, IE-4 and 
IE-5 yield primary transcripts which are spliced (Watson et 
al., 1981; Rixon and Clements, 1982; Perry et al., 1986) in 
contrast to IE-2 and IE-3 (Rixon et al., 1982; Whitton et 
al., 1983).
Functional transcription regulatory domains of the IE 
genes have been defined by determining the levels of 
expression from an indicator gene linked to sequences from 
the 5' non-transcribed and non-translated leader portions of 
the viral IE genes. Such hybrid plasmids have been 
recombined into HSV thymidine kinase minus (TK ) genomes 
(Post et al., 1981), incorporated into eukaryotic cellular 
genomes (Post et al., 1981, 1982; Mackem and Roizman,
1982a,b,c; Kristie and Roizman, 1984; Mosca et al., 1985), 
microinjected into Xenopus oocytes (Cordingley et al., 
1983), or transfected into eukaryotic cells (Cordingley et 
al. , 1983; Lang et al., 1984; Preston et al., 1984; Preston 
and Tannahill, 1984; Kristie and Roizman, 1984). Indicator 
genes utilised, selected for the relative ease with which 
the gene products can be assayed as a measure of gene 
expression, include viral TK, chloramphenicol acetyl 
transferase and interferon. These investigations have 
demonstrated that the regions upstream of the IE mRNA cap 
sites can be dissected into at least 2 components, a 
promoter region and a far upstream region. The IE upstream 
promoter-regulatory components have been sequenced (Mackem 
and Roizman, 1982a,c; Murchie and McGeoch, 1982; Whitton et 
al., 1983; Whitton and Clements, 1984a) and multiple
Figure 1.5. GENOMIC LOCATIONS OF THE HSV-1 
IMMEDIATE EARLY TRANSCRIPTS.
The relative locations and transcriptional 
orientations of the IE mRNAs are shown. References for 
mapping data are as follows:
IE-1 - Perry et al. , 1986.
- Mackem and Roizman, 19 82c
- Rixon et al., 1982.
IE-2
IE-3
IE-4 and IE-5 - Rixon and Clements, 19 82
The spliced regions of the immediate early 
mRNAs are indicated.
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cis-acting elements have been identified which respond to a 
variety of cellular and trans-acting factors.
Promoter sequences present within 110 bases upstream 
of IE-3 and 69 bases upstream of IE-4/5 initiation sites, 
impart upon indicator genes the capacity to be expressed, 
but not to be regulated as an IE gene (Mackem and Roizman, 
1982a,c; Cordingley et al., 19 83). A TATA box is located 
20-30 bases upstream of the mRNA initiation site (Mackem and
Roizman, 1982c) analogous in position to the TATA homology
T T .(£ATAT£AAG) which is important in the efficiency and
positioning of transcriptional initiation and is present 5'
to many RNA polymerase II transcribed genes (Proudfoot,
19 79; Benoist et al., 1980; Benoist and Chambon, 1981). In
IE-3, for example, sequences -37 to -16, which are
non-essential for promoter function in Xenopus oocytes but
appear to be important for precise initiation of
transcription, include at -29 to -22 the sequence TATATGAG
(Cordingley et al., 1983).
The far upstream sequences of HSV-1 and HSV-2 IE 
genes, positioned between -331 and -110 in IE-3, impart upon
the indicator gene plus promoter sequences the capacity to 
be expressed at higher than the basal levels of expression 
produced by the promoter alone and the ability to be 
regulated as an IE gene (Post et al., 1981; Mackem and 
Roizman, 1982a,c; Cordingley et al., 1983); both effects act 
at the transcriptional level, in an orientation-independent 
manner and at distances of up to 1000 bases (Lang et al., 
1984; Preston and Tannahill, 1984). IE far upstream regions 
also contain elements which respond to negative regulation 
by IE polypeptide Vmwl75 as discussed below in the context 
of IE protein functions.
Positive regulation of IE gene expression is mediated 
in trans by a virion structural component, a conclusion 
based on observations that expression from IE 
promoter-regulatory regions, but not from E gene upstream 
regions, could be augmented by infection with an HSV mutant 
which could penetrate cells but was incapable of expressing 
IE genes (Post et al., 1981; Mackem and Roizman, 1982a; 
Batterson and Roizman, 1983; Batterson et al., 1983; 
Cordingley et al., 1983; Preston and Tannahill, 1984;
16
Kristie and Roizman, 1984). Identification of the gene
encoding the HSV-1 virion trans-inducing factor (TIP) was
achieved by analysis of TK activity in cells co-transfected
with TK genes linked to IE-3 promoter-regulatory regions
along with specific HSV sequences which together represented
the entire HSV genome (Campbell et al., 1984). The gene,
HSV-1 UL48, located in (J of the HSV genome, has been
Li
sequenced (Dalrymple et al., 19 85; Pellett et al., 19 85) and
encodes a phosphorylated protein of apparent M of 65,000
(by SDS-PAGE), identified by Campbell and coworkers (1984)
and termed Vmw6 5 (also known as VP16), which is a major
structural component of the virion tegument (Marsden et al.,
1978; Lemaster and Roizman, 1980) expressed late in the HSV
lytic cycle (Marsden et al., 1976; Hall et al., 1982). In
vitro mutagenesis studies have identified regions of Vmw65
which appear to be involved in trans-induction (Triezenberg
et al., 1988b; Ace et al., 1988) and which, incidentally,
are distinct from those regions of the protein essential for
virus assembly (Ace et al., 19 88). The importance of Vmw65
activity in the HSV lytic cycle has recently been
demonstrated by construction and analysis of an HSV-1 mutant
defective in Vmw65-mediated stimulation of IE gene
expression. The mutant was found to have a particle to pfu
ratio at least 100-fold higher than that of wtHSV-1 in baby
5hamster kidney cells and up to 10 -fold higher m  human 
foetal lung cells (Ace et al., 1989).
IE far-upstream regulatory domains contain at least 1 
and frequently multiple copies of an AT-rich element of 
consensus TAATGARATTC (R=purine) (Mackem and Roizman, 
1982a,c; Cordingley et al., 1983; Whitton and Clements, 
1984a; Preston et al., 1984; Kristie and Roizman, 1984; 
Figure 1.4.) which comprises at least part of a cis-site for 
the Vmw65-mediated induction of IE genes (Campbell et al., 
1984; Gaffney et al., 1985; Bzik and Preston, 1986).
Functional analyses of deletion mutations in IE far upstream 
regions suggest that a single TAATGARAT consensus signal 
located at position -115 to -106 (TAATGGAAT) in IE-3 can 
respond efficiently to Vmw65 induction (O'Hare and Hayward,
1987), yet, similar studies suggest a requirement for 
additional sequence elements in the IE far upstream regions
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to maximise Vmw65-mediated induction at a TAATGARATTC motif 
located at -265 to -256 (Preston et al., 1984; Kristie and 
Roizman, 1984; Bzik and Preston, 1986). Far upstream 
elements notable for enhancer-like activity (Mackem and 
Roizman, 1982a; Lang et al., 1984), distinct from homologues 
of the TAATGARATTC consensus, include multiple GC-rich and 
GA-rich elements (Figure 1.4.). The regulatory region of 
IE-3 contains six copies of the GC-rich sequence 5'GGGCGG3', 
which is a binding site for the eukaryotic cellular 
transcription factor Spl (Jones and Tjian, 1985; Briggs et 
al., 1986). Two of the Spl binding motifs are required for
basal levels of expression from the IE-3 regulatory region 
and others may be involved in facilitating the response to 
Vmw65 (Post et al., 1981; Jones et al., 1985; McKnight and 
Tjian, 1986; Triezenberg et al., 1988a; Dynan and Tjian, 
1983). The GA-rich elements, generally found in close 
proximity to at least one TAATGARATTC consensus, have been 
implicated in IE gene regulation (Kristie and Roizman, 1984) 
and shown to increase TAATGARATTC-mediated responsiveness to 
Vmw65 (Bzik and Preston, 1986; Triezenberg et al., 1988a).
Despite the sequence specificity of Vmw65 action, the 
protein has no substantial affinity either for DNA 
containing the TAATGARATTC motif or non-specifically for ds 
DNA (Marsden et al., 1987). Various studies have shown that 
Vmw65 forms a complex (IEC) with at least 2 cellular 
proteins and the TAATGARATTC domain (McKnight et al., 1987; 
Preston et al., 1988; O'Hare and Coding, 1988; Gerster and 
Roeder, 1988) and that formation of the complex correlates 
directly with Vmw65-mediated stimulation of IE gene 
expression (O'Hare and Goding, 1988; Ace et al., 1988). An 
affinity purified transcription factor OTF-1 not only binds 
to the TAATGARATTC domain, but is required in the formation 
of IEC (Gerster and Roeder, 1988). OTF-1, which is 
functionally equivalent to transcription factor NFIII, 
occurs in a wide variety of different cell types and is 
involved in the regulation of RNA polymerase II-transcribed 
genes, RNA polymerase III gene-specific transcription 
(Rosales et al., 1987; Sollner-Webb, 1988) and adenovirus 
DNA replication (Prujin et al., 1986). OTF-1 interacts with 
the conserved octamer sequence motif ATGCAAAT and stimulates
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in vitro transcription via such interaction (Fletcher et 
al., 1987; Scheidereit et al., 1987). A homologue of the
octamer motif overlaps the 5' end of many TAATGARATTC 
elements of IE genes (O'Hare and Goding, 1988; Prujin et 
al., 1986). Gerster and Roeder (1988) have recently reported 
that both the octamer sequence (ATGCTAAT) and the GATAT 
moiety of the IE-1 gene element ATGCTAATGATAT are required 
for the formation of IEC, and, Preston and coworkers (19 88) 
have demonstrated that the sequence TAATGAGAT is sufficient 
for complex formation. Complementation studies, in which 
purified OTF-1 was added to nuclear extracts depleted of 
endogenous OTF-1, showed that at least one cellular factor 
in addition to OTF-1 and Vmw65 is required for the efficient 
formation of IEC (Gerster and Roeder, 1988).
On the basis of these findings and on the evidence 
that Vmw65 possesses an acidic carboxy terminus (Dalrymple 
et al., 1985) required for activation of transcription from 
the IE-3 gene promoter (Triezenberg et al., 1988), Gerster 
and Roeder (1988) have proposed the possibility that the 
role of OTF-1 and the other cellular factor(s) involved is 
to position the activation domain of Vmw65 on the herpes IE 
promoters. Furthermore, these authors suggest that the 
requirement for the GARAT motif as well as the octamer 
element in IEC formation may ensure that only the viral IE 
and not all other cellular octamer-containing genes are 
responsive to trans-activation by Vmw65.
1.2.3.2. Properties and Functions of Immediate Early 
Gene Products
Since protein synthesis inhibitor treatment of 
HSV-1 infected cells at the time of infection results in 
transcription of a limited set of HSV genes (the IE genes) 
and the overproduction of IE mRNAs, but no E or L gene 
transcription, it was postulated that the IE mRNA 
translation products had important functions in the early 
stages of the viral lytic infection. The functions of the IE 
proteins have been investigated utilising mutant viruses 
with ts mutations, insertions or deletions in the IE genes 
and utilising cloned IE genes.
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Vmwl7 5
The IE-3 gene product, Vmwl75, is
post-translationally modified by phosphorylation and 
poly(ADP-ribosyl)ation, can exist in 3 forms distinguishable 
by differences in electrophoretic mobility, and accumulates 
in the nucleus (Pereira et al. , 1977; Preston and 
Notarianni, 1983). A mutant, tsK, has been isolated which 
contains a mutation in IE-3 such that the gene product 
possesses a ts lesion (Preston, 1979a; Preston, 1981). At 
the NPT Vmwl75 fails to be processed normally to the forms 
of lower electrophoretic mobility and migration to the 
nucleus is impaired. These properties, which are reversible 
upon downshift of tsK-infected cells (Preston, 1979b), are 
correlated with the production of a restricted polypeptide 
profile of tsK at the NPT in which only the IE polypeptides, 
including the aberrant Vmwl75, and Vmwl36 are produced 
(Marsden et al., 1976; Preston, 1979b). Functional Vmwl75 
is, therefore, essential for the transition from the IE to 
the E and L phases of transcription and, since temperature 
upshift of tsK-infected cells reverses the migration
characteristics and processing of Vmwl75 and arrests the
ar»dL
normal pattern of viral polypeptide^synthesis, the 
functional polypeptide is probably required for most of the 
viral lytic cycle and not just transiently (Preston, 1979b;
(^ lofcson and. ) .
Other mutants containing ts lesions in Vmwl75 (tjsD, tsT) 
possess phenotypes comparable to ^tsK at the NPT in that the 
RNA species produced are very similar (Watson and Clements,
1978), IE polypeptides are overproduced and Vmwl75 shows 
increased electrophoretic mobility and impaired migration to 
the nucleus. Polypeptides detected in _tsD and _tsT infected 
cells at the NPT include limited amounts of some non-IE gene 
products as well as the IE proteins (Preston, 1979b). An 
insertion mutant, in!411, has an 8bp oligonucleotide linker 
insertion in IE-3, which also creates an in-frame amber 
termination codon in the Vmwl75 coding sequences, and 
therefore does not produce IE polypeptide Vmwl75. i_nl411, as 
well as HSV mutants containing deletions in IE-3, are not 
viable under non-permissive conditions, fail to induce the 
synthesis of early and late proteins and to autoregulate
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immediate-early protein synthesis, and are therefore 
phenotypically similar to tsK (N.D. Stow and E.C. Stow, 
personal communication; Russell et al., 1987).
The essential role of Vmwl75 in promoter activation 
during the transition from IE to E and L gene expression has 
also been demonstrated in transfection experiments. 
Transcription from E gene (gD/TK) promoters was detected 
following infection with HSV-1; trans-activation of E gene 
promoters was not induced by HSV-1 infection in the presence 
of the protein synthesis inhibitor cycloheximide, or, by 
infection with tsK at the NPT (Everett, 1983; El Kareh et 
al., 1985). In short term transfection assays, in which
genes containing E regulatory regions were cotransfected 
into cells with plasmids containing IE genes, Vmwl75 was 
shown to be capable of E promoter trans-activation; the 
level of promoter activation varied according to the assay 
system used (Everett, 1984a, 1986; Quinlan and Knipe, 1985; 
O'Hare and Hayward, 1985a; Gelman and Silverstein, 1986). An 
enhanced level of transcription from E promoters was 
observed in the additional presence of VmwllO (DeLuca and 
Schaffer, 1985; Everett, 1986; O'Hare and Hayward, 1985a). 
The E gene sequence elements required for trans-activation 
by Vmwl75 are discussed in Section 1.2.3.3..
The role of Vtnwl75 in autoregulation or repression of 
IE genes has been studied by assay of the level of 
expression from genes under IE promoter control 
cotransfected into cells with plasmids expressing Vmwl75. It 
was shown that both constitutive and induced levels of 
transcription from the IE-3 promoter could be repressed by 
Vmwl75 (O'Hare and Hayward, 19 85b), and that, whereas low 
doses of Vmwl75 stimulated transcription from IE-1, IE-3 and 
IE-4/5 promoters, increasing doses of Vmwl75 resulted in 
reduction in transcription from these IE promoters (DeLuca 
and Schaffer, 1985; Gelman and Silverstein, 1986). 
Parenthetically, there is also evidence for an involvement 
of later gene products in autoregulation or repression of IE 
gene transcription (Dixon and Schaffer, 1980; Godowski and 
Knipe, 1986).
The various roles of Vmwl75, in the transactivation 
of E and L gene transcription, in autoregulation and in the
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repression of IE gene expression, could be mediated by the 
formation of specific Vmwl75-DNA complexes. Several 
investigators have reported that incubation of radiolabelled 
DNA with HSV-infected cell extracts (Kristie and Roizman, 
1986a,b; Muller, 1987) or partially purified preparations of 
Vftiwl75 (Beard et al. , 1986; Faber and Wilcox, 1986, 1988; 
Michael et al., 1988) can result in the formation of stable 
protein-DNA complexes that contain Vmwl75 and specific viral 
DNA sequences. Muller (1987) reported that Vmwl75 binds 
specifically to a sequence at the transcriptional start site 
of IE-3; complex formation between Vmwl75 and the start site 
sequence are not detected prior to 2h post-infection, which 
is around the time of repression of IE-3 transcription. A 
sequence in the same region of the IE-3 gene was previously 
reported to be involved in the response to autoregulation 
(O'Hare and Hayward, 1987). Therefore, formation of the 
complex is implicated in the autoregulation of IE genes 
(Muller, 1987). Vmwl75, resolved from other proteins by 
SDS-PAGE, transferred to nitrocellulose and renatured, was 
able to bind to specific DNA fragments (Michael et al., 
1988). This finding, together with results from recent 
investigations using DNA affinity chromatography to purify 
Vmwl75 and DNase protection analysis, demonstrated that 
Vmwl75 binds directly to specific DNA sequences in the 
absence of any other virus- or cellular-encoded proteins 
(Kattar-Cooley and Wilcox, 1989). The target sequences 
involved in the Vmwl75-DNA complex formation associated with 
autoregulation and repression of IE gene expression and with 
stimulation of E gene expression, include the hexanucleotide 
sequence 5'-ATCGTC-3' (Faber and Wilcox, 1986).
The regions of the Vmwl75 polypeptide important for 
the repression of the IE-3 promoter, and for transactivation 
of an HSV E gene promoter in synergy with HSV IE protein 
VmwllO, have been investigated by construction of small 
in-frame insertion and deletion mutants of a plasmid-borne 
copy of IE-3 and subsequent analysis of the activity of the 
resultant mutant polypeptides in transient transfection 
assays. Large stretches of the protein are apparently 
relatively unimportant for either function. The two regions 
most sensitive to disruption correlate to sequences
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conserved between Vmwl75 and VZV 140K, a transactivating 
protein of VZV with homology to HSV Vmwl75 (Paterson and 
Everett, 19 88).
Vmwl10
HSV-1 IE-1 gene product VmwllO is a predominantly 
nuclear, phosphorylated protein (Pereira et al., 1977; Hay 
and Hay, 1980; Ackermann et al., 1984). Virus mutants 
containing ts lesions in VmwllO have not been isolated. 
Variants of HSV-1 and HSV-2 have been isolated which contain 
only one copy of the IE-1 gene (Poffenberger et al. , 1983; 
Harland and Brown, 1985), and viruses containing deletions 
in TR and IR copies of the VmwllO gene have been
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constructed (Stow and Stow, 1986; Sacks and Schaffer, 1987). 
HSV-1 mutant d_11403 contains a 2000bp deletion in both 
copies of IE-1 and specifies a truncated form of the 
polypeptide consisting of the original N-terminal 105 amino 
acids followed by a reading frame not used by VmwllO. The 
IE-1 gene product is not absolutely essential for virus 
growth in tissue culture, since dll403 was able to replicate 
and produce plaques on BHK cells, but at low m.o.i. (for 
example, 0.01 pfu/cell) on BHK cells the effect of the 
deletion is a 20-100 fold reduction in virus yields compared 
to wt HSV-1; growth and plaquing efficiencies of dd.1403 are 
reduced even further on HFL cells. The effect is largely 
overcome at higher virus doses and viral polypeptide 
synthesis, DNA replication, DNA encapsidation and production 
of viral particles do not differ significantly in d!1403 or 
wt HSV-1 infected cells; as a result stocks of d!1403 
exhibit significantly higher particle to pfu ratios than wt 
HSV-1 stocks (Stow and Stow, 1986). Interestingly, the 
defect at low m.o.i. in HFL cells can be complemented by 
HCMV and VZV, as discussed in Section 4.4.5. (Stow and Stow, 
19 89 ) .
A positive role for VmwllO in E promoter activation 
has been demonstrated in transient expression assays; VmwllO 
was shown to be a potent trans-activator of IE, E and L 
classes of viral genes (Everett, 1984a; Mavromara-Nazos et 
al. , 1986; Quinlan and Knipe, 1985 ) and also to act
synergistically, in some systems, with Vmwl75 in the
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activation of a variety of viral promoters (DeLuca and 
Schaffer, 1985; Everett, 1986; O'Hare and Hayward, 1985a) 
and cellular promoters (Everett, 1984a; O'Hare and Hayward, 
1985a).
In transfection experiments, insertion or deletion 
mutant alleles of VmwllO expressed from plasmids were tested 
for the ability to activate genes under E (gD) promoter 
control. Several regions of the VmwllO polypeptide required 
for its ability to activate gene expression were defined 
(Everett, 1987b) and it was apparent that the relative 
importance of such regions was dependent upon the presence 
or absence of Vmwl75. A region crucial for VmwllO function 
in the absence of Vmwl75, in the second exon of IE-1, 
includes a potential zinc finger domain (Berg, 1986). A
region towards the carboxyl terminus was more important for
VmwllO function in the presence of Vmwl75.
Mutant HSV-1 viruses were constructed with insertion 
and deletion mutations in IE-1 and, growth and plaque 
formation of the mutants were examined, as well as their 
ability to activate a transfected HSV E (gD) gene promoter. 
The effect produced by mutations in VmwllO, which occurred 
at the level of gene expression, was a reduction in the 
efficiency of plaque formation by HSV-1, the extent of which 
was dependent upon the position of the mutation within the 
polypeptide, the multiplicity of infection and the cell 
type. Analysis of the mutant FXE, which is phenotypically 
similar to dll403, indicated that the region of VmwllO
affected by mutation in FXE is essential for VmwllO function
in plaque formation and in the ability to trans-activate a 
transfected HSV E promoter (Everett, 1989). In FXE, this 
region of the VmwllO polypeptide lacks 45 amino acids 
spanning the potential metal-binding domain which was 
previously shown, in transfection experiments, to be 
functionally important for trans-activation by VmwllO 
(Everett, 19 87b).
Interestingly, despite the ability of VmwllO alone to 
trans-activate E gene expression in transfection 
experiments, the protein appears to be incapable of 
fulfilling this function in a virus containing a ts lesion 
in Vmwl75 during infection at the NPT (Preston, 1979a,b).
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There is evidence for interference by the Vmwl75 ts mutant 
protein on the normal transport of VmwllO into the nucleus 
(Knipe and Smith, 1986), on VmwllO-induced activation of 
gene expression (Gelman and Silverstein, 1986) and for a 
trans-dominance of the tsK form of Vmwl75 over the wt 
protein (Gelman and Silverstein, 1986). However, since a 
virus with a deletion in IE-3 (dl20) which expresses a 
severely truncated Vmwl75 protein is also unable to grow in 
normal cell lines and exhibits an IE polypeptide profile 
(DeLuca et al., 1985), it seems that VmwllO by itself is
unable to stimulate E gene expression efficiently during HSV 
infection.
Vmw63
HSV-1 Vmw6 3, the gene product of IE-2, is a 
phosphoprotein and localises to the nucleus of infected 
cells (Wilcox et al., 1980; Knipe et al., 1987). Virus
mutants containing ts lesions in Vmw63 have been isolated; 
at the NPT, Vmwl75 and Vmw63 are overproduced, normal levels 
of E and some E/L proteins are synthesised and viral DNA is 
replicated, but production of "true1' L polypeptides is 
severely restricted (Sacks et al., 1985). Mutant viruses 
with deletions in IE-2 have been constructed which lack the 
transcriptional start site as well as portions of the 
promoter and coding sequences of the gene. Vmw63-specific 
transcripts and proteins were not specified, and the viruses 
were replication incompetent. The deletion mutant phenotypes 
were characterised by the synthesis of greatly reduced 
levels of viral DNA, overexpression of E proteins, reduced 
levels of E/L proteins and absence of "true" L proteins; 
alterations in viral protein synthesis appeared to occur at 
the level of transcription (McCarthy et al., 1989).
Analysis, by transient expression assay, of the 
capacity of Vmw63 to trans-activate transcription has 
yielded variable data. Although the results of several 
investigators suggest that Vmw63 alone does not possess 
significant trans-activation potential (Everett, 1984a; 
Mavromara-Nazos et al., 19 86), a recent report has
demonstrated trans-activation of transcription from an E 
gene promoter (gB) (Rice and Knipe, 1988). There is more
25
abundant evidence that Vmw6 3 has the capacity to repress the 
expression of viral genes (IE and E) (Gelman and 
Silverstein, 1987: Rice and Knipe, 1988; Sekulovich et al., 
1988), and to stimulate further the expression of genes 
under L promoter control (Everett, 1986; Sekulovich et al. , 
1988; Rice and Knipe, 1988), when the expression of these 
genes is induced by Vftiwl75 and VmwllO.
Taken together, these observations are consistent 
with the hypothesis that Vmw6 3 is not involved directly in 
viral DNA synthesis, but that the synthesis of reduced 
levels of viral DNA in the absence of Vmw63 is a consequence 
of the aberrant regulation of viral genes, the products of 
which are involved in DNA synthesis. It has therefore been 
suggested that Vmw63 has an essential function in the 
modulation of E and L gene transcription (McCarthy et al., 
19 89 ) .
Vmw6 8
The protein Vmw6 8 (the product of HSV-1 IE gene 4) is 
nuclear and phosphorylated (Pereira et al., 1977; Hay and 
Hay, 1980; Ackermann et al., 1984). A virus mutant has been 
constructed which contains a 500bp deletion in IE-4. The 
truncated IE-4 gene specifies a protein of M 30,000 which 
does not possess the carboxyl terminal one-third of the 
Vmw68 protein (Post and Roizman, 1981; Sears et al., 1985a). 
The growth properties of the IE-4 deletion mutant vary 
between different cell lines, a finding which led to the 
proposal that a host cell factor can substitute for the 
function of Vmw68 in some cell lines. It has been suggested 
that the reduction in viral growth observed in certain 
mutant-infected cell lines can be attributed to a lack of L 
viral gene products (Sears et al., 1985a).
Vmwl 2
In contrast to the other IE polypeptides, Vmwl2 is 
non-nuclear and unphosphorylated (Pereira et al., 1977; Hay 
and Hay, 1980; Marsden et al., 1982). It has been
demonstrated that IE-5 is not an essential gene for viral 
growth in tissue culture, since viable deletion mutants 
which lack the entire IE-5 gene have been isolated
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(Longnecker and Roizman, 1986; Umene, 1986; Brown and 
Harland, 19 87).
1. 2 . 3 . 3. Regulation of Early Gene Expression
Early gene expression, which reaches a maximum level 
at 4h to 6h post adsorption, requires prior synthesis of IE 
gene products (Honess and Roizman, 1974; Preston, 1979a,b);
E gene promoters respond to transactivation by Vmwl75 and 
VmwllO (Everett, 1984a; O'Hare and Hayward, 1985a; Gelman 
and Silverstein, 1985; Quinlan and Knipe, 1985; DeLuca and 
Schaffer, 19 85 ) .
Early gene promoter sequence requirements for the 
activation of transcription in trans by viral gene products 
have been analysed by determining the levels of expression 
from an indicator gene linked to mutagenised E promoter 
sequences (of the TK gene, (JL23, and of the gD gene, (JS6) 
and microinjected into Xenopus oocytes (McKnight et al., 
1981, 1982; Jones et al., 1985) or transfected into
eukaryotic cells (Everett, 1983, 1984b). Additionally, 
mutagenised E (TK gene) promoter sequences have been 
introduced into the HSV-1 genome and analysed for the 
ability to function as promoters (Coen et al., 1986). Such 
investigations have demonstrated that the E promoters of the 
TK and gD genes contain several functional regions, 
including a cap site, a TATA box, and upstream GA-rich 
elements and GC-rich (Spl-binding) regions; an inverted 
CCAAT motif is also present in the promoter of the TK gene 
(McKnight and Kingsbury, 1982; Everett, 1983, 1984b; 
Eisenberg et al., 1985; El Kareh et al., 1985; Coen et al.,
1986). The relative importance, in quantitative terms, of 
these regions in E gene expression was dependent upon the 
assay system utilised; in the virus, the upstream promoter 
region of the TK gene was functionally less important, 
whereas the TATA box and cap site regions are especially 
important for full activation of genes under the control of 
the TK and gD promoters (Coen et al., 1986; Everett, 1984b; 
Figure 1.4.). Results, from analysis of the activities of 
deletion and insertion mutants within the gD promoter region 
after induction during HSV-1 infection and in response to
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activation by linkage of the promoter sequences to the SV40 
enhancer, showed that mutations which resulted in a 
reduction of the response to trans-activation by viral gene 
products also resulted in a reduction of the response to 
cis-activation by the SV40 enhancer. Promoter sequence 
requirements in trans- and cis- activation of transcription 
are therefore equivalent (Everett, 1984b; Figure 1.4.). No 
domain in the E TK gene specifically responsive to 
trans-activation by viral gene products has been identified. 
These findings imply that IE gene products activate E gene 
transcription either by binding sequences recognised by 
cellular transcription factors or by altering the activity 
of cellular transcription factors (Eisenberg et al., 1985; 
Coen et al., 19 86). There is evidence to suggest an
important role for the TATA box in E gene expression in 
infected cells. Analysis of transcription from hybrid SV40 
promoters, in which the TATA box region of gD (responsive to 
trans-activation) was substituted for the TATA box element 
of SV40 (poorly responsive), demonstrated that the gD TATA 
box could confer, upon the SV40 promoter, the ability to be 
efficiently trans-activated by HSV gene products (Everett,
1988). Furthermore, the most severe effect on E gene 
transcription in infected cells was observed with mutations 
affecting the TATA box element of the promoter region (Coen 
et al., 19 86).
1.2.3.4. Regulation of Late Gene Expression
Late genes require HSV DNA replication for maximal 
expression; expression is first detected at 2h to 3h post 
adsorption (note that DNA synthesis is initiated 
approximately 2h post adsorption and reaches maximum levels 
at approximately 8h post adsorption) and the accumulation of 
L gene products reaches its maximum by lOh to 16h post 
adsorption (Munk and Sauer, 1964; Roizman, 1969). Although 
the requirement for Vmwl75 and VmwllO in true late gene 
expression is not clear, activation of a late promoter (L42) 
by cotransfection with IE genes has been detected in 
transient assay systems (DeLuca and Schaffer, 1985; 
Mavromara-Nazos et al., 1986).
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Promoter sequence requirements for L gene expression 
have been delineated in a transient assay system (Johnson 
and Everett, 1986b), in which "true" L gene (US11) promoter 
deletions were located on plasmids containing an HSV-1 
origin of replication (ori0 ), which enables replication of 
transfected plasmid DNA in the presence of infecting HSV 
(Johnson and Everett, 1986a; Stow and McMonagle, 1983), and 
activation of gene expression was determined. DNA promoter 
sequence elements required for fully efficient regulated 
expression of US11 lie within 31bp of the RNA cap site, and 
therefore consist only of a proximal TATA box and cap-site 
region (Johnson and Everett, 1986b; Figure 1.4.). The 
promoter sequences required for expression of the gC gene 
were demonstrated to be similar (Homa et al., 1986). The 
conversion of an E HSV gene (gD) into a L gene, in terms of 
its characteristics of expression, was achieved by removal 
of sequences 5 1 to its TATA box, thus confirming that a 
proximal TATA box is sufficient for L gene expression 
(Johnson and Everett, 1986b). The promoter sequences 
necessary for induction of L promoters by Vmwl75 and VmwllO 
are also contained within the 31bp region upstream of the 
RNA cap site (Johnson and Everett, 1986b).
1. 2 . 3 . 5. Herpes Simplex Virus - Encoded Polypeptides
The functions and properties of the HSV IE 
polypeptides are discussed in Section 1.2.3.2. Enzymes and 
proteins involved in DNA replication are encoded, primarily, 
by HSV E genes and are dealt with in Section 1.2.4. 
Interestingly, the E gene product DBP (major DNA binding 
protein) appears to have a role in the general repression of 
HSV gene transcription in the absence of viral DNA synthesis 
(Godowski and Knipe, 1983, 1986 ) as we.ll as a role in HSV 
DNA replication.
There are at least 30 different species of virion 
structural proteins, encoded primarily, but not exclusively, 
by the HSV L genes, including the HSV glycoproteins, capsid 
and tegument proteins. There are seven known HSV-1 
glycoproteins; gB (encoded by UL27), gC (UL44), gD ((JS6) 
(Spear, 1976), gE (US8) (Baucke and Spear, 1979), gG (US4),
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gH (UL22) (Marsden et al., 1978, 1984; Frame et al., 1986; 
McGeoch et al., 1987, 1988) and gI((JS7) (Longnecker et al., 
1987 ). Furthermore, (XO ORF in US possesse$the potential to 
encode a glycoprotein (McGeoch et al., 1985 ). There exist 
HSV-2 homologues to all the HSV-1 glycoproteins,
although gG-2 contains an insert of DNA 
which is absent from gG-1 (McGeoch, 1989). Mutant studies 
have shown that gB and gH are essential for growth in tissue 
culture (Little et al., 1981; Weller et al., 1983a;
Buckmaster et al., 1984; Gompels and Minson, 1986), but that 
several of the glycoproteins, including gC (Heine et al., 
1974) gE, gG, gl and US5 (Longnecker and Roizman, 1986; 
Longnecker et al., 1987; Harland and Brown, 1988) are
non-essential. Certain of the glycoproteins have roles in 
viral adsorption and penetration, as discussed in Section
1.2.1. The HSV capsid consists of at least 6 polypeptides, 
including the major capsid protein, of M 155,000 (ICP5, 
VP5), encoded by UL19 (Marsden et al., 1978; Morse et al., 
1978; McGeoch et al., 1988a); the polypeptide p40, encoded 
by UL46, is a component of empty capsids, and is discussed 
in Section 1.2.4. in the context of encapsidation (Addison, 
1986; Rixon et al., 1988). HSV tegument polypeptides are 
generally virion proteins not classified as capsid species 
or glycoproteins and are released by solubilisation of the 
virion with non-ionic detergent (Lemaster and Roizman, 1980; 
Roizman and Furlong, 1974; Spear, 1980). The IE 
transcriptional transactivator Vmw65 is a major constituent 
of the tegument (Marsden et al., 1978; Lemaster and Roizman, 
1980). Other constituents of the tegument include, the 
extremely large product of gene UL36, and proteins encoded 
by US9 and US10 (Batterson et al., 1983; Rixon and McGeoch, 
1984; Frame et al., 1986b).
1.2.4. Replication, Encapsidation and Assembly
Circularisation of linear HSV DNA molecules occurs
following entry into the cell nucleus (Jacob and Roizman, 
1977), perhaps via direct ligation of the termini (Davison 
and Wilkie, 1983b; Poffenberger and Roizman, 1985). DNA
replication results in the formation of large head to tail
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concatemers and therefore probably occurs by a rolling 
circle mechanism (Jacob et al., 1979; Jongeneel and
Bachenheimer, 1981). Electron microscopic analysis suggested 
that the HSV genome contained one or more specific sequences 
at which DNA replication initiated (Friedman et al., 1977). 
Characterisation of two classes of defective genomes has 
identified three origins of replication (Figure 1.1.) 
(Vlazny and Frenkel, 1981; Spaete and Frenkel, 1982), two of 
which (ori ; Class I defectives) are within IR and TRb O b
sequences, localised to the non-transcribed region between 
IE genes 3 and 4 (Stow and McMonagle, 1983), while the third 
(oriT ; Class II defectives) lies in (JT sequences between the
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DNA polymerase gene and the DBP gene (Weller et al., 1985;
Quinn and McGeoch, 1985; Lockshon and Galloway, 1986). HSV-1
orip contains an imperfect palindrome, each arm consisting
of 21bp, with a central A-T rich sequence which, along with
sequences outside the palindrome, is essential for ori
function (Stow and McMonagle, 1983; Stow, 1985). HSV-2
contains two copies of ori ,^ within almost identical 137bp
direct repeats (Whitton and Clements, 1984). A nuclear
protein from HSV-1 infected cells has been demonstrated to
bind directly to an 18bp region across one end of the
palindrome of ori^ DNA (Elias et al., 1986). HSV-1 orir
 O Li
contains a perfect palindrome with arms of 72bp and a
central AT-rich sequence with high homology to ori^ , and
HSV-2 ori contains a 136bp palindrome very similar in
Li
sequence to HSV-1 orir (Weller et al. , 1985; Quinn and
J_j
McGeoch, 1985; Lockshon and Galloway, 1986). The 
significance of the presence of three ori sites in the HSV 
genome is not known. Indeed, studies with mutant viruses 
have shown that deletion of oriT or one copy of ori0 has
Li b
little or no effect on viral replication in cultured cells 
(Longnecker and Roizman, 1986; Polvino-Bodnar et al., 1987). 
Furthermore, since ori0 and oriT share extensive sequenceO Li
homology, and since equivalent proteins are necessary for
orig- and ori^- dependent replication (see below), it is
likely that ori^ and orir are functionally equivalent. b --- Li
The induction of virus-specific replicative functions 
by HSV was inferred from the requirement of helper viruses 
to replicate defective genomes or plasmids containing an HSV
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origin of replication (Vlazny and Frenkel, 1981; Stow, 1982) 
and these functions have been analysed by characterisation 
of mutant viruses. Functions essential to HSV DNA 
replication include DNA polymerase (UL30) (Keir and Gold, 
1963; Chartrand et al., 1979, 1980), DBP (UL29) (Conley et 
al. , 1981; Weller et al., 1983 ), alkaline exonuclease (UL12) 
(Keir and Gold, 1963; Preston and Cordingley, 1982; Banks et 
al. , 1983; Moss, 1986) and ribonucleotide reductase (RR)
(UL39 and UL40) (Cohen, 1972; Dutia, 1983), while enzymes 
involved in DNA metabolism but non-essential for virus 
growth in tissue culture include dUTPase (UL50) (Wohlrab and 
Francke, 1980; Preston and Fisher, 1984), uracil-DNA 
glycosylase (UL2) (Mullaney et al., 1989) and TK (UL23) (Kit 
and Dubbs, 1963; Jamieson et al., 19740, although the latter 
may assume a more important role in non-dividing cells 
(Field and Wildy, 1978). TK and RR catalyse reactions in the 
biosynthesis of DNA precursors. The latter consists of two 
subunits, Vmwl36 and Vimw3 8, encoded by separate but 
contiguous genes (UL39, UL40) (Preston et al., 1984;
Bacchetti et al., 1984; Frame et al., 1985; McLauchlan and 
Clements, 1983). The HSV DNA polymerase, a protein of M
136.000 involved directly in viral DNA replication, differs 
from most eukaryotic polymerases by virtue of its 3' to 5 1 
exonuclease activity which may have a proof-reading effect 
(Powell and Purifoy, 1977; Purifoy and Powell, 1981; Knopf,
1979). It has been suggested that DBP, a protein of M
128.000 which has been shown to dissociate the strands of 
duplex DNA in vitro (Powell et al., 1981) acts in a 
replication complex with DNA polymerase and HSV exonuclease, 
since ts lesions in purified DBP impair the function of the 
two enzymes at the NPT (Littler et al., 1983). Additional 
proteins involved in HSV DNA synthesis include, possibly, 
DNA topoisomerase(s ) (Biswal et al., 1983; Muller et al., 
1985 ) and protein kinases encoded by US3 and UL.13, the 
latter mapped by virtue of its sequence homology to other 
known protein kinase genes (McGeoch and Davison, 1986).
It has been shown that five cloned restriction
fragments of HSV-1 DNA together can supply all of the
trans-acting functions essential for replication of plasmids
containing ori„ or orir when cotransfected into Vero cells 
S  -Li
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(Challberg, 1986). Based on these findings, a transient
complementation assay has been developed which, in
combination with sequencing data, has enabled the
identification of seven HSV genes which are both necessary
and sufficient for origin-dependent replication. Two of
these genes encode the viral DNA polymerase and DBP (Wu et
al. , 1988). The other five genes, designated UL5, UL8, LJL9 ,
UL42 and UL52, are predicted to encode proteins of M
99,000, 80,000, 94,000, 51,000 and 114,000 (McGeoch et al.,
1988b). The UL42 gene product has been identified as a
previously recognised DNA-binding factor found in extracts
of HSV-1 infected cells (Parris et al., 1988). Evidence has
recently been presented which indicates that the UL9 gene
product, of M 82,000, is an origin-binding protein (Olivo
et al., 1988). UL5 is a component of the DNA helicase found
in infected cells (Crute et al., 1988; McGeoch et al.,
1989 ). The products of genes (JL5, UL.8, UL9 and UL52 are
located in the nucleus, appear early after infection and are
expressed despite inhibition of viral DNA synthesis, which
is consistent with the idea that they are the products of
early genes (Olivo et al., 1989).
There is evidence to suggest that the HSV 'a'
sequence is involved in inversion of the L and S components
of the HSV-1 genome relative to each other (Section 1.1.4.),
and in cleavage and packaging of the viral genome. The 'a'
sequence of HSV-1 strain 17 has the format:
(DR1)(U )(DR2),o(U,)(DR1), where U and U, are unique a 18 b a b
sequences and DR1 and DR2 are direct repeats of 17 and 12bp, 
respectively (Davison and Wilkie, 1981). DR2 was proposed to 
be a cis-acting sequence for isomerisation, which occurs via 
intermolecular and intramolecular recombination (Mocarski et 
al, 1980; Mocarski and Roizman, 1982; Chou and Roizman,
1985), although, the HSV-2 'a' sequence does not possess DR2 
repeats (Davison and Wilkie, 1981) and isomerisation of the 
genome of some HSV-1 mutants lacking 'a1 sequences has been 
demonstrated (Pogue-Geile et al., 19 85; Longnecker and
Roizman, 1986). Cleavage of concatemeric DNA into unit 
length molecules occurs as a prerequisite to or concomittant 
with the packaging of DNA into capsids. A role for the 'a' 
sequence in cleavage and packaging of DNA was suggested by
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the finding that progeny of plasmid molecules which contain 
HSV ori^ (Stow, 1982) were encapsidated, in the presence of 
helper virus, only when an 'a' sequence was also located on 
the plasmid molecule (Stow et al., 1983). The 'a1 sequence 
at both the L and S termini of the HSV genome ends in a 
partial copy of the DR1 element, the complete sequence being 
recreated by ligation of L and S termini (Davison and 
Wilkie, 1981; Mocarski and Roizman, 1982). Varmuza and 
Smiley (19 85) proposed that the generation of termini was 
via 2 distinct cleavage events and that the mechanism of 
cleavage involved: introduction of ss nicks, possibly in Ub
and Uc, followed by strand repair synthesis, a model which 
could also account for doubling of 'a' sequences; or, the 
introduction of ds nicks in the 'a1 sequence, at L-S 
junctions positioned in the same orientation, and subsequent 
production of molecules with or without 'a' sequences, the 
latter being rapidly degraded. Ts mutants have been isolated 
which are defective in both cleavage and packaging events 
(_tsl204, tsl201) (Preston et al. , 1983; Addison, 1986).
A defect in the processing of a major structural (tegument) 
protein, p40 (Vmw40), a product of gene UL26 (Preston
et al., 1983; McGeoch et al., 1988a) to forms of lower
electrophoretic mobility, was observed in cells infected 
with tsl201 at the NPT; the unprocessed proteins became 
associated with empty capsids which accumulated in the cell 
nuclei in large numbers (Preston et al., 1983). A mutant 
ts!203, which makes but fails to package viral DNA at the 
NPT, also assembles partially cored capsids, but, in 
contrast to tsl201, t.sl203 processes p40 normally at the NPT 
(Matz et al., 1983). It has recently been shown that p40 is 
present in empty capsids, but is not a major component of 
full capsids or of mature virions. It has, therefore, been 
suggested that p40 becomes transiently associated with 
capsids at an early stage in their assembly and that its 
removal from capsids is linked with the process of packaging 
(Rixon et al., 1988). Nucleocapsids are enveloped at the
inner lammella of the nuclear membrane; only capsids 
containing an approximate genome equivalent of DNA are 
enveloped and transported to the cytoplasm as mature virions 
(Roizman and Furlong, 1974; Vlazny et al., 1982; Stow
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et al.,19 86).
The outcome of a lytic infection of HSV is the 
production of progeny HSV particles and lysis of the 
infected cell, and is, therefore, in contrast to that of 
a latent HSV infection, which will be discussed below.
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1.3. HERPES SIMPLEX VIRUS LATENT INFECTION
The capacity to establish a latent infection appears
to be a general property of herpesviruses. Latent viral 
infection occurs between episodes of acute disease and 
involves the persistence of virus within specific tissues 
such that infectious virus is undetectable and there are no 
overt signs of viral replication, cell damage or disease. 
The latent infections produced by HSV types 1 and 2, which 
will be considered together, and EBV are the most studied of
those produced by viruses of the Herpesviridae.
1.3.1. Herpes Simplex Virus Latency - Animal Model Systems
HSV establishes latent infections in both man and 
experimental animals. Following primary peripheral HSV 
infection, or inoculation, of skin, mucous membrane or eye, 
HSV travels through associated sensory nerves; there is 
evidence, from studies in mice and rabbit models, that 
travel from the site of infection to the primary site of 
latency in the peripheral nervous system occurs via 
retrograde axonal transport. The virus becomes established 
in a latent state in neuronal cells of the corresponding 
sensory ganglia or other nervous tissue. Reactivation from 
the latent state results in productive infection in 
previously latently infected neurons, the subsequent 
reappearance of infectious virus in the locality of the 
primary infection and asymptomatic shedding of infectious 
virus (recurrence) or the production of lesions 
(recrudescences) at the periphery (Goodpasture, 19 29; 
Stevens, 1975; Wildy et al., 1982; Blyth and Hill, 1984; 
Hill, 1985; Stanberry, 1986; Sugden, 1986; Roizman and 
Sears, 1987; Baichwal and Sugden, 1988).
The basic pattern of establishment of latent HSV 
infection is similar in various experimental animals. The 
mouse footpad model was the first latency system to be 
developed (Stevens and Cook, 1971, 1973a,b; Walz et al.,
19 74). HSV inoculation of a mouse rear footpad results in a 
local cutaneous infection and, following centripetal 
movement of virus through the peripheral and central nervous
Figure 1.6. SCHEMATIC REPRESENTATION OF HSV 
LATENCY IN VIVO.
A schematic representation of HSV latency in 
vivo, based on evidence from animal model latency systems 
and information from HSV latent infections of humans. 
Details of HSV latency are presented in Section 1.3..
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systems to the brain, an acute infection develops in the 
nervous system, the outcome of which may be temporary or 
permanent posterior paralysis and possibly death of the 
mouse; surviving mice which recover from paralysis within 3 
weeks are used for studies of latency. During the acute 
infection (1-10 days post inoculation) HSV can be recovered 
from sciatic nerve, sacrosciatic spinal ganglia, dorsal 
roots, spinal cord and brain. Thereafter, infectious HSV 
cannot be demonstrated in homogenates of nervous tissues. 
Explantation and cocultivation of the nervous tissues with 
indicator cell monolayers results in the reappearance of 
infectious HSV (Stevens and Cook, 1971), thereby 
demonstrating that HSV is harboured in a latent state in 
these tissues.
Latent HSV infection can be established in the 
lumbosacral dorsal root ganglia of guinea pigs subsequent to 
rear footpad or vaginal inoculation (Scriba, 1975, 1976). In 
mouse (Knotts et al. , 1974; Walz et al., 1974 ) and rabbit 
(Stevens et al., 1972) eye models, HSV resides in a latent 
state in the trigeminal ganglia after infection of the 
cornea via scarification or inoculation. Latent infections 
have also been established in the trigeminal ganglia and 
cervical dorsal root ganglia of mice following lip and ear 
inoculation, respectively (Walz et al., 1974; Hill et al. , 
1975 ) .
Reactivation of HSV and recurrence or recrudescence 
occurs spontaneously in some animal systems, including the 
rabbit eye model (Nesburn et al., 1977) and the mouse ear 
model (Hill et al., 1975), as well as the guinea pig model 
system for genital HSV infection (Scriba, 1976). 
Reactivation of HSV to produce an acute infection in the 
ganglia can be induced by neurectomy in certain systems 
(Walz et al., 1974; Price and Schmitz, 1978). Reactivation 
can also be induced in some systems by exposure of the 
exterior to various physical and chemical stimuli as 
described in Section 1.3.3.3., or exposure to systemic 
stimuli, which, in the mouse ear model for instance, result 
in the reappearance of infectious HSV in the skin of the ear 
and in the cervical dorsal root ganglia (Hill, 1985).
Animal model latency systems in which recurrence
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and/or recrudescence occurs spontaneously or can be induced 
have been useful in exploration of the mechanism(s) 
responsible for recurrent herpetic disease, whereas systems 
in which spontaneous recurrences are rare or not inducible 
have been used in the study of viral and host factors 
involved in establishment and maintenance of latent disease. 
In vitro cell culture latency systems have also been 
developed and utilised to elucidate the molecular nature of 
the latent HSV infection, as will be discussed in Section 
1.3.6. Ultimately, findings from in vivo and in vitro 
studies must be confirmed in humans wherever possible.
1.3.2. Establishment of Latency in Ganglia
1.3.2.1. Sites of Latency
The idea of a connection between production of 
herpetic lesions and the nervous system initially arose from 
clinical observations that lesions tended to recur in the 
same locality. Involvement of the sensory ganglia in 
development of herpetic lesions was suggested by the 
observations that there was a correlation between the sites 
of recrudescence and histological changes in the related 
ganglia (Goodpasture and Teague, 1923) and that destruction 
of trigeminal ganglia resulted in a corresponding inability 
to produce lesions (Cushing, 1905). In addition, various 
clinical and experimental observations led to the theory
that herpesvirus resides in a latent state in the cells of 
the sensory ganglia and other nervous tissues (Goodpasture, 
1929; Carton and Kilbourne, 1952; Carton, 1953; Paine,
1964) .
Direct evidence has come from experimentation in 
mouse, rabbit and guinea pig systems (Stevens and Cook,
1971; Walz et al., 1974; Stevens et al., 1972; Knotts et
al. , 1973; Baringer and Swoveland, 1974; Scriba, 1975, 1976) 
and, importantly, from human tissues (Plummer, 1973; Bastian 
et al., 1972; Baringer and Swoveland, 1973; Rodda et al.,
197 ^ )r's’inrce^C';?s described in Section 1.3.1., infectious HSV 
can be reactivated from sensory ganglia following 
explantation of the nervous tissues and organ culture in the
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presence of indicator monolayer cultures. The presence of 
HSV DNA has also been demonstrated in such tissues (Walz et 
al., 1976; Puga et al., 1978; Cabrera et al., 1980; Fraser
et al., 1981; Rock and Fraser, 1983; Kennedy et al., 1983;
Puga et al., 1984; Stroop et al., 1984). Depending on the 
site of primary infection, HSV can establish a latent 
infection in any type of nerve ganglion, including autonomic 
ganglia in mice (Price et al., 1975a) and humans (Warren et 
al., 1978). Furthermore, latent infection has been
demonstrated in the central nervous system of rabbits and 
mice (Plummer et al., 1970; Knotts et al., 1973; Cook and 
Stevens, 1976; Cabrera et al., 1980) by explant culture, and 
HSV DNA has been detected in human brain tissue (Sequiera et 
al., 19 79; Fraser, 19 81). Infectious HSV was recovered, by 
explantation and cocultivation, from brain tissue of 5% and 
from trigeminal ganglia of 9 5% of latently infected mice, 
although HSV DNA was detected in brain in 30% of the mice 
which harboured latent HSV in their trigeminal ganglia. 
There may, therefore, be a difference in the ability to 
reactivate HSV, by explantation and cocultivation, between 
the central and peripheral nervous systems (Cabrera et al., 
1980 ) .
Certain experimental findings have been put forward 
as evidence to suggest that latent HSV may be harboured in 
non-neural tissues. For instance, the phenomenon of shedding 
of infectious virus in the absence of clinical disease 
(recurrence) in body secretions of humans or rabbits 
(Kaufman, 1967; Douglas and Couch, 1970) or in peripheral 
tissues of mice (Hill et al., 1980), and, the detection of 
infectious HSV following explantation and cocultivation of 
tissues of the mouse vagina (Walz et al., 1977), ear (Hill 
et al., 1980) and footpad (Al-Saadi et al., 1983), of
clinically normal rabbit corneas (Cook et al., 1987) and of 
tissues of the guinea pig footpad (Scriba, 1977) and genital 
regions (Scriba, 1976, 1981; Scriba and Tatzber, 1981;
Stanberry et al., 1985b,c). As yet, there has been no
detection of HSV in homogenates or explant cultures of human 
peripheral tissues, such as skin from sites of frequent 
recurrent HSV infection (Findlay and MacCallum, 1940; 
Rustigian, et al., 1966), although herpes lesions have been
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observed in denervated areas of skin (Hoyt and Billison,
19 76) and herpes virus has been isolated from human corneal 
explants in culture (Shimeld et al., 1982; Tullo et al. , 
1985 ) .
In guinea pigs, spontaneous reactivation of HSV from 
latency often takes place with concurrent and almost 
continuous production of the disease at the periphery
(Scriba, 1977). HSV was detected in skin explants of guinea 
pig footpads which had been surgically manipulated to 
destroy the nerve supply to, and thus prevent establishment 
of latent infection in, corresponding ganglia; a low
incidence of spontaneous recurrent disease was also
demonstrated (Scriba, 1981). However, Scriba (1981) found 
that phosphonoacetic acid (PAA) or acycloguanosine (ACG) 
eliminated HSV infection in peripheral tissue but did not 
eliminate the ability of latent HSV to reactivate in ganglia 
following explantation, and suggested that HSV exists in a 
productive state in the peripheral tissues of guinea pigs, 
as opposed to a latent state.
In a recent study by Bernstein and Kappes (1988), the 
addition of a demethylating agent, hexamethylenebisacetamide 
(HMBA), to explant cultures of latently infected guinea pig 
dorsal root ganglia, genital skin and uterine cervix 
increased the recovery of HSV. It was suggested that, since 
HMBA had no effect on HSV replication in vitro, it probably 
induced reactivation via demethylation in both neural and 
non-neural tissues and, therefore, that persistent infection 
in the non-neural tissues was probably equivalent to the 
latent infection of dorsal root ganglia and not a low level 
chronic productive infection that would have been unaffected 
by demethylation (Bernstein and Kappes, 1988).
It has been postulated by Hill and coworkers that the 
presence of HSV in the skin of latently infected mice 
exhibiting no clinical disease could reflect the presence of 
microfoci of infection from an input of virus from the 
primary site of latency (sensory ganglia) rather than a 
latent infection of the skin from which virus had 
reactivated (Hill et al., 1980). In mice latently infected 
in the cervical ganglia the initial site of inoculation (ear 
skin) was denervated (cervical nerve section) and then the
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denervated ears were stripped with cellophane tape to induce 
recurrent disease; infectious virus was isolated from the 
skin very rarely and recurrent disease was not seen (Hill et 
al. , 1983 ), implying that recurrent disease in the mouse
requires an intact nerve supply to the skin. Hill and 
coworkers (19 83) suggested that in these experiments the 
virus isolated had originated from minor nerve supplies to 
the pinna from the trigeminal or jugular ganglia, or was 
present in the skin before nerve section, and reflected 
chronic viral multiplication in an environment made 
susceptible by the process of enervation or by incomplete 
enervation, rather than a latent infection of the peripheral 
tissues.
Clements and Subak-Sharpe (19 88) and Al-Saadi et al. 
(1988) have recently presented compelling evidence that HSV 
can establish latent infection in non-neuronal cells as well 
as neuronal cells. Infectious HSV can be recovered from 
explant cultures of the footpad (site of inoculation) and/or 
the sensory ganglia of mice latently infected with 
differents strains or ts mutants of HSV-1 and HSV-2 
(Al-Saadi et al., 1983; Clements and Subak-Sharpe, 1983;
Subak-Sharpe et al., 1984a,b; Al-Saadi, 1984). Recovery of 
virus from the footpad following explantation and 
cocultivation was not prevented by treatment of infected 
mice with acycloguanosine (ACG, an inhibitor of HSV which 
can eradicate persistent but not latent infections), or by 
section of the nerves of the inoculated leg, or by nerve 
section and ACG treatment combined (Clements and 
Subak-Sharpe, 1988; Al-Saadi et al., 1988). It was concluded 
that, since nucleated neuronal cell bodies are absent from 
the footpad, latent HSV can reside in cells other than 
neurons. Furthermore, viral RNA has been detected in a 
sub-population of epithelial cells of the explanted footpad 
by in situ hybridisation analysis using HSV-specific probes. 
The footpad cell types in which HSV can establish latency 
have been identified as the basal cells and root sheath 
cells of hair follicles, as well as epithelial cells of the 
sebaceous glands and cells within the epidermis (Clements 
and Jamieson, 1989).
Therefore, although it is clear that the predominant
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site of latency of HSV in humans and in experimental animal 
model systems is the dorsal root ganglion, HSV latency has 
also been demonstrated in non-neuronal tissues in the mouse, 
an observation which may or may not be relevant to HSV 
latency in humans.
1. 3 . 2.2 . Nerve Tissue Cells Harbouring Latent HSV
Electron microscopic studies have demonstrated that, 
during the acute phase of HSV infection in the nervous 
system of mice, Schwann, satellite and other supporting 
cells are infected abortively or are resistant to HSV 
infection (Dillard et al., 1972; Stevens and Cook, 1973a; 
Cook and Stevens, 1973; Knotts et al., 1974). The majority 
of evidence suggests that latent HSV resides in the neuronal 
cell body. Indirect support for this hypothesis comes from 
the observations that in mice and rabbits HSV can be 
reactivated (by explantation) from ganglia, which contain 
neuronal cell bodies, but not from nerve roots, which do 
not, both tissues otherwise containing equivalent cell types 
(Baringer and Swoveland, 1973; Cook et al., 1974). 
Immunofluorescence and electron microscopy studies on 
latently infected ganglia implanted in millipore chambers 
and transplanted into syngeneic mice have shown that virus 
antigen and virus particles were first detected in neuronal 
cells; thymidine incorporation into virus DNA also commenced 
in neurons rather than satellite cells. Kennedy and 
associates (1983) also detected HSV antigens initially in 
neurons, identified by antineuronal monoclonal antibody, as 
opposed to satellite cells, of dissociated cultures from 
latently infected mouse ganglia. In situ hybridisation 
analyses showed that viral DNA could be detected in the 
nuclei of neurons prior to detection in satellite cells of 
ganglia from mice (Cook et al., 1974) and rabbits (zur 
Hausen and Schulte-Holthausen, 1975) and that viral mRNA 
could be detected first in the neurons of human ganglia 
(Galloway et al., 1979). In the studies of McLennan and
Darby (1980), ts mutants of HSV-1 were used to latently 
infect mice (which have a core temperature of 3 8.5°C, the 
restrictive temperature for mutant growth) and were
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reactivated by peripheral nerve section in vivo or by 
explantation at the restrictive temperature in vitro; since 
the spread of reactivated virus from the site of activation 
was not possible and detection of viral antigens was limited 
to neuronal cells, it was concluded that latent HSV must 
reside in the neuronal cells. An HSV transcript has recently 
been detected in latently infected ganglia, in the absence 
of acute infection, which is localised to the nuclei of 
neuronal cells (Stevens et al., 1987; Section I.3.4.2.).
1. 3 . 2 . 3 . Factors Affecting Establishment of Latency
HSV growth in peripheral infection is normally of 
limited duration and can be affected by genetic attributes 
of the virus, the route of infection, host resistance to HSV 
infection and immunological mechanisms which remove virus 
from the peripheral site and terminate the acute infection 
(Nash and Wildy, 1983). The extent of productive infection 
at the periphery influences the amount of virus available to 
enter the nerve endings and probably, thereby, the incidence 
of latent infection in neuronal cells. The incidence of 
latent infection is usually greater after symptomatic virus 
disease (Harbour et al., 19 81), appears to be related to the 
severity of the peripheral infection (Tullo et al., 1982) 
and is therefore influenced by the immune status of the host 
(Walz et al., 1976; Tullo et al., 1982). Suppression of
virus multiplication at the mouse periphery, by application 
of phosphonoacetic acid at the site of inoculation, has been 
shown to correlate with a drop of virus titre in the 
corresponding ganglia (Klein and Destefano, 1981). However, 
there is evidence that there is no prerequisite for viral 
replication in the establishment of a latent infection in 
the ganglia. Treatment of mice pre- and post- primary 
inoculation with anti-HSV antiserum, to the extent that 
virus was never isolated from skin or ganglia, did not 
prevent the establishment of latency (Sekizawa, 1980), 
although it is possible that in these studies virus 
replication was not entirely suppressed.
The incidence of infectious HSV in the ganglia of 
animal model latency systems tends to follow a set pattern;
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for instance, in the mouse footpad model of Stevens and Cook 
(1971) infectious virus can be isolated from sensory ganglia 
for up to about 10 days post-inoculation (Cook and Stevens, 
1973), suggesting that a productive infection may occur in 
the ganglia, but is not demonstrable thereafter. The immune 
status of the host influences the virus titre but does not 
eliminate the acute phase of the ganglionic infection 
(Openshaw, et al., 1979; Kino et al., 1982). There have been 
some reports that, following the period of productive 
infection of the ganglia, there is a background incidence of 
isolation of infectious virus, estimated at 1% (Blyth and 
Hill, 1984), at 10% (Stevens et al., 1975) and at 20% (after 
6 months, in this instance reduced from 80% at 1 month) 
(Schwartz et al., 1978). Electron microscopy studies have 
also demonstrated the presence of virions in a low 
percentage of neurons in latently infected rabbit trigeminal 
ganglia (Baringer and Swoveland, 1974), although this may 
reflect the presence of reactivated virus since spontaneous 
reactivation occurs frequently in the rabbit.
The production of infectious virus in nerve tissue is 
likely to affect the number of neurons harbouring latent 
HSV. Even so, since ts DNA-negative mutants of HSV can cause 
latent infection in ganglia and brains of mice, albeit at 
reduced levels (Lofgren et al., 1977; McLennan and Darby, 
1980; Watson et al., 1980; Al-Saadi et al., 1983), and on 
the assumption that the DNA phenotype of the mutants was 
fully restricted, it would appear that productive viral 
infection of nervous tissues is not essential for latency to 
occur.
In conclusion, the factors affecting establishment of 
latency are complex. The extent of latent infection appears 
to be influenced by the level of viral replication, both at 
the periphery and in the ganglia, which may be controlled by 
various immunological and other factors (Walz et al., 1976; 
Openshaw et al., 1979; Kino et al., 1982; Tullo et al.,
1982; Kapoor et al., 1982). However, it has not been
possible to determine absolutely whether or not viral 
replication at the periphery or in the ganglia is essential 
for the establishment of latency.
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1.3.3. Factors Affecting Maintenance of Latency,
Reactivation and Recurrence/Recrudescence
1.3 . 3 .1. The Physiological State of the Neuronal Cell
An important factor in maintenance of latent HSV 
infection in neuronal cells is the physiological state of 
the neuron as it relates to permissiveness to HSV 
replication (Price and Schmitz, 1978). The neuron is a fully 
differentiated cell with specialised functions; in the rat, 
some 30,000 genes are expressed exclusively in brain tissue 
and there is evidence to suggest that control of 
neuronal-specific gene expression is via specific identifier 
sequences (Sutcliffe et al., 1984) and/or via alternative 
RNA processing (Rosenfeld et al., 1984). The neuronal cell 
is long-lived and non-dividing. Therefore, cellular DNA 
synthesis occurs only as a consequence of DNA repair 
mechanisms (Sanes and Okun, 1972; Ishiwaka et al., 1978) and 
large areas of the genome remain untranscribed. The 
relatively quiescent state of the neuronal genome, in terms 
of DNA replication and transcription, might permit the virus 
to reside in a similarly inactive state.
HSV reactivation can be induced upon cutting or 
damage of nerves or nerve root, as occurs, for instance, 
during explantation of nervous tissues. The mechanism(s) by 
which explantation of latently infected tissue induces 
reactivation probably involves an alteration in the 
physiological state of the neuron, perhaps due to an effect 
of changes in the levels of components in the extra- and 
intra- cellular environments, such as immunological factors 
(Section 1.3.3.2.) and nerve growth factors (Section 1.3.5.) 
or, alternatively, via an effect of cellular repair 
processes, which result in increased transcription, protein 
synthesis and DNA synthesis and which are activated by nerve 
section (Watson, 1974; Grafstein, 1975; Hill, 1984). Neurons 
in the central nervous system have a relatively reduced 
ability to regrow and repair nerve processes (Grafstein,
19 75), so that if reactivation does involve increased gene 
expression and DNA synthesis via cellular repair mechanisms, 
this might account for the finding that reactivation is a
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less frequent event in the central nervous system than in 
the peripheral nervous system, as mentioned in Section
1.3.2.1. (Hill, 1984).
1.3.3.2. Immunological Influences
Maintenance of HSV in a latent state in neuronal 
cells in vivo might be due to an active effect of a host 
factor(s), possibly a component of the immune system, rather 
than the physiological state of the neuron per se. A role 
for immunological mechanisms in the maintenance of HSV in a 
latent state has therefore been examined (Nash, 1981; Wildy 
et al., 1982; Wildy and Gell, 1985; Stanberry, 1986).
Experiments in which latently infected ganglia in 
millipore chambers were transplanted into the peritoneal 
cavities of immune and non-immune mice, removed after 4 days 
and assayed for the presence of HSV antigens and HSV DNA, 
suggested that antibody (anti-herpes IgG) was important in 
the maintenance of latent HSV infection, because the ganglia 
from immune mice developed only small discrete foci compared 
to the extensive areas of virus replication in ganglia from 
non-immune mice (Stevens and Cook, 19 74). However, as the 
initial transplantation of ganglia could have reactivated 
HSV, it is likely that the results reflect the effect of 
antibody on the spread of reactivated virus rather than the 
effect on maintenance of latency. Two pieces of data make it 
unlikely that neutralising antibody plays a major role in 
maintenance: in humans there is no correlation between the
level of neutralising antibodies and the frequency of 
recurrent disease, and pre-existing antibody to HSV-1 does 
not prevent recurrence of HSV-2 genital disease (Corey et 
al., 1980; Reeves et al., 1981); in mice, inoculated in the 
lip or cornea with HSV-1 then passively immunised with 
anti-HSV-1 antibody, a latent infection developed in the 
trigeminal ganglia which was maintained even after clearance 
of antibody from the circulation (Sekizawa et al., 1980).
Suppression of cell-mediated immunity in latently 
infected immunocompetent mice, by treatment with 
cyclophosphamide and/or X-irradiation, resulted in 
reactivation of HSV in up to 7 0% of animals even in the
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presence of high concentrations of neutralising antibody, 
suggesting a possible involvement of cell-mediated immunity 
in maintenance of latency, although it is also possible that 
the treatments per se reactivate HSV (Openshaw et al., 1979; 
Sekizawa et al., 1980). In guinea pigs it has been found
that animals that do not have recrudescences appear to be 
immunologically competent, while those that have 
recrudescences have impaired cell-mediated immunity to 
herpes (Donnenberg et al., 1980). It has also been reported 
that humans undergoing recrudescence of HSV skin lesions 
have impaired cell-mediated immunity, which manifests itself 
in a failure of T lymphocytes to produce macrophage 
inhibition factor specifically in response to herpes 
antigens (Shillitoe et al., 1977). Furthermore, interferon 
production, or associated immune events, appears to protect 
against recurrences of herpes labialis (Cunningham and 
Merigan, 19 83). However, these experiments do not 
distinguish between the factors that maintain the latent HSV 
infection in the neuron and factors that are involved in the 
control of events following reactivation until production of 
herpetic lesions.
1. 3 . 3 .3 . Reactivation and Recurrence/Recrudescence
In humans, reactivation can be induced by a variety 
of stimuli including exposure to ultraviolet light, fever, 
stress and hormonal changes (Stevens, 1980; Wildy, 1982; 
Hill, 1985), and, in animals reactivation can be induced by 
exposure of the periphery to various physical and chemical 
stimuli, as discussed below.
Three main theories have been proposed by Hill and 
Blyth (1976; Hill, 1985), from their investigation of the 
mouse ear model of latency, to explain the ability of 
external stimuli to induce reactivation of virus from an 
internal site and to account for events leading to the 
presence of infectious HSV and/or the production of 
recrudescent lesions at the periphery. In the "skin trigger" 
theory, a peripheral stimulus produces local alterations in 
the tissues, leading to increased susceptibility of the 
tissue to HSV infection and/or depression of local defence
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mechanisms. As a result, microfoci of HSV infection already 
present at the periphery (either as a latent infection or 
derived from reactivation of latent infection in the 
ganglia) grow and produce a clinical lesion. The "ganglion 
and skin trigger" theory proposes that, following a 
peripheral stimulus, reactivation of the latent infection in 
the ganglion results in the production of infectious virus, 
and that this virus, or subviral particles, proceeds along 
the associated nerves to the periphery. Local alterations 
from a peripheral stimulus, as described, enable the 
incoming virus to replicate in epidermal cells and produce a 
clinical lesion. The "ganglion trigger" theory suggests that 
peripheral stimuli can reactivate HSV from the ganglia to 
produce shedding of infectious virus but no recurrent 
disease at the periphery unless, either, a sufficient amount
of virus is produced so as to overwhelm the peripheral
defence mechanisms, or, the host has a defective immune 
response. There is evidence that the "ganglion and skin 
trigger" theory provides the most accurate account of 
induced recurrent HSV disease. It has also been suggested 
that HSV reactivation in the ganglion is a constant
occurrence, although the infection does not always produce a 
herpetic lesion (Hill and Blyth, 1976; Hill, 1985). Since 
productive HSV infection destroys host cells and since there 
is no evidence for a decrease in the number of cells 
harboring latent HSV with increasing recurrences, it has 
been suggested that, whenever a recurrent lesion occurs, HSV 
produced travels up the peripheral nerve and latently 
infects more neurons, the so-called "round trip" hypothesis 
(Klein, 19 76).
In the mouse model, peripheral stimuli (skin
triggers) which lead to the reappearance of infectious HSV
in the skin of the ear and in the cervical dorsal root 
ganglia include exposure of the peripheral site of 
inoculation to (JV light (Blyth et al. , 1976), repeated 
applications of cellophane tape (Hill et al., 1983) or 
chemicals such as dimethylsulphoxide (DMSO) or xylene 
(Harbour et al., 19 83). There is some evidence for an effect 
on local immune responses and/or the susceptibility of skin 
cells to infection with HSV in response to such peripheral
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stimuli, which might involve depletion of Langerhans cells 
(macrophage-like cells) in the epidermis and the production 
of prostaglandins (hormone-like substances produced locally 
in tissues) (Sprecher and Becker, 1988; Hill, 1985).
Inj ection of prostaglandin also induces infectious virus 
in the skin (Blyth et al., 1976).
Reactivation in the ganglion presumably results from 
the disruption of the processes which maintain HSV in a 
latent state. To resolve the molecular mechanisms involved 
in both maintenance of latency and reactivation, it is 
essential to examine the action of the stimuli which trigger 
reactivation in the ganglion.
Reactivation can be induced experimentally by several 
techniques including dissection of the nerve root associated 
with the latently infected ganglion (Walz et al., 1974; 
Price and Schmitz, 1978) and explantation of latently 
infected ganglia or other nervous tissue (Stevens et al., 
1971). The possible effects of nerve damage on the 
physiological state of neurons have been outlined (Section
I.3.3.I.). Reactivation from explanted latently infected 
ganglia can be enhanced by cocultivation of intact or 
dissociated ganglia on permissive cell monolayers (Stevens 
et al., 1972; Knotts et al., 1973; Wohlenberg et al., 1979; 
Harbour et al., 19 81), by intertypic superinfection (Thomas 
et al., 1985) of ganglia or by exposure of ganglia to
demethylating agents (Bernstein and Kappes, 1988; 
Stephanopoulos et al., 1988).
Methylation of cytosine bases in DNA is associated 
with transcriptional inactivity. DMSO, which can cause 
hypomethylation of cellular DNA (Christman et al., 1977), 
has been shown to induce reactivation of HSV in ganglia 
(Hill et al. , 1983; Harbour et al. , 1983); 5-azacytidine, 
which functions to prevent methylation of DNA and therefore 
is effective in replicating cells, and HMBA, a demethylation 
agent, both induce reactivation of latent HSV from explants 
of neural and non-neural tissues (Bernstein and Kappes, 
1988; Stephanopolous et al., 1988). Since only a very small 
region of the HSV genome (LAT) is transcribed during latent 
infection (Stevens et al., 1986; Section I.3.4.2.), one 
possibility is that HSV is maintained in a latent state in
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neurons by extensive methylation; exposure of latently 
infected cells to demethylating agents might cause 
activation of HSV gene expression directly or indirectly by 
conversion of the host cell to a permissive state for HSV 
replication via cellular gene activation. Latent EBV is 
heavily methylated (Kintner and Sugden, 1981; Diala and 
Hoffman, 1983; Saemundson et al., 1984); 5-azacytidine has 
been shown to induce the EBV lytic cycle in latently 
. EBV-infected cell lines (Ben-Sasson and Klein, 1981) and 
activation of the lytic cycle of EBV by known inducers of 
differentiation has been associated with an active DNA 
demethylation mechanism (Szyf et al., 1985). There is also 
evidence for extensive methylation of the HSV genome in an 
in vitro latency system utilising human lymphoblastoid cells 
of T-cell origin (Youssoufian et al., 1982; Section 1.3.6.), 
of the herpes saimiri genome integrated into the genome of 
lymphoid tumour cells (Desrosiers et al., 1979), as well as 
of an inactive TK gene in mouse cells transformed by HSV, 
which could be activated by treatment with 5-azacytidine 
(Clough et al., 1982). Nonetheless, Dressier et al. (1987) 
have reported that latent HSV-1 is not extensively 
methylated in vivo.
An interesting observation has been the retrieval of 
HSV genetic information from latently infected ganglia, both 
in vitro (Brown et al., 1979; Lewis et al., 1984) and in 
vivo (Thomas et al., 19 85), by heterotypic HSV
superinfection. Previous observations had suggested that 
ganglia colonised with one strain of herpes were resistant 
to establishment following superinfection by another strain. 
However, the results of Thomas et al. (19 85) suggest that it 
is possible to superinfect a latently infected ganglionic 
neuronal cell with a heterotypic HSV strain and that the 
superinfecting virus acts in trans to induce reactivation of 
the latent HSV. Superinfection experiments might aid in a 
resolution of the events involved in reactivation.
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1.3.4. The Molecular Biology of HSV Latency
1.3.4.1. The Latent HSV Genome
Several groups have reported the detection of HSV or 
HSV DNA sequences in neurological tissue from latently 
infected animals (Stevens and Cook, 1971; Stevens et al., 
1972; Knotts et al., 1973; Walz et al., 1976; Puga et al., 
1978; Brown et al., 1979; Cabrera et al., 1980; Fraser et 
al., 1981; Puga et al., 1984; Rock and Fraser, 1983; Kennedy 
et al., 1983; Stroop et al., 1984). From the results of
infectious centre assays, performed on cells from 
dissociated dorsal root ganglia of mice acutely (6 to 8 days 
post inoculation) or latently (6 weeks to 15 months post 
inoculation) infected with HSV, it was estimated that 
infectious virus could be recovered from 1.0% of the cells 
from the acute phase and 0.1% of the cells from the latent 
phase (Walz et al., 19 76). As the neuron is accepted to be 
the site of latent HSV (Cook et al., 1974; McLennan and 
Darby, 1980) and the dorsal root ganglion contains 5% to 10% 
neurons, approximately 2% of the neuronal cells harboured 
latent HSV which could be reactivated (Walz et al., 1976). 
In a similar study, Kennedy and coworkers (19 83) deduced 
that, in mice latently infected with HSV, 0.4% of neuronal 
cells from dissociated dorsal root ganglia harboured a 
latent HSV genome with reactivation potential. Obviously, 
sequences representing the entire HSV genome must reside in 
at least this proportion of latently infected neurons. 
Southern hybridisation studies using cloned HSV DNA 
fragments as probes have demonstrated that DNA sequences 
from all regions of the genome are detectable in latently 
infected tissue from mice and humans (Rock and Fraser, 1983; 
Fraser et al., 1981; Efstathiou et al., 1986), as a 
consequence of which, defective genomes are unlikely to play 
a major role in HSV latency.
Levels of viral-specific DNA have been measured, in
trigeminal ganglia of mice during the acute and latent
stages of infection, by analysis of the reassociation
12 5kinetics of a trace of high specific activity I-labelled 
virus DNA mixed in liquid phase with a vast excess of
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ganglionic D NA. D N A  was detected at 1.2 to 2.0 genome
equivalents per cell during the acute stage and at
approximately 0.1 genome equivalents per cell during the 
latent stage (Puga et al., 1978). Southern hybridisation 
analyses have produced estimates, for the mean number of 
latent HSV genomes in mice ganglion, of 0.015 to 0.15 (Rock 
and Fraser, 1983) and of 0.78 (Efstathiou et al., 1986) 
copies per cell genome equivalent. Latent HSV D N A  has also
been detected in the mouse central nervous system (Rock and
Fraser, 1983; Stroop et al., 1984; Efstathiou et al., 1986), 
at mean concentrations of 0.26 copies per cell for brainstem 
tissue and 0.19 copies per cell for spinal cord tissue, and 
in human trigeminal ganglia, at 0.01 to 0.1 viral genomic 
copies per cell genome equivalent (Efstathiou et al., 1986). 
Since 5-10% of cells in mice ganglia are neuronal (Walz et 
al., 19 76) and assuming that only 0.4-2% of neurons harbour 
latent HSV, each latently infected cell could contain up to 
3900 copies of the latent genome. This may be an 
overestimate because evaluation of the percentage of neurons 
which harbour latent HSV was based on the amount of virus 
reactivated following explantation and cocultivation of 
ganglia, while it is possible that HSV resides in some
neurons in a latent state from which it may not be induced
to reactivate by this procedure, such as has been 
demonstrated in brain tissues of mice (Cabrera et al., 1980) 
and in ganglia of humans (Brown et al., 19 79). Recent in
situ hybridisation analysis studies have revealed that a
latency associated transcript (Section 1.3.4.2.) is present 
in 3% of neurons from the trigeminal ganglia of rabbits 
latently infected with HSV-1 (Rock et al., 1987a). The 
significance of the copy number per cell of latent HSV will 
be considered in Section 5.0..
Analysis of the physical structure of HSV DNA from 
mouse and human neurological tissues may provide useful 
information concerning the molecular mechanisms involved in 
HSV latency. Latent HSV genomes could exist as unit length, 
linear molecules, characteristic of virion DNA, or in an 
alternative state (Figure 1.7.). Circularisation or 
concatemerisation of the genome results in the loss of the 
terminal restriction endonuclease fragments and the
Figure 1.7. SCHEMATIC REPRESENTATION OF POSSIBLE PHYSICAL 
STATES OF THE LATENT HSV GENOME
Virion DNA is unit length and linear, whereas 
latent HSV DNA is endless, contains bimolar joint fragments 
and may therefore be circular, concatemeric, concatemeric 
and integrated into the cellular genome, or unit length, 
linear and integrated into the cellular genome via regions 
of the viral genome other than the termini (Rock and Fraser, 
1983; Rock and Fraser, 1985; Efstathiou et al., 1985).
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consequent production of an additional joint fragment, such 
that the molar ratio of joint to unique sequences tends to 
2:1. This characteristic has been exploited in analysis of 
the latent state of the genome; cloned radiolabelled DNA 
fragments representing the joint and terminal regions of HSV 
have been used to probe DNA from latently infected tissue in 
Southern hybridisation analyses.
In a report by Puga et al. (1984), novel-sized DNA 
fragments, hybridising to an HSV terminal fragment probe, 
were detected in DNA, from trigeminal ganglia of latently 
infected mice, enriched for viral DNA by reverse phase 
chromatography. The finding led these workers to conclude 
that structural changes, such as may result from extensive 
gene rearrangement or integration into a limited number of 
sites in the cellular genome via the terminal regions, had 
occurred in the genome concomitantly with the establishment 
of latency.
However, in contrast to these findings, Rock and 
Fraser (1983, 1985), also in an analysis of DNA from
trigeminal ganglia and brains of latently infected mice, 
demonstrated a lack of terminal fragments of HSV DNA in the 
latently infected tissues, despite the presence of HSV 
sequences from other regions of the genome (Rock and Fraser, 
1983). Virion joint fragments were shown to be present at an 
approximately 2:1 molar ratio with respect to unique 
sequences of HSV (Rock and Fraser, 1985). It was therefore 
proposed that the majority of HSV DNA which resides in 
latently infected cells exists in an "endless" state and was 
not unit length and linear, extensively rearranged or 
integrated into the cellular genome via the terminal 
f ragments.
Efstathiou et al. (1986) confirmed the presence of 
HSV DNA in an "endless" configuration in DNA from the 
trigeminal ganglia, brainstems and spinal cords of latently 
infected mice, showed that the viral DNA was maintained in a 
stable form in these tissues over a 4 month period and, 
further, demonstrated that HSV DNA from human trigeminal 
ganglia was also harboured in an "endless" state. All 4 
isomeric forms of the HSV genome were present in tissues 
from both latently infected mice and humans (Efstathiou et
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al., 1986). It is possible, therefore, that the novel
fragments detected by Puga et al. (1984) were entirely 
cellular, since there are homologies between cellular DNA 
sequences and HSV DNA sequences (Peden et al., 1982; Puga et 
al., 1982), and it may be either that the procedure used had 
enriched for specific cellular DNA sequences, or that latent 
HSV infection had caused amplification of certain cellular 
DNA sequences which were then enriched for by the technique 
employed.
The presence of "endless" molecules of HSV in 
latently infected cells could be indicative of 
circularisation or concatemerisation of the genome or of 
integration of the genome into the cellular chromosome 
either as a concatemer or via regions of the genome other 
than the termini (Figure 1.7.). In an attempt to distinguish 
between possibilities, Mellerick et al. (1987) examined the
HSV-1 genome in both acutely and latently infected mice by 
caesium chloride buoyant density centrifugation. It was 
found that most HSV-1 specific DNA from latently infected 
mouse brains banded at the buoyant density of virion DNA. A 
small fraction banded at the density of the mouse
chromosomal DNA, although the amount of hybridisation of 
this fraction to an HSV-1 specific probe did not 
significantly exceed that which arose due to the
cross-hybridisation of HSV-1 and uninfected mice brain DNA. 
No latent HSV-1 banded as extrachromosomal DNA following 
re-centrifugation of the chromosomal DNA fraction in caesium 
chloride, suggesting that the latent HSV-1 DNA is not an 
extended replicating intermediate but rather a compact form 
that resists trapping. Mellerick et al. (1987) therefore
concluded that the majority of the latent HSV DNA exists in
an extrachromosomal state in the mouse model, probably in a 
circular episomal form, although this has yet to be 
confirmed.
The majority of HSV DNA in a productive infection 
would bo likely to be replicated and linear, and indeed, it 
has been shown that HSV-1 DNA in acutely infected brain 
tissue is in the linear configuration characteristic of 
virion DNA (Rock and Fraser, 1983). Therefore, the majority 
of HSV DNA in the brain and trigeminal ganglia of latently
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infected animals and humans is unlikely to be participating 
in a productive infection, since the evidence suggests that 
latent HSV DNA is "endless".
1.3.4.2. HSV Gene Expression in Latently Infected Cells
A competent viral genome can reside in a latent state 
within a cell which is potentially capable of allowing it to 
multiply only if viral or host cell factors are present 
which function to establish and/or maintain the latent 
state. The theory that HSV has developed functions involved 
in latency is based on the argument that it is advantageous 
for HSV to reside in a latent state from which spontaneous 
reactivation may occur because latent HSV, in its protective 
site in cells of the nervous system, can avoid immune 
elimination and thereby provide a significant reservoir for 
production of the herpetic lesions which are involved in 
dissemination of the virus in the human population.
There have been 2 main approaches to the 
determination of which, if any, HSV genes are involved in 
latency; investigation of the HSV genes essential for 
establishment, maintenance and/or reactivation, and an 
investigation of the HSV genes expressed by the latent viral 
genome.
The former approach initially centred upon a study of 
the ability of various ts HSV mutants to establish and 
maintain a latent state in the nervous system of the mouse, 
the core temperature of which (38.5°C) is restrictive for 
these mutants. Studies utilised the available HSV-1 and 
HSV-2 ts mutants and the mouse latency model system (Lofgren 
et al., 1977; Watson et al., 1980; Al-Saadi et al., 1983);
mutant virus detectable following explant and cocultivation 
of appropriate tissues at the permissive temperature for 
mutant growth was judged to have established latency. Two 
classes of mutants were identified, those which established 
latency efficiently, and those which did not. Since HSV-1 
and HSV-2 mutants both capable and incapable of DNA 
synthesis at the restrictive temperature could establish a 
latent infection by these criteria, viral DNA synthesis was 
proposed to be irrelevant to the establishment of latency. A
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loose correlation between paucity of virus-specific 
morphological products at the restrictive temperature and 
latent infections was apparent; also, there was no obvious 
clustering of genes apparently associated with latent 
infection (Watson et al. , 1980; Al-Saadi et al., 1983). 
Watson and associates (19 80) proposed that the expression of 
Vmwl75 is a prerequisite for establishment of the latent 
state, on the basis that an HSV-1 mutant, tsK, in which a ts 
mutation involves the gene encoding IE V)mwl75, was unable to 
establish a latent infection in mice by their criteria. The 
mutant tsl, which produces most HSV polypeptides and
synthesises DNA at the NPT, was also apparently unable to 
establish a latent infection, which suggested that
additional viral genes, produced late in infection, could be 
involved in establishment. In subsequent studies, a
revertant of tsl, RI-1, which produces wt yields of virus at 
38.5°C (the NPT for _tsl) , was tested for its ability to 
establish a latent state in lumbosacral ganglia of mice
following footpad inoculation; RI-1 was able to establish a 
latent state in the ganglia but appeared to be ts for 
reactivation by explantation and cocultivation. This finding 
suggests that _tsl contains multiple ts mutations, one of 
which might effect a gene required for reactivation, but 
does not indicate whether or not tsl possesses a mutation in 
a gene essential for the establishment of latency (Cook et 
al., 1986). Complexities in the interpretation of data from 
such studies are discussed in Section 4.3.6.; the subsequent 
availability of insertion and deletion mutants of HSV 
provided better material for latency studies in animals. The 
ability of a deletion or insertion mutant of HSV to 
establish a latent state in a mouse or rabbit experimental 
model system following peripheral inoculation would suggest 
that there was no absolute requirement in latency for the 
function(s) affected by the mutation. Preliminary studies 
with a TK- mutant, selected by growth in
arabinofuranosylthymine (ara-T) which inhibits replication 
of TK+ HSV, had suggested a requirement for TK in efficient 
establishment, although a role for other possible defects in 
the TK mutants could not be excluded (Tenser et al., 1979). 
However, it has recently been demonstrated, utilising a
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well-characterised TK- mutant, HSV-l(F) 305, with a 700bp 
deletion in the TK gene (Post et al., 1981), that the viral 
TK gene is not essential for establishment of latency; 
interestingly, this TK- mutant was able to establish a 
latent infection in rabbits but was unable to establish 
latency in mice (Meignier et al., 1988). Experiments 
utilising insertion and deletion mutants of HSV have shown 
that genes for IE vmwllO (Clements and Stow, 19 89), IE Vmwl2 
(Meignier et al., 1988), IE Vmw68, TK (Sears et al.,
1985a,b; Meignier et al., 1988), glycoproteins G and E, a. 
viral protein kinase (Meignier et al., 1988) and also the 
oriL region of the HSV genome (Polvino-Bodnar et al., 1987) 
are not essential for establishment (or reactivation) of 
latency.
In attempts to define HSV genes expressed by the 
latent viral genome, various techniques have been employed 
including hybridisation procedures for the detection of HSV 
RNA and immunological procedures for the detection of HSV 
proteins.
In the liquid-phase hybridisation studies of Puga and 
coworkers (1978), in which HSV-specific RNA was measured in 
murine trigeminal ganglia during the acute and latent stages 
of infection, virus-specific RNA was found at the acute 
stage but not during the latent stage of infection. However, 
due to the relatively low level of sensitivity of this 
method, limited transcription of the latent genome could 
have occurred and escaped detection (Puga et al., 1978). 
Indeed, there have since been various reports of viral gene 
expression during HSV latency.
HSV polypeptides were detected in latently infected 
trigeminal ganglia of rabbits by indirect immunofluorescence 
using antisera to HSV-1, and specifically the IE polypeptide 
Vmwl75 was detected using monospecific antisera to Vmwl75 
(Green et al., 1981). In subsequent studies, no Vmwl75
protein was detected in the trigeminal ganglia of mice using 
antisera to Vmwl75 and the avidin-biotin complex 
immunoperoxidase method (Pepose et al., 1986), and, 
furthermore, no Vmwl75 mRNA was detected, using in situ 
hybridisation analysis with cloned radioactively labelled 
fragments, in the trigeminal ganglia of rabbits (Rock et
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al., 1987a). It is, however, possible that Vmwl75 is
produced during establishment of latency in neurons of the 
rabbit trigeminal ganglia and persists in these cells, 
although spontaneous reactivation cannot be ruled out as an 
explanation for the detection of Vmwl75 in latently infected 
trigeminal ganglia of rabbits.
Despite a report that enzymatically active 
HSV-specific TK could be detected in sensory ganglia of 
latently infected mice (Yamamoto et al., 1977), it has been 
shown, as previously mentioned, that the early HSV-1 gene TK 
is not essential for establishment of a latent infection 
(Sears et al., 1985b; Meignier et al., 1988) and,
furthermore, that TK mRNA is undetectable in latently 
infected mouse, rabbit or human ganglia by in situ 
hybridisation analysis (Stevens et al., 1987; Puga and 
Notkins, 1987; Deatly et al., 1987; Rock et al., 1987a; 
Steiner et al., 1988).
In situ hybridisation studies using cloned fragments 
representing the HSV genome have, however, demonstrated that 
HSV-2 specific RNA is present in latently infected human 
paravertebral ganglia removed from humans at autopsy 
(Galloway et al., 1979; 1982) and in latently infected
trigeminal ganglia of guinea pigs (Tenser et al., 1982). 
HSV-1 specific RNA has been detected in the trigeminal 
ganglia and olfactory systems of mice (Stroop et al., 1984; 
Stevens et al., 1987; Deatly et al., 1987; Puga and Notkins,
1987) and in human trigeminal ganglia (Steiner et al.,
1988) during HSV-1 latent infection.
A recent major development has been the discovery, 
initially by Stevens and associates (1987) using in situ 
hybridisation with probes from defined regions of the 
genome, that the viral-specific RNA detectable in the 
sensory ganglia of latently infected mice, rabbits and 
humans hybridises to the R, region of the HSV-1 genome whichLi
encodes the IE polypeptide VmwllO (Stevens et al., 1987; 
Puga and Notkins, 1987; Deatly et al., 1987, 1988; Rock et 
al., 1987a; Steiner et al., 1988). Surprisingly, the RNA is 
transcribed from the strand opposite from that encoding 
VmwllO (Stevens et al., 1987; Rock et al., 1987a; Figure
1.8.). This RNA, known as the latency-associated
Figure 1.8. THE GENOMIC LOCATION OF THE
LATENCY-ASSOCIATED TRANSCRIPT
The location of LAT (Section 1.3.4.2.) in the IR
Li
region of the HSV genome is shown relative to the position
of VmwllO mRNA. Spliced regions are shown as raised
sections; all copies of LAT are spliced. The exact
position of the 3' end of LAT is not known. Numbering of
nucleotides begins at the IR junction 'a' sequence (Perry
Li
et al., 19 86) .
This figure was kindly provided by R. Harris.
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transcript(s ) (LAT), was localised to the neuronal nucleus 
and was present in relatively high abundance (Stevens et 
al., 1987; Deatly et al., 1987, 1988; Rock et al., 1987a;
Steiner et al., 1988).
There are at least 1 and possibly 2 LATs; an abundant 
major LAT detected in approximately 3% of the neurons from 
latently infected rabbit trigeminal ganglia which hybridises 
to the HSV-1 BamHI B restriction fragment and a less 
abundant LAT present in less than 0.3% of the neurons which 
hybridises to the HSV-1 BamHI K fragment (Rock et al., 
1987a). At least 2 latency-related RNA bands, of 1.8 to 
2.3kb and of 1.2 to 1.5kb, have been identified by Northern 
blot analysis of RNA from latently infected trigeminal 
ganglia. These RNAs map within the HSV-1 BamHI restriction 
fragment B and partially overlap the 3' terminus of IE-1 on 
the opposite DNA strand (Spivack and Fraser, 1987). The 
1.8-2.3kb RNA has also been detected at low levels in HSV-1 
infected cultured cells and in trigeminal ganglia of mice 
during the acute phase of infection, in contrast to the 
1.2-1.5kb RNA which is not detectable in HSV-1 infected 
cultured cells and which is only found in mice during the 
latent phase of infection (Spivack and Fraser, 19 87; Spivack 
and Fraser, 1988a). Studies of Spivack and Fraser (1988a) 
suggested that the 1.8-2.3kb RNA was not regulated as an IE 
gene in cultured cells, since protein synthesis inhibition 
was shown to prevent the expression of the LAT gene, but 
this conclusion was not supported by the studies of Wagner 
et al. (1988b) in which expression of the LAT gene occurred
despite protein synthesis inhibition. Furthermore, during 
latent infection the LATs appear to be expressed in the 
absence of detectable levels of IE gene expression (Stevens 
et al., 1987; Rock et al., 1987a; Spivack and Fraser, 1987) 
suggesting that the LATs are transcribed as IE transcripts. 
The genomic location of the abundant 1.8-2.3kb RNA has been 
determined by Northern blot hybridisation using 
radioactively-labelled subclones of the BamHI B fragment 
and, more accurately, by SI nuclease and primer extension 
analyses. The 5' end is located approximately 1210 
nucleotides downstream from the 3' end of IE-1, while the 3 1 
end, which cannot be determined precisely as there are no
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polyadenylation sites close to the mapped end, overlaps IE-1 
by approximately 1000 nucleotides, (Wagner et al. , 1988; 
Wechsler et al., 1988). Recent fine mapping studies indicate 
that the 1.8-2.3kb and 1.2-1.5kb RNAs appear to share their 
5' and 3 ’ ends and that they are produced by alternative 
splicing (Wechsler et al., 1988; Wagner et al., 1988; Figure
1.8.); splicing to produce the 1.2-1.5kb RNA appears to be 
specific to latently infected neurons (Spivack and Fraser, 
1988a; Wagner et al., 1988). The LAT detected by in situ 
hybridisation with the HSV-1 BamHI K restriction fragment, 
located to the right of the BamHI B restriction fragment, is 
physically separated from the BamHI B associated 
transcripts; this transcript maps to the 5' end of IE VmwllO 
and might represent an additional minor exon resulting from 
splicing in the 3 1 region of the major LAT to within BamHI-K 
(Wechsler et al., 1988), but it is present in such small
amounts that its size has not yet been determined by 
Northern blot analysis (Rock et al., 1987a).
The sequences of the major LAT are known for HSV-1 
strains 17 and KOS, the homology between which is high 
(Perry and McGeoch, 1988; Wagner et al., 1988a). The main 
features of the major LAT sequence are as follows. 
Interestingly, there is an RNA polymerase III B element 
homology (Galli et al., 1981) at the cap site, although 
there is no A element 5' to this region (Wagner et al., 
1988a). The sequence 5' to the cap site was proposed by 
Wagner and associates (19 88a) to have some features of an 
RNA polymerase II promoter, including a weak TATA box 
homology approximately 25 bases 5 ! of the cap site and 2 
elements of poor homology to CCAAT boxes (CAGTA and CACT). 
However, computer analysis of the sequence upstream of the 
cap site of LAT in HSV-1 17 syn+ (Perry and McGeoch, 1988) 
suggested that the first potential TATA box was as far away 
as position -686 (note that the predicted 5' end of the 
major LAT TCCAGGTAG is designated position 1, Wechsler et 
al., 19 88), that the first likely CCAAT box began at
position -817 and that three GC boxes (Spl-binding sites) 
were located starting at positions -886/ -862 and -589. A 
second potential promoter region, including a TATA box 
beginning at position +827 and upstream accompanying GC rich
60
regions, was located just upstream of the longest potential 
open reading frame in the LAT gene. Potential splicing sites 
were located at positions predicted by hybridisation data 
(Wechsler et al., 1988; Wagner et al., 1988b). There are no 
consensus polyadenylation signals in close proximity to the 
3' end of LAT (Perry and McGeoch, 1988; Wagner et al., 
1988a; Wechsler et al., 1988), a finding which correlates 
well with the results of Wagner et al. (1988a) who showed
that the majority of the 1.8-2.3kb RNA is present in the 
poly (A) fraction of RNA from latently infected cells. 
However, Wagner et al. (1988a) also reported that a small
amount of the 1.2-1.5kb RNA species detected by Northern 
blot hybridisation can be eluted in the poly (A)+ fraction. 
Although there are open reading frames (ORFs) of significant 
size within the genomic sequence, the codon contents of 
these ORFs are not characteristic of other parts of the HSV 
genome, and it has therefore been suggested that LAT is 
unlikely to encode a protein (Perry and McGeoch, 1988). 
Furthermore, analysis of latently infected cells using 
antipeptide antisera raised against predicted sequences of 
the LAT ORF has not resulted in the detection of a protein 
product from this region of the genome (E. Wagner, quoted at 
the 1988 Herpesvirus Workshop, Los Angeles, USA).
Several roles have been proposed for the major LAT 
gene in HSV latency (Stevens et al., 1987). An attractive 
possibility is for LAT gene expression to produce an effect 
on the expression or processing of the mRNA encoding VmwllO, 
since the LAT gene overlaps the IE-1 gene and because there 
is evidence that VmwllO is involved in the regulation of HSV 
gene expression, absence of which might, therefore, result 
in the establishment of a latent state (Section 5.0.). LAT 
RNA might be involved in antisense suppression of VmwllO 
production by 3 1 or 5 1 complementarity (Green et al., 1986; 
Kim et al., 19 85) or as a trans-acting factor in the
regulation of expression from IE-1 or other HSV genes. In 
favour of the involvement of LAT RNA are its localisation to 
the nuclei of cells from latently infected ganglia, as shown 
ky in situ hybridisation analyses (Stevens et al., 1987; 
Rock et al., 1987a; Deatly et al., 1987, 1988; Steiner et 
al., 1988), and the apparent absence, in studies using
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antipeptide antisera, of a protein product in latently 
infected cells. However, as previously mentioned, there are 
putative open reading frames within the LAT gene nucleotide 
sequence (Perry and McGeoch, 1988; Wagner et al., 1988a) and 
therefore, if there is synthesis, at low levels, of LAT gene 
product(s), such protein(s) might be involved in latency in 
some regulatory capacity influencing the expression of HSV 
genes. A further possibility, suggested by Rock and 
coworkers (1987), is that transcription of the LAT gene 
might have a cis-acting effect on sequences in its 
proximity, perhaps preventing the transcription of IE-1 or 
other HSV genes.
It is worth noting that a similar transcript has been 
detected in the neuronal cells of rabbit trigeminal ganglia 
latently infected with bovine herpesvirus (BHV-1) which maps 
to a region of the BHV-1 genome encoding a major IE gene, 
indicating the possibility of a role for such transcripts in 
both HSV and BHV-1 latency. Even so, there is no evidence 
for a high degree of sequence conservation between the LAT 
RNAs, as probes containing the HSV-1 and BHV-1 LAT genes 
failed to cross-hybridise (Rock et al., 1987b).
Interestingly, a 1400bp sequence without an assigned 
function exists in the genome of VZV at a position 
corresponding to the LAT region of HSV-1 (Davison and Scott, 
1986; Perry and McGeoch, 1988).
Work is currently underway to determine the 
importance of the LAT gene in HSV latency. Recent studies in 
which HSV mutants, apparently incapable of expressing LAT, 
have been tested for the ability to establish a latent 
infection imply that LAT is not essential for HSV latency 
(Wagner et al., 1988a; Steiner et al., 1989).
1.3.5. The Molecular Biology of EBV Latency
Lymphocytes latently infected with EBV in vitro or in 
vivo proliferate indefinitely in tissue culture, retain the 
complete EBV genome in episomal form and express a limited 
set of the approximately 80 to 9 0 genes encoded by the EBV 
genome (Dambaugh et al., 19 86). Some latently infected
lymphocytes become permissive for EBV replication at low
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frequency, while certain EBV infected cell lines, such as 
Namalwa (an African BL cell line) and IB4 (a cell line 
established by infection and growth transformation of normal 
human foetal lymphocytes with EBV B9 5-8), are almost or 
completely non-permissive for productive infection (Klein 
and Dombos, 1973; King et al., 1980) and are therefore used 
for analysis of viral genes involved in latency. EBV, in 
immortalised B cells Raji (a Burkitt's lymphoma non-producer 
cell line) and B95-8 (a producer cell line isolated from 
marmoset lymphocytes transformed with EBV B95-8 DNA), has 
been induced to enter the lytic cycle by treatment with 
various chemicals, by superinfection with EBV, or by 
transfection of specific EBV DNA fragments into latently 
infected cells. Activation of the latent genome results in 
the production of over 50 mRNAs (King et al., 1981; Hummel 
and Kieff, 1982); polyadenylated RNAs expressed during 
latent infection are not detected in productively infected 
cells (Hummel and Kieff, 1982). Specific transcripts, from 
regions of the EBV genome including BamHI M, BamHI Z and 
BamHI R (Figure 1.9.), are classified as IE RNAs since they 
can be produced in the absence of protein synthesis (Sample 
et al., 1984; Biggin, M., Dyson, P.J. and Farrell, P.J.,
Herpesvirus Workshop, Ann Arbor, Michigan, 19 85). In B9 5-8 
infected cells induced to permissive infection with TPA, 
Hummel and Kieff (1982) identified a persistent early class 
of RNAs and a late class of RNAs, the abundances of which 
were relatively resistant or sensitive, respectively, to 
viral DNA synthesis inhibition. Genes have been identified 
which code for transcription trans-activators, proteins 
involved in replication of the EBV genome and glycoproteins 
(McGeoch, 19 89). An origin of replication (oriLyt), composed 
of elements of 321bp and 374bp separated by a 263bp 
non-essential region and containing multiple repeats, has 
been identified, which functions in lytic infection (FigureS
1.9.). EBV replicated during the lytic phase is in 
concatemeric configuration (Hammerschmidt and Sugden, 1988). 
The onset of the lytic cycle leads irreversibly to cell 
death.
Figure 1.9. GENOMIC LOCATIONS OF IMMEDIATE EARLY 
TRANSCRIPTS OF EPSTEIN-BARR VIRUS
Part of the MIR and the U regions of the EBVJLi
genome (see also Figures 1.1. and 1.10.) with the locations 
of EBV IE RNAs BZLF1, BRLF1, BMLF1 and BMRF1 and an oriLyt 
sequence are shown.
Abbreviations are as follows:
YR1 - BamHI Y rightward reading frame 1
MR1 (M R 2 ) - BamHI M rightward reading frame (BMRF) 1 (2)
ML1 - BamHI M leftward reading frame (BMLF) 1
ER1 (ER2,ER3) - BamHI E rightward reading frame 1 (2,3)
ZL1 (ZL2) - BamHI Z leftward reading frame (BZLF1) 1 (2)
RL1 - BamHI R leftward reading frame (BRLF1) 1
RR2 (RR3) - BamHI R rightward reading frame 2 (3)
KR1 - BamHI K rightward reading frame 1
oriLyt - origin of DNA replication during lytic cycle
at direct repeat left (D )Li
MIR - major internal repeat consisting of direct
3072bp repeats (open box regions)
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1.3.5.1. The Latent EBV Genome
Latently infected immortalised lymphocytes usually 
contain more than one copy of the complete EBV genome (zur 
Hausen et al., 1970; Nonoyama and Pagano, 1971, 1973; Kawai 
et al., 1973). Nearly all of the human B-type, lymphoid cell 
lines established in continuous culture maintain a 
characteristic number of latent EBV genomes, for example, 
the Raji cell line contains 50 to 60 copies of EBV per cell 
(Nonoyama and Pagano, 1973; Pritchett et al., 1976). In 
virions EBV DNA is linear, whereas the bulk of EBV DNA in 
most latently infected cell lines is in the form of 
covalently closed circular episomes (Nonoyama and Pagano, 
1972; Tanaka and Nonoyama, 1974; Lindahl et al., 1976; 
Kaschka-Dierich et al., 1977), formed by covalent linkage 
between the terminal repeat (TR) sequences of the genome 
(Dambaugh et al., 1980). EBV DNA in latently infected cells 
is thought to be replicated by cellular DNA polymerase 
(Summers and Klein, 1976; Colby et al., 1980). The DNA 
multiplies in tandem with the replication of the B 
lymphocyte, but the stable retention of a constant number of 
genomes in actively dividing cells cannot be explained 
simply by the semi-conservative replication of viral DNA as 
an integral part of the host chromosome (Adams, 1987). 
Doubling of EBV DNA occurs early during the cellular S phase 
of non-producer Raji cells (Hampar et al., 19 74); electron 
microscopy studies suggest that episomal forms of the EBV 
DNA act as independent replicons (Gussander and Adams,
1984). A Meselson-Stahl density transfer experiment 
indicated that the majority of latent EBV DNA molecules each 
replicate once during the cell cycle (Adams, 1987). A single 
replication origin, oriP, has been identified which is 
required for EBV plasmid replication (Yates et al., 1984, 
1985; Reisman et al., 1985) (Figure 1.10.). In cell lines 
harbouring one or few copies of the EBV molecule, such as 
Namalwa (which contains only one copy; Pritchett et al., 
1976) and IB4 (which contains several episomal copies; King 
et al., 1980), it has been possible to investigate the
integration of EBV DNA into the cellular genome. In Namalwa 
and IB4 the EBV genomes were found to be collinear with
Figure 1.10. GENOMIC LOCATIONS OF EPSTEIN-BARR VIRUS 
LATENCY-ASSOCIATED TRANSCRIPTS
Regions of EBV associated with gene expression 
during latency include BamHI WYH (LT1), BamHI K (LT2), BamHI 
Nhet (LT3) and BamHI E (LT4). The locations of EBV
latency-associated transcripts within these regions (YRl, 
ER1, ER2, ER4, KR1 and NLl - named according to the
following format; YRl = BamHI Y rightward reading frame 1 
[BYRF1]) are shown.
The translation products of the transcripts are
as follows:
YRl - EBNA2 (EBV nuclear antigen 2)
ERl - EBNA3A (EBNA3)
ER2 - EBNA3B (EBNA4)
ER4 - EBNA3C (EBNA6)
KR1 - EBNAl
NLl - LMP (latency membrane protein)
The small non-polyadenylated RNAs, EBERl and EBER2, which 
are incorporated into ribonucleoprotein particles (RNP), and 
the oriP origin of replication are also shown.
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linear virion DNA, however, recombination of EBV DNA into 
the cellular genome had occurred on Namalwa chromosome 1 and 
IB4 chromosome 4 (Henderson et al., 19 83). EBV DNA
integration into the IB4 genome was not via TR, and is 
likely to have been via an episomal intermediate. 
Integration of EBV DNA via TR into the Namalwa genome was 
accompanied by a deletion of more than 15kb of host DNA 
(Matsuo et al., 1984; Kieff et al., 1984). The biological 
significance of EBV DNA integration has not yet been 
resolved.
1. 3.5.2 . EBV Gene Expression in Latently Infected Cells
Latent EBV DNA is heavily methylated, unlike virion 
DNA (Kintner and Sugden, 1981; Diala and Hoffman, 1983; 
Saemundson et al., 1984), which is, perhaps, significant, 
since only a limited number of regions of the genome are 
expressed during latent infection. Four of the regions known 
to code for latent polyadenylated transcripts are: BamHI WYH 
(LT1), BamHI K (LT2), BamHI Nhet (LT3), BamHI E (LT4) 
(Figure 1.10.). These regions give rise to at least six 
different nuclear proteins and the latent membrane protein 
LMP.
EBNA1, a protein of M 65,000-80,000 encoded by the 
first rightward reading frame of BamHI K (BKRF1) (Sample et 
al., 1986; Speck and Strominger, 1985), binds to repetitive 
sites within a cis-acting element of EBV, a putative ori 
sequence (oriP) (Figure 1.10.); both trans-acting EBNAl and 
oriP are required for the replication of plasmids derived 
from EBV (Yates et al., 1984, 1985; Reisman et al., 1985; 
Rawlins et al., 1985). Furthermore, since EBNAl is a
trans-acting activator of- transcription from promoters 
linked to a cis-acting component of oriP, it may be required 
for the expression of viral genes, or possibly cellular 
genes containing EBNAl binding sites, in the transformed 
cell (Reisman et al., 1985; Reisman and Sugden, 1986;
Sugden, 1986) .
EBNA2, a protein of MR 88,000 (Dambaugh et al., 19 84; 
Hennessy and Kieff, 1983, 1985), is encoded by BYRF1 (Rowe 
et al., 1985; Sample et al., 1986; Figure 1.10.). EBV P3HR-1
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virus, which contains a 6800bp deletion within LT1 such that 
there is no production of EBNA2, is unable to transform 
lymphocytes (Miller et al., 1974; Ragona et al., 1980; Skare 
et al., 1985; Volsky et al., 1984; Dambaugh et al., 1986).
There is evidence for the involvement of EBNA2 in initiation 
of cell growth transformation (Rickinson et al., 1987).
The BNhetLl open reading frame in LT3 encodes the
latent membrane protein (LMP) (Figure 1.10.), of M 58,000,
R
which possesses potential transmembrane domains and an 
acidic carboxy terminus of 200 amino acids that appears to 
be located in the inner aspect of the plasma membrane of 
latently infected cells (Hennessy et al., 1984; Fennewald et 
al., 1984; Mann et al., 1985). It has been proposed that
LMP, like EBNA2, could be involved in the stimulation of 
cell DNA synthesis and maintenance of cell proliferation 
(Wang et al., 19 85) and could be responsible for the
response of immune T cells which leads to immune cytolysis 
and suppression of the growth of EBV infected lymphocytes 
(LYDMA reactivity) (Thorley Lawson and Israelsohn, 1987).
The LT4 region contains 3 open reading frames, BERFl, 
BERF2b and BERF4 (Figure 1.10). The functions of the 
translation products, termed EBNA3A (also designated EBNA3), 
EBNA3B (EBNA4) and EBNA3C (EBNA6) (Hennessy et al., 1986; 
Petti et al., 1988; Ricksten et al., 1988), are unknown. The 
EBV-immortalised, non-producer cell line IB4 lacks EBNA4, 
which is, therefore, clearly non-essential for the latent 
state.
A latency-associated protein termed EBNA5 or "leader 
protein", again of unknown function, is translated from 
multiple exons in MIR, the set of large internal repeats in 
LT1 (Sample et al., 1986; Speck et al., 1986; Dillner et 
ad., 19 86 ) .
Additionally, a gene which spans the ends of the EBV 
genome and which is, therefore, complete only when the 
genome is circular, encodes the so-called terminal protein 
which is expressed during latency and which is likely to be 
a membrane-inserted species (Laux et al., 1988).
Two small non-polyadenylated RNAs transcribed from 
Ug, EBER1 and EBER2, which are incorporated into 
ribonucleoprotein particles, are also detectable in
66
EBV-latently infected cells (Figure 1.10.). Interestingly, 
EBER1 and EBER2 are able to substitute for VAI and VAII in 
adenovirus replication (Bhat and Thimmappaya, 1983); these 
RNAs are similar to adenovirus VA RNAs in terms of size 
(King et al., 1981; Lerner et al., 1981) and their
transcription by RNA polymerase III (Rosa et al., 1981; 
Arrand and Rymo, 1982). Possible roles for EBERl and EBER2 
in EBV latency have not yet been characterised; EBERl and 
EBER2 are expressed in greater abundance in productively 
infected cells and are of the early RNA class (Hummel and 
Kieff, 19 82 ).
1.3.5.3 . Reactivation of Latent EBV
Most clones of EBV-immortalised lymphoblasts release 
infectious EBV, but do so inefficiently and at such low 
levels that detection of cell-released EBV is rare, although 
virus can be detected following lethal X-irradiation and 
cocultivation of the cells with nontransformed B lymphocytes 
(Wilson and Miller, 19 79; Sugden, 1984). EBV latency can be 
overcome in producer and non-producer cell lines by exposure 
to the tumour promoter TPA or to other chemical inducers 
(Gerber, 1972; zur Hausen et al., 1978; Jeang and Hayward, 
1983; Faggioni et al., 1986; Boos et al., 1987).
Superinfection of EBV latently infected cells with a variant 
of non-transforming EBV P3HR-1 can also activate latency 
(Henle et al., 19 70), a property which has been correlated 
with the presence of heterogeneous EBV DNA fragment BamHI 
WZhet in the EBV P3HR-1 variant genome (Miller et al., 1984; 
Countryman and Miller, 1985). Transfection into latently 
infected cells of EBV DNA fragments containing BZLF1 (a 
subfragment of BamHI WZhet, BamHI-Z left reading frame) 
(Figure 1.9.), under the control of sequences known to 
promote and enhance mRNA transcription in eukaryotic cells, 
induced early EBV antigen production in Raji cells and 
production of infectious virus in another latently infected 
cell line (Countryman and Miller, 1985; Takada et al., 1986; 
Chevallier-Greco et al., 1986; Grogan et al., 1987) via the 
activity of the IE BZLF1 gene product (Countryman et al., 
1987).
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EBV trans-activator R, an EBV IE protein encoded by 
BamHI R leftward ORF (BRLF1) (Figure 1.9.), activates 
expression of an EBV cytoplasmic early antigen in 
cotransfection experiments (Hardwick et al., 1988). The 
expression of EBV nuclear IE antigens encoded by BamHI M 
rightward (BMRF1) and leftward (BMLF1) ORFs (Figure 1.9.) 
has been correlated with trans-activation of transcription 
from heterologous promoters and, although the BMLF1 encoded 
trans-activator does not activate EBV E antigen expression 
(Hardwick et al., 1988), expression of an EBV activatable E 
promoter was shown to depend upon the presence of both the 
BZLF1 and BMLF1 gene products (Chevallier-Greco et al., 
1986). A possible role for these proteins in the regulated 
expression of the EBV genome has, therefore, been suggested 
(Oguro et al., 1987).
Nevertheless, the BZLF1 gene product is both 
necessary and sufficient for activation of the EBV lytic 
cycle induced by superinfection and by transfection of EBV 
DNA fragments, which presumably involves switch on of E EBV 
genes by the BZLF1 IE transactivator protein. Surprisingly, 
then, the mechanism of activation by TPA seems to require de 
novo synthesis of cellular proteins, since neither BamHI Z, 
BamHI M, nor any other region of the EBV genome contains 
genes which are induced by TPA in the presence of 
cycloheximide (Laux et al., 1988). Cellular and viral DNA 
hypomethylation have also been associated with induction of 
the EBV lytic cycle (Bensasson and Klein, 1981; Szyf et al.,
1985).
1.3.6. HSV Latency in Cultured Cells
In vitro HSV-host cell interactions which have been 
described include the following: lytic infections, in which 
infectious virus is produced with subsequent destruction of 
the host cell; persistent or carrier infections, in which 
expression of viral antigens and production of infectious 
virus occur continuously, but cultures are maintained; 
abortive infections, in which there may be limited 
expression of the viral genome but no production of 
infectious virus; and latent infections, in which the
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complete viral genome resides within the host cell, limited 
gene expression may occur and no infectious virus is 
detectable, but the HSV genome can be reactivated with 
subsequent production of infectious virus. HSV infection can 
also result in the transformation of host cells, as 
described in Section 1.1.3.
The development and characterisation of in vitro cell 
culture systems for HSV which reproduce the in vivo latent 
virus-host cell interaction is essential for analysis of the 
intracellular molecular mechanisms involved in latency and 
reactivation. While the absence of variable parameters 
involved in the modulation and control of virus replication, 
such as serum antibody, cell-mediated immunity, interferon 
(IFN) and hormones, could be levied as a criticism of the 
use of in vitro latency systems to study latency at the 
molecular level, it is, in fact, these same characteristics 
that make such systems inherently useful due to their innate 
simplicity and relative reproducibility. It has been 
proposed that an ideal HSV latency system would possess the 
following characteristics: survival of infected cells;
absence of infectious particles in the surviving cultures; 
persistence of the complete viral genome in the surviving 
cells; induction of the synthesis of infectious virus by 
some manipulation of the culture (Levine et al., 1980). It 
has also been suggested that in vitro latency should involve 
cells of neuronal origin, since HSV resides in a latent 
state in neuronal cells in vivo. However, there is recent 
evidence that HSV can be harboured in a latent state in 
non-neuronal cells (Clements and Subak-Sharpe, 1988; 
Al-Saadi et al., 1988; Clements and Jamieson, 1989).
Non-productive in vitro HSV-cell interactions have been 
established in transformed neuronal cell lines (Adler ^t 
al., 1978; Doller et al., 1979; Levine et al., 1980),
permissive and semi-permissive cells of neuronal origin 
(Wigdahl et al., 1984a,b; Nilheden et al., 1985; Wilcox and 
Johnson, 1987; Biswal et al., 1988) and permissive and 
semi-permissive cells of non-neuronal origin (O'Neill et 
al., 1972, 1977; Wigdahl et al., 1982b; Scheck et al., 1986; 
Shiraki and Rapp, 1986; Wrzos and Rapp, 1987; Youssouffian 
et al., 1982; Notarianni, 1986; Russell and Preston, 1986).
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Inhibition of the cytocidal potential of HSV in permissive 
cells of non-neuronal or neuronal origin relies on transient 
or continuous exposure of the infected cell cultures to 
antiviral inhibitors and/or suppressive temperatures. Herpes 
simplex viruses possessing no cytocidal capabilities under 
appropriate conditions, such as viruses possessing lethal 
ts, insertion or deletion mutations, or UV-irradiated HSV, 
have also been used to infect permissive cells to achieve 
non-productive interactions. The salient features of certain 
in vitro latency systems are described in the following 
section.
A non-productive interaction between HSV-1 and a line 
of chemically transformed neuronal cells (B103) has been 
characterised (Adler et al., 1978) and demonstrated to be a 
multiplicity- and temperature-dependent phenomenon, with 
minimum virus yields at a low multiplicity of infection 
(0.01 pfu/cell) and an elevated temperature (39°C) (Levine 
et al., 1980). Inability of the virus to replicate was not
due to failure of the virus to adsorb to the cell surface 
and there was no apparent presence of a viral inhibitor in 
the cells. HSV DNA synthesis was not detectable. Thymidine 
kinase, DNA polymerase and virus structural proteins were 
produced (Adler et al., 1978), but the high molecular weight 
glycoproteins normally produced in HSV infections were 
absent (Levine et al., 1980). HSV-1 nucleic acid sequences 
were, therefore, retained within the cells, although it wan 
not established whether the entire HSV genome was harboured 
in the cells since attempts to recover infectious virus were 
not successful.
Advantage has been taken of the restriction of HSV 
replication in mouse C1300 neuroblastoma cells, compared to 
other murine cells, in the development of an in vitro 
latency system. Following the observations that low 
multiplicity HSV infection produces C1300 cell cultures 
which only occasionally or persistently release virus into 
the culture fluid and that a C1300 cell has to be infected 
with more than one HSV particle to produce progeny virus 
(Vahlne et al., 1981), Nilheden et al. (1985) produced
clones of C1300 cells with increased resistance to HSV 
following exposure of the cells to successively increasing
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m.o.i.'s of HSV for a great number of cell passages. The 
clones tolerated higher m.o.i.'s of HSV, produced lower 
yields of progeny virus and higher activities of a 
non-interferon HSV inhibitor, although growth rate and HSV 
adsorptive and penetrative capacities did not differ from 
those of the parental cells. Culture of the hyper-resistant 
cells in the presence of HSV-neutralising antibody for one 
or two passages after infection and further passage without 
antibody resulted in a latent virus-cell interaction; 
progeny HSV-1 could be rescued by HSV-2 superinfection, 
though retrieval of HSV-1 decreased with passage of the 
latently infected cells.
Youssoufian et al. (1982) have described a system
utilising a lymphoid cell line (CEM) persistently infected 
with HSV-1, usually productive in terms of infectious virus 
and viral antigen but also demonstrating two transient 
latent stages when no infectious virus or viral antigen were 
detectable. Virus production could be induced from cells in 
the transient latent periods by a single treatment with the 
mitogen phytohaemagglutinin. The latent state could be made 
permanent by a single treatment of the non-producing cells 
with the mitogen concanavalin A. Viral DNA, present in these 
latently infected cells at approximately 1 copy per genome 
equivalent, was shown, by restriction endonuclease cleavage 
studies, to be heavily methylated at CG dinucleotides, in 
contrast to the DNA from CEM cells productively infected 
with HSV-1 which contained 40 to 80 copies of non-methylated 
viral DNA. This finding is of particular interest in view of 
the recent reports of enhanced reactivation of latent HSV 
from explanted neural tissues with demethylating agents 
(Bernstein and Kappes, 1988; Stephanopoulos et al., 1988). 
Furthermore, although most, if not all, of the viral genome 
was present in cells from productive and latent stages, a 
terminal fragment of the short region of HSV-1 DNA was 
distinctly underrepresented in DNA from the latent cells but 
not in DNA from the producer cells, indicating an endless 
configuration for latent DNA in the lymphoid cell line, 
perhaps comparable to the endless state of latent DNA in 
vivo (Youssoufian et al., 1982).
A latent state of HSV-2 has been established in a
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human neuroblastoma cell line (SMS-KCNR) by exposure of the 
infected cells to antiherpetic acyclovir (ACV) and human IFN 
for 3 days; thereafter, the cells could be propagated 
without any antiherpetic agents. No infectious virus was 
detected in the cell cultures, although almost 60% of the 
cell population contained an HSV genome, as judged by in 
situ hybridisation analysis. Infectious HSV-2 could be 
rescued following extensive treatment of the latently 
infected cells with bromodeoxyuridine, which resulted in 
differentiation and maturation of the cells to flat cell 
types. Two intracellular polypeptides with M 85,000 and 
67,000 were reactive with hyperimmune anti-HSV-2 rabbit 
serum, but it is not clear whether they were HSV-2 gene 
products. Two cellular enzymes, involved in metabolism of 
neurotransmitters, were expressed at a higher level in 
latently infected cells than in mock-infected control cells, 
and one possibility is that IE HSV proteins, which are 
capable of stimulating cellular promoters stably integrated 
into the host cell genome, may have activated the expression 
of the genes encoding the enzymes (Biswal et al., 1988).
An interesting latency system has been described by 
Wilcox and Johnson (1987), in which primary sympathetic 
neuronal cultures, inoculated with HSV and incubated in 
medium containing 2% anti-HSV antiserum for 14 days, were 
subsequently maintained for up to 5 weeks without evidence 
of viral infection. Deprivation of nerve growth factor (NGF) 
induced the reactivation of infectious HSV, indicating that 
the cells contained the full complement of HSV information. 
This in vitro latency model has suggested a possible role 
for NGF in the regulation of latency in vivo; nerve damage 
is known to stimulate the reactivation of HSV in vivo and it 
is postulated that such damage could result in reduction or 
cessation of retrograde transport of NGF to the neuronal 
soma and, therefore, that reactivation in vivo could be a 
consequence of NGF deprivation (Wilcox and Johnson, 1987).
HSV latency systems, in which HSV is maintained in a 
repressed state for a variable number of days by treatment 
with chemical inhibitors followed by incubation at elevated 
temperatures (39.5 to 4 0.5°C), have been set up in cultures 
of human diploid fibroblasts (O'Neill et al., 1972), human
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neurons (Wigdahl et al., 1984b) and rat sensory neurons 
(Wigdahl et al., 1984a). Inhibitors, or combinations of
inhibitors, used include, cytosine arabinoside (ara-C) 
(O'Neill et al., 1972), (E)-5-(2-bromovinyl)-21-deoxyuridine 
(BVDU) plus IFN (Wigdahl et al., 1982b) or ACV plus IFN 
(Scheck et al., 1986), which will all inhibit DNA synthesis 
(Silagi, 1965), and the protein synthesis inhibitor 
cycloheximide (Shiraki and Rapp, 1986). Interestingly, ts 
mutants of HSV-1 (DNA positive phenotype) have been 
maintained in a repressed state in HEL cells, for at least 
40 days, by incubation at the elevated temperature of 40.5°C 
(Wrzos and Rapp, 1987). Productive HSV infection can be 
activated several days after lowering the temperature of 
incubation or within 24h following intertypic superinfection 
(Colberg-Poley et al., 1979).
In the system described by O'Neill et al. (1972), HEL 
cells pretreated with ara-C were infected with HSV (at 0.1 
to 0.5 pfu/cell) and maintained in growth media plus ara-C 
for 7 days; infectious virus was not detectable for 5-11 
days following removal of inhibitor. HSV RNA was not 
detectable in these cells, within the limits of the in situ 
hybridisation assay utilised (Colberg-Poley et al., 1981). 
Elevation of the temperature from 37°C to 4 0.5°C for HSV-1 
(Wigdahl, 1981), or to 39.5°C for HSV-2, at the time of 
ara-C reversal resulted in a prolongation of HSV latency for 
at least 128 days post infection (O'Neill, 1977). In the 
presence of ara-C, "empty", non-enveloped, herpesvirus-like 
particles were present in nuclei with fragmented chromatin, 
and, following removal of ara-C and temperature elevation, 
no virions were found (Hung et al., 1984). Subsequent 
reduction of the temperature to 3 7°C at any time during the 
latent period resulted in reactivation of infectious virus 
after an incubation period at 37°C of at least 11 days 
(O'Neill, 1977).
Reactivation was also achieved within 24h after 
superinfection of quiescent cultures at 39.5°C or 40.5°C 
with wt HCMV and with ts mutants of HCMV or HSV-2 
(Colberg-Poley et al., 1979; Colberg-Poley et al., 1981;
Wigdahl et al., 1982a). The involvement of early viral
functions in the reactivation event is likely since HSV was
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reactivated from its repressed state within 12h of wt HCMV 
superinfection, before newly synthesised HCMV was apparent 
(Colberg-Poley et al., 19 81), and by superinfection with ts 
DNA-negative mutants of HCMV and HSV and with HSV mutants 
capable of expressing only early genes at the NPT 
(Colberg-Poley et al., 1981; Wigdahl et al., 1982).
Superinfection with a transcription negative ts mutant 
(_tsB7) was unable to induce reactivation, suggesting that 
viral adsorption and penetration were not sufficient to 
trigger the reactivation event (Scheck et al., 1987). Scheck 
and associates (19 87) also found that HSV-1 superinfection, 
of cultures harbouring HSV-2 in a repressed state, in the 
presence of BVDU, which selectively inhibits transcription 
of late and a subset of early HSV-1 genes, failed to 
reactivate HSV-2 replication, thereby suggesting that early, 
as well as immediate early, HSV-1 genes are required for 
HSV-2 reactivation in this system. Additionally, although 
there is no direct evidence, Vonka and associates (1986b) 
have suggested that cellular DNA synthesis, or associated 
processes, play a key role in the activation of latent HSV, 
on the basis that HSV reactivation can be induced by methods 
known to induce cell DNA synthesis, including HCMV 
superinfection (Stinski, 1983).
Infectious centre assays (performed at 37°C) of cells 
from cultures in which HSV was in a repressed state 
suggested that the proportion of cells harbouring an HSV 
genome that can be reactivated was 0.0002% to 0.02% (O'Neill 
et al., 1972; Colberg-Poley et al., 1981); at 12h post HCMV 
superinfection (at 0.2 pfu/cell), before newly synthesised 
HCMV was apparent, 0.01% of cells (initially infected with 
HSV-2 at 0.02 pfu/cell) expressed HSV RNA (Colberg-Poley et 
al., 1981).
The system was, therefore, modified in an attempt to 
increase the percentage of cells harbouring a latent HSV 
genome (Wigdahl et al., 1982b). HEL cells, rat neurons or 
human neurons were pretreated with BVDU in combination with 
IFN, infected at high multiplicity (2.5 pfu per cell) with 
HSV and incubated for 7 days in the presence of the 
inhibitors. Infectious virus was not detectable for at least 
9 days in surviving human neurons following inhibitor
removal (Wigdahl et al., 1984b), but was detected within 3 
days of inhibitor removal in HEL and rat neuron cultures. 
However, HSV could be maintained in a repressed state in HEL 
and rat neuron cultures for at least 60 days and 15 days, 
respectively, by temperature elevation to 40.5°C after 
inhibitor removal (Wigdahl et al., 1984a). Reactivation of 
infectious HSV could be induced, via temperature reduction 
or HCMV superinfection, in at least 1% to 3% of the 
surviving HEL cells and indirect immunofluoresence studies 
and blot hybridisation analyses indicated that, 10 hours 
after HCMV superinfection at 1 pfu per cell, 10% of 
surviving cells were positive for HSV antigens (Wigdahl et 
al., 1982b). HSV specific immunofluorescence was apparent in 
approximately 50% of rat neuronal cells, treated in the same 
manner, 3 days after inhibitor removal and incubation at 
37°C (Wigdahl et al., 1983). Southern hybridisation studies 
demonstrated that, on average, HEL cultures contained 0.25 
to 0.5 copies, and rat neuron cultures contained 8 to 10 
copies, of most, if not all, HSV fragments, per haploid cell 
genome equivalent. There was no detectable alteration in 
size or molarity of the HSV terminal or junction DNA 
fragments and, therefore, the predominant form of the HSV 
genome was unit length and linear (Wigdahl et al., 1984a), 
in contrast to the endless state of the latent HSV genome in 
human peripheral and mouse central and peripheral nervous 
system tissues (Rock and Fraser, 1983, 1985; Efstathiou
75
2. MATERIALS
2.1. Tissue Culture Cells
Human foetal lung (HFL) cells and human 
foreskin fibroblasts were supplied by Dr. B. Carritt and 
Dr. M. Hodgins, respectively, and were used in HSV latency 
experiments. BHK-21/C13 cells were derived by Macpherson 
and Stoker (1962) and were used routinely in the preparation 
and titration of HSV stocks.
2.2. Tissue Culture Cell Media
Cells were routinely grown in Eagle's medium (GMEM, 
Gibco) (Busby et al., 1964) which contained 6mM glutamine, 
0.25% sodium bicarbonate, lOOunits/ml of penicillin, 
lOOug/ml of streptomycin, and other supplements as listed 
below:
EF10 or EF5 Eagle's medium containing 10% or
5% foetal calf serum (Gibco) and 
1% non-essential amino acids 
ETC10 Eagle's medium containing 10% calf
serum and 10% tryptose phosphate 
EHu5 Eagle's medium containing 5% human
serum
Other media used in tissue culture are as follows:
170mM NaCl, 3.4mM KCl, 2mM KH2P04 , 
lOmM Na2HP04 (pH 7.2) 
(Phosphate-Buffered Saline),
PBSA plus CaCl2H20 and MgCl26H20 
both at lg/1 
(Tris-Buffered Saline),
14OmM NaCl, lOmM KCl, lOmM Tris,
ImM MgCl2
Tris-Saline 140mM NaCl, 30mM KCl, 280mM Na2HP04 ,
lmg/ml glucose, 0.001% (w/v) phenol 
red, 25mM Tris HC1 (pH 7.4), 
lOOunits/ml penicillin, lOOug/ml
PBSA
PBS
TBS
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Trypsin
Versene
streptomycin
0.25% (w/v) trypsin in Tris-Saline 
0.6mM EDTA in PBSA containing 
0.002% (w/v) phenol red
2.3. Virus Stocks
HSV-2 wild type (wt) strain HG52, HSV-1 wt strain 17, 
and temperature sensitive (ts) mutants of HSV-2 (ts3, ts5, 
ts9, tsll) and HSV-1 (tjsl, tsK, [both of syncytial plaque 
morphology]) were obtained from stocks maintained in the 
Institute of Virology by M. Murphy. The virus u.v.tsK 
is JlsK which was irradiated with ultraviolet light, by 
Dr. C. Preston, to prevent gene expression and reduce the
5
titre by a factor of 5x10 . HSV-2 wt strains UW268 and 186 
were initially obtained from Dr. P. Schaffer, and HSV-2 wt 
strain 333 was initially obtained from Dr. F. Rapp. The 
HSV-1 deletion mutant dll403 and the dll403 marker rescued 
viruses (Stow and Stow, 1986) were supplied by E.C. Stow. 
The HSV-1 insertion mutant _inl411 (Russell et al. , 1987) 
was provided by E.C. Stow.
Human Cytomegalovirus (HCMV) strain AD169 was 
supplied by Dr. K. Fletcher.
Adenoviruses strain 2 (Ad2) and strain 5 (Ad5) were 
provided by Dr. R. Hay.
2.4. Bacterial Strains
Escherichia coli K12 DH-1 (rec Al, nal A, —R-/
endoI~, B~, rel Al) (Hanahan, 1983) was used throughout.
2.5. Bacterial Culture Media
Bacteria were routinely grown in L.Broth [1% (w/v) 
NaCl, 1% (w/v) Bactopeptone, 0.5% (w/v) yeast extract] and 
L.Broth Agar [L.Broth plus 1.5% (w/v) agar].
2.6. Plasmids
Genomic libraries of cloned HSV DNA fragments were
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established in the Institute of Virology. Clones were grown 
from seed stocks supplied by Dr. V. Preston.
2.7. Enzymes
Restriction enzymes and DNA polymerase I were 
purchased from Bethesda Research Laboratories and used 
according to the suppliers recommendations. Lysozyme, 
proteinase K, deoxyribonuclease I (bovine pancreas) and 
ribonuclease A (bovine pancreas) were purchased from Sigma 
(London) Chemical Company Limited. The large (Klenow) 
fragment of DNA polymerase was purchased from Boehringer 
Corporation Limited.
2.8. Chemicals
Chemicals used were of the highest purity available 
and were obtained from Sigma Chemical Company, BDH 
Chemicals, or an alternative supplier. Other suppliers were: 
Kochlight Limited, (boric acid, acrylamide, caesium 
chloride, sodium hydroxide, TCA [trichloroacetic acid]); 
Pharmacia Fine Chemicals, (sephadex G50, ficoll, 
hexadeoxyribonucleotides [pdN6]); Boehringer Corporation 
Limited (Tris [tris hydroxymethyl aminomethane]); L.C. 
Services Coorporation, (TPA [12-0-tetradecanoyl phorbol 13 
acetate]).
2.9. Radiochemicals
Amersham supplied all radiochemicals utilised.
3Specific activities were 40-60 Ci/mmol for [ H]-thymidine,
>800Ci/mmol for [^^S]-methionine, and, 3000Ci/mmol for the 
3 25'-alpha-[ P]-deoxynucleoside triphosphates.
2.10. DNA Electrophoresis Buffers
EEB (Electroelution Buffer),
40mM Tris, 5mM sodium acetate, 
ImM EDTA (pH 7.8)
TBE 9 0mM Tris, 9OmM Boric Acid,
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ImM EDTA (pH 8.3)
TBE Loading Buffer
49% (v/v), lxTBE, 1% (w/v) SDS,
50% (v/v) glycerol, 0.1% (w/v) 
bromophenol blue 
E Buffer 36mM Tris, 3 0mM NaH2P04 ,
ImM EDTA (pH 7.8)
Dye-Ficoll (Loading Buffer)
10% (w/v) Ficoll, 0.1M EDTA,
5xE Buffer, Bromophenol Blue
2.11. Polypeptide Electrophoresis Buffers
Tank Buffer 0.1% SDS, 52mM Tris, 53mM Glycine
Gel Buffer 0.4% SDS, 1.5M Tris pH 8.9
Stacking Gel Buffer
0.4% SDS, 0.5M Tris pH 6.7 
ESB (Electrophoresis Sample Buffer),
30% (v/v) Glycerol, 5.7% (v/v) 
Stacking Gel Buffer, 
lluM beta-mercaptoethanol
2.12. Lysis Buffers
TK Lysis Buffer 20mM Tris HCl (pH 7.5), 2mM MgCl2 ,
lOmM NaCl, 0.5% (v/v) Nonidet P40 
Nuclei Lysis Solution I
50mM Tris HCl (pH 7.8), lOmM EDTA, 
lOOmM NaCl, 0.4% SDS 
Nuclei Lysis Solution II
lOOmM Tris HCl (pH 7.8), 5 0mM EDTA, 
200mM NaCl, 0.8% SDS 
STET:Lysozyme (9:1)
5 0mM Tris HCl (pH 8.0), 5OmMEDTA,
8% (w/v) sucrose, 5% (v/v)
Triton X100, 0.1% (w/v) lysozyme
2.13. DNA Blot Hybridisation Solutions
Gel Soak I 3M NaCl, 1M NaOH
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Gel Soak II 1.2M NaCl, 2M Tris (pH 8.0)
150mM NaCl, 15mM Trisodium citrate 
(Transfer Solution),
0.6M NaCl, 0.4M NaOH 
(Neutralising Solution),
SSC
TS
NS
1M NaCl, 0.5M Tris HCl (pH 7.0) 
Hybridisation Solution
Pre-Hybridisation Solution
6.6xSSC, 5xDenhardts, 0.5% SDS, 
18ug/ml denatured calf thymus DNA 
Denhardt's Solution
Nick Translation Buffer
0.5M Tris HCl (pH 7.5), 0.1M MgCl2, 
1 mM DTT, 500ug/ml BSA 
PE Reaction Mix (Primer Extension) Reaction Mix, 
(Solution A):(Solution B):(Solution C)
0.02M Tris HCl (pH 7.5), 6xSSC, 
50xDenhardts, ImM EDTA, 0.5% SDS, 
50ug/ml denatured calf thymus DNA
0.02% (w/v) Ficoll,
0.02% (w/v) polyvinylpyrollidine, 
0.02% (w/v) BSA (Denhardt, 1966)
2.14. Radio-Labelling Solutions
2 5 3
Solution B 
Solution C
Solution 0
Solution A
1.25M Tris Hcl (pH 8.0) ,
0.125M MgCl2 
Solution 0 plus 0.25M 
betamercaptoethanol,
20uM dTTP and 20uM dATP 
2M Hepes pH 6.6
Hexadeoxyribonucleotides (pDN6)
at 90 OD units/ml in
lOmM Tris HC1 (pH 7.5), ImM EDTA
2.15. Other Solutions
Fix
Des tain
1% glacial acetic acid, 9% methanol 
5% methanol, 7% glacial acetic acid
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Giemsa 1.5% (w/v) suspension of Giemsa in
glycerol, heated at 56°C for 120 min 
and diluted with an equal volume of 
methanol
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3. METHODS
3.1. Cell Culture
Monolayer cultures of human foetal lung (HFL) cells
and of human foreskin fibroblasts (HFF) were grown in
EF10 medium at 3 7°C in an atmosphere of 5% 9 5% air.
The cultures were passaged every 2 to 3 days; cells from
confluent monolayers were harvested by addition of 10ml
of a 1:1 solution of trypsin:versene, followed by 10ml of
SvVik cxa<1
medium, and resuspended cells wereAused to seed monolayers.
7
Confluent monolayers of cells yielded approximately 6x10
2 6 cells per 175cm plastic tissue culture flask, 1x10 cells
per 35mm diameter Petri dish and 3x10 cells per 50mm
diameter Petri dish.
Baby hamster kidney (BHK-21 [C13]) cell monolayers
were grown and maintained in ETC10 medium at 3 7°C in an
atmosphere of 5% CO^, 9 5% air. Cultures were passaged every
2 to 3 days, as described above. Confluent monolayers
8 2 yielded approximately 3x10 cells per 850cm plastic roller
bottle, 1x10 cells per 3 5mm diameter Petri dish and 3x10
cells per 50mm diameter Petri dish.
For analysis of plaque formation, 5% human serum was
substituted for foetal calf or calf serum (EHu5).
3.2. Virus Stocks
3.2.1. Herpes Simplex Virus
Stocks of herpes simplex virus were propagated in BHK 
cells, with the exception of in!411 which was grown in M65 
cells (Davison and Stow, 1985) by N.D. Stow and E.C. Stow.
Cell monolayers in plastic roller bottles were
infected with virus at an m.o.i. of 0.01 pfu per cell or 
with plaque isolate material, in 100ml of ETC10. Infected 
cultures were maintained at 31°C for 3-4 days until the 
appearance of extensive cytopathic effect (CPE). The bottles 
were shaken vigorously to dislodge the cells into 20ml 
medium. Centrifugation, at 996£ for 15min at 4°C, produced
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a pellet containing cell-associated virus (CAV) and a 
supernatant containing cell-released virus- (CRV). The 
CAV-containing pellet was sonicated in 1ml of ETC10, to 
release the virus, and recentrifuged at 996^ for 15min at 
4°C to remove cell debris. CAV in the supernatant was stored 
in aliquots at -70°C. The CRV-containing supernatant was 
centrifuged at 13,200£ for 2h at 4°C and the pellet of CRV 
was resuspended in a small volume of ETC10, sonicated, and 
stored at -70°C. Sterility checks (on blood agar plates) 
were performed on CRV and CAV stocks, and the viral stocks
were titrated on BHK cells. It should be noted that HSV-2
infections in cell culture produce relatively low 
concentrations of CRV and that stocks used were therefore 
only CAV.
3.2.2. Human Cytomegalovirus (HCMV)
Stocks of HCMV strain AD169 were produced by
infection of HFL monolayers at 0.01 pfu per cell. The
infected cultures were incubated at 37°C for 1.5 to 2h to 
allow viral adsorption and penetration. The inoculum was 
removed, the monolayers were washed in EF5 medium, overlaid 
with fresh EF5 and incubated at 37°C for several days. 
Medium was changed if it became acidic. The medium was 
removed from cultures in which extensive CPE was apparent 
(5 to 7 days pi), and stored at -70°C. Fresh medium was 
added to the cells and incubation was continued. This 
procedure was repeated daily until all the cells detached 
into the medium (10 days pi). Stocks were pooled, sonicated 
and stored at -70°C.
3.3. Titration of Virus
HSV stocks, with the exception of _inl411, were 
titrated on BHK cell monolayers, and HCMV stocks were 
titrated on HFL cell monolayers. Serial 10-fold dilutions of 
virus were made in ETC10 or EF10, and 0.2ml samples of each 
dilution were inoculated onto cell monolayers from which 
growth medium had been aspirated. Following an adsorption 
period of lh (HSV) or 1.5h (HCMV) at a temperature
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permissive for viral growth (31°C, HSV ts mutants; 37°C, HSV 
and HCMV), the cells were overlaid, either with EHu5 (HSV), 
to neutralise unadsorbed virus and thereby prevent the 
formation of secondary HSV plaques, or with EF5 (HCMV). 
Incubation was continued at the appropriate temperature for
2-4 days (HSV) or 8-10 days (HCMV) until plaques were of 
sufficient size. The medium was then removed and the cells 
were stained with Giemsa Stain. After the stain was washed 
off, the viral plaques, clearly visible under a dissecting 
microscope, were scored for each dilution, and the number of 
plaque-forming units of virus per ml was calculated.
3.4. Plaque Isolates
Plaque isolates were picked under EF10 from infected 
cell monolayers containing separated plaques. The plaque 
isolate was sonicated and stored in 0.5ml of EF10. Isolates 
were titrated on BHK cells.
3.5. Growth Curves
Confluent monolayers of HFL cells in 35mm diameter 
Petri dishes were infected with virus at 0.003 pfu per cell. 
Virus was allowed to adsorb to and penetrate the cells for 
lh at 38.5°C and infected cells were washed once with EF5, 
overlaid with EF5 and incubated at 38.5°C for 16, 24 and 
48h. At the appropriate time points, samples were harvested, 
by scraping into the medium with sterile rubber policemen, 
sonicated and titrated on BHK cells.
3.6. Outline of in vitro Latency System for HSV
The basic in vitro latency system for HSV is outlined 
schematically in Figure 3.1.. Confluent monolayers of HFL 
cells on 35mm diameter Petri dishes were infected with HSV 
at 0.003 pfu per cell (3000 pfu per dish). The virus was 
allowed to adsorb to and penetrate the cells for lh at 3 7 C, 
the remaining virus inoculum was aspirated and the 
monolayers were washed once in EF10. Infected monolayers 
were overlaid with EF5 and incubated at 42°C for 6 days.
FIGURE 3.1. SCHEMATIC REPRESENTATION OF THE 
IN VITRO LATENCY SYSTEM FOR HSV
ESTABLISHMENT 
AND 
MAINTENANCE 
OF THE 
LATENT STATE
REACTIVATION 
OF 
HSV 
FROM THE 
LATENT STATE
HFL CELLS 
\
INFECTION, 0.003 PFU/CELL 
WT HSV (MUTANT)
*
ADSORPTION, 37 C (38.5 C), 1H 
EF5 OVERLAY
i
42 C, 6 DAYS
I
37 C (31C), 4 DAYS
SUPERINFECTION, 0.03,0.1,0.3 PFU/CELL 
HSV MUTANTS, HCMV
I
ADSORPTION, 38.5 C (31C), 1H 
\
1. EHU5 OVERLAY, 38.5 C(31 C), 2(3) DAYS-*- GIEMSA STAIN
2. EF5 OVERLAY, 38.5 C(31 C), 2(3) DAYS -► PLAQUE ISOLATES 
-►  DNA PROFILES / GROWTH STUDIES
3. EF5 OVERLAY, 38.5 C(31 C), 2(3) DAYS- *" CELL HARVESTS 
—► SOUTHERN BLOT HYBRIDISATION ANALYSIS
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Medium changes were performed at two day intervals as 
rapidly as possible at room temperature (RT) using EF5 which 
was prewarmed to 42°C. Cultures were shifted to 37°C (or 
31°C) for a further 4 days, during which time the medium was 
changed every day or on alternate days. Throughout this 37°C 
incubation, sample monolayers were scraped into the culture 
medium, sonicated thoroughly, and tested for the presence of 
infectious virus by plaque assay. Superinfection was carried 
out after the 4 day incubation at 37°C. Superinfecting virus 
was allowed to adsorb to and penetrate the cells for 1 to 
1.5h at 38.5°C (or 31°C). The cells were overlaid with EHu5, 
incubated for 2 days at 38.5°C (or 31°C), stained with 
Giemsa Stain and then examined for the presence of viral 
plaques.
3.7. Preparation of Competent Bacteria
lOOul of a glycerol stock of Escherichia coli strain
DH-1 was added to 10ml of L-Broth and incubated overnight
(o/n) at 37°C. A 2ml sample of this overnight culture was
added to 200ml L-Broth which was then shaken at 3 7°C for
2.5 to 3h until the OD._,,A had reached 0.2. The culture was
d 3U
placed on ice for lOmin prior to centrifugation at 830cf for 
15min. The L-Broth supernatant was removed, and the pellet 
was resuspended in a half volume of ice cold lOOmM CaCl^ and 
left on ice for lh prior to recentrifugation. The resultant 
pellet was resuspended in 2ml of lOOmM CaC^.
The DH-1 bacteria were competent at this stage and were 
either stored o/n at 0°C or transformed directly.
3.8. Transformation of DH-1
Plasmid DNA (ampicillin ) samples were mixed with 
lOOul aliquots of competent bacteria, set on ice for lh with 
occasional mixing, then heated to 42°C for 1.5min and added 
to 2ml of warm L-Broth. The mixture was shaken for 9 0min 
at 37°C. 0.2ml aliquots of the suspension were plated out
in 9 0mm plastic dishes containing agar plus ampicillin at 
50ug/ml. The plates were incubated at 3 7°C o/n. Colonies 
were picked and stored at 4°C o/n or at -20°C in a mixture
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containing 40% glycerol and 1% bactopeptone.
3.9. Small Scale Preparation of Plasmid DNA
Transformed DH-1 colonies were picked and resuspended 
in 2ml of L-Broth plus ampicillin (50ug/ml). The cultures 
were shaken at 37°C for 5 to 6h until dense. Chloramphenicol 
was added to a final concentration of 25ug/ml and the 
cultures were left shaking at 37°C o/n. The cultures were 
brought to RT and 1.5ml of each was centrifuged at 2,9 00g 
for 5min. The supernatant was removed, and the pellet was 
resuspended by vortexing in lOOul of a 9:1 solution of 
STET:Lysozyme (lOmg/rnl). The mixture was immediately heated 
at 100°C for lmin, and then centrifuged at ll,600g for 
lOmin. The supernatant was added to 0.4ml of 0.3M sodium 
acetate, and 0.5ml of isopropanol was added. After storage 
at -20°C for 30min, the DNA was pelleted by centrifugation, 
redissolved in 30ul of de-ionised water (DW) and stored at 
-20°C. The DNA was analysed by restriction enzyme analysis.
3.10. Large Scale Preparation of Plasmid DNA
Quantities shown are for a 200ml culture.
An overnight culture of transformed DH-1 (20ul) in 
L-Broth (10ml) plus ampicillin (50ug/ml) was grown at 37°C, 
and 1ml of this culture was added to 200ml of L-Broth and 
shaken at 37°C for several hours. Chloramphenicol was added 
at a concentration of 2 5ug/ml and the cultures were shaken 
o/n at 37°C. The cultures were centrifuged at 4,800g for 
lOmin. The pellet was resuspended in 5ml of 25% sucrose/ 
50mM Tris-HCl, pH 8.0. 2.5ml of 5mg/ml lysozyme was added 
and the mixture was set on ice for 30min. Following the 
addition of 2ml of 250mM EDTA, pH 7.5, the mixture was left 
on ice for 5min. 1.5ml of 5M NaCl and 1.5ml of 20% SDS were 
added, and the mixture was mixed gently and placed on ice 
for 2 to 3h prior to centrifugation at 36,900^ for lh at 
4°C. The supernatants were phenol/chloroform extracted and 
ethanol precipitated (see below). The pellet of nucleic acid 
plus protein was dissolved in 9ml of 20mM Tris HCl, pH 7.5, 
lOOmM NaCl, ImM EDTA. Degradation of RNA and protein was
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achieved by treatment with 2 0ul of 5mg/ml RNAase A at 3 7°c 
for 2 to 4h, followed by proteinase K at lOOug/ml at 37°C 
for 2 to 16h. The volume was increased to 4.5ml, and DNA was 
phenol:chloroform extracted, then isopropanol precipitated 
(see below). The DNA pellet was redissolved in 300ul of DW. 
Plasmid DNA was stored at -20°C.
3.11. Phenol;Chloroform Extraction of DNA
Purification of DNA from protein contaminants was 
achieved by extraction of DNA in phenol:chloroform. DNA 
in aqueous solution was mixed with an equal volume of 
phenol:chloroform (1:1), agitated (gentle agitation is 
required for extraction of large DNA fragments and total 
cellular DNA, to prevent shearing of DNA), and centrifuged. 
Centrifugation was at ll, 600cf for 5min with sample volumes 
of <1.5ml, or at l,557g_ for 15min with sample volumes of 
>5ml. The aqueous phase containing the DNA was re-extracted 
in phenol:chloroform, and then extracted once in chloroform 
to remove contaminating phenol. DNA was ethanol/isopropanol 
precipitated.
3.12. Ethanol and Isopropanol Precipitation of DNA
DNA in aqueous solution was mixed with 2 volumes 
of ethanol and sodium acetate (0.3M final concentration), 
and placed at -20°C for >2h. As an alternative, larger DNA 
fragments were precipitated in an equal volume of 
isopropanol, and sodium acetate (0.3M final concentration) 
left at RT for >2h, to reduce contamination with DNA 
fragments of <20 base pairs which are not precipitated in 
isopropanol. Following precipitation, DNA was pelleted by 
centrifugation, with the exception of total cellular DNA, 
the globular mass of which was lifted out of the ethanol
with a pipette. DNA was washed in ethanol, recentrifuged,
dried and redissolved in DW.
3.13. Restriction Enzyme Digestion
DNA was digested in a solution containing lxRE Buffer
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(HSB, MSB) and 0.01% BSA, or commercial RE Buffer [BRL], and 
restriction enzyme (1 unit/ug DNA, BRL). For the preparation 
and analysis of DNA fragments, or, for the analysis of in 
vivo-labelled DNA fragments the digestions, in 20ul or 150ul 
volumes, were normally carried out at 37°C for 4h.
For the digestion of high molecular weight total cellular 
DNA, in volumes ranging from 45ul to 9 00ul, the DNA was 
incubated with 1 unit of restriction enzyme per ug of DNA 
at 37°C o/n; a further 0.5 units of enzyme per ug of DNA 
was then added and incubation was continued for a further 
4h period.
3.14. Electrophoresis of DNA
3.14.1. Minigels
Analysis of small amounts of DNA utilised horizontal, 
0.5% agarose, 50ml gels in TBE Buffer (100mmx70mmx7mm). DNA 
samples plus TBE Loading Buffer in a final volume of lOul 
were loaded into gel slots and electrophoresed in TBE Buffer 
at constant current, 40mA for lh. Following electrophoresis, 
the gel was stained in TBE Buffer plus ethidium bromide 
(4ug/ml) for 15 min. DNA was visualised by exposure of the 
gel to ultraviolet light and photographed on Polaroid 667 
film.
3.14.2. Large Agarose Gels
Analysis and preparation of DNA restriction fragments 
utilised horizontal, 1% agarose, 300ml gels in E Buffer 
(2 60mmxl60mmx7.5mm) plus ethidium bromide (0.5ug/ml). 
Southern transfer of DNA samples to GeneScreen Plus 
Hybridisation Transfer Membrane (DuPont) was from 
horizontal, 0.6% agarose, 200ml gels (260mmxl60mmx5mm) 
in E Buffer plus ethidium bromide (0.5ug/ml). DNA samples 
in Dye-Ficoll were electrophoresed in E Buffer at constant 
current, 40mA for 16-18h. DNA was visualised by exposure of 
the gel to ultraviolet light and photographed on Polaroid 
667 film. Gels for autoradiography were dried on a glass 
plate in an oven at 60°C.
88
3.15. Electroelution of DNA Fragments
DNA was electroeluted from agarose to dialysis 
membrane in EEB in an electroelution apparatus at 20mA 
per sample for lh. The DNA was removed from the dialysis 
membrane in 200ul of EEB. The volume was increased to 4 00ul 
by the addition of 160ul of DW and 40ul of 3M sodium 
acetate. The DNA was phenol:chloroform extracted, then 
isopropanol precipitated. The DNA pellet was redissolved 
in DW.
3.16. Estimation of DNA Concentration
Endonuclease-digested DNA samples were 
electrophoresed in minigels with DNA of known concentration. 
DNA bands were visualised under uv irradiation. Approximate 
estimations of DNA concentrations were obtained by 
densitometric analysis of DNA bands on negative Polaroid 
665 film.
3.17. Radiolabelling of DNA
3.17.1. In vivo Labelling of Viral DNA
The method used was that of Lonsdale (1979), as 
modified by Park (1983).
Confluent BHK cell monolayers in 1.5cm diameter
5
L m b r o  wells (2x10 cells per well) were infected with
3-5 pfu per cell of virus in lOOul volume and incubated
at 37°C for lh to allow viral adsorption and penetration.
The inoculum was removed, and monolayers were washed twice
in Phosphate-Free Medium, then overlaid with 250ul of
Phosphate-Free Medium for 4h at 37°C. At 5h pi 50uCi of 
3 2[ P]-orthophosphate (PBS II carrier-free) m  300ul of 
phosphate-free medium was added to each well and incubation 
was continued at 37°C for 24-48h, until 70-100% CPE was 
apparent. Cells were lysed by addition of 250ul of 0.5% SDS 
per well and careful pipetting up and down, then transferred 
to 1.5ml vials. The DNA was phenol:chloroform extracted,
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then ethanol precipitated on dry ice for 30min. The DNA 
pellet was resuspended in lOmM Tris HC1, pH 7.5, ImM EDTA 
plus 0.2 5mg/ml RNase A in a final volume of lOOul, and 
incubated at 37°C for 2h. Samples were stored at -20°C.
323.17.2. In v i t r o — P-Labelling and Preparation of DNA Probes
Nick Translation (Rigby et al., 1977).
A solution of 0.25 to 0.5ug of DNA in 2ul; 2.5ul of 
lOx Nick Translation Buffer plus non-radioactive dATP and 
dTTP, each at 2 0uM; and 2ul of DNAase (2x10  ^ mg/ml); was 
incubated on ice for 2 to 3min and diluted to 17ul. Then, 
3ul (30uCi) each of [ -^P]dGTP and [ -"^PJdCTP and 2 ul of 
E.Coli polymerase I (1 unit/ul) were added and the solution 
(final volume 25ul) was incubated at 14°C for 2 to 3h.
Hexanucleotide Primer Extension 
(Feinberg and Vogelstein, 1983).
DNA (O.lug) in 20ul was boiled for lOmin, cooled at
RT and centrifuged briefly.
A 50ul solution consisting of the 20ul DNA, lOul of
Reaction Mix, 400ug/ml of BSA, 5ul (50uCi) of [ -^P]dGTP or 
3 2[ - PjdCTP, 2uM of non-radioactively labelled dCTP or dGTP
(as appropriate), and 2.5 units of Klenow DNA polymerase,
was incubated at RT o/n.
3 2Preparation of P-Labelled DNA for Hybridisation
The probes were purified by passage through a 5ml
Sephadex G-50 (medium) column to separate the labelled DNA
from the unincorporated triphosphates. The probe was eluted
in approximately 800ul of lOmM Tris HCl, pH 7.5, ImM EDTA.
The specific activity was usually of the order of 
6 71x10 to 1x10 cpm/ug of DNA by nick translation, or,
g
4x10 cpm/ug of DNA by primer extension.
The radiolabelled probe in 800ul volume was denatured 
by addition of 200ul of IN NaOH at RT for lOmin. The 
solution was neutralised by addition to 8.8ml of 
Hybridisation Solution plus 200ul of 1M HCl.
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3.18. Extraction of Nuclear and Cytoplasmic DNA
Monolayer cultures were scraped from tissue culture 
plates into 0.5ml of PBS by the use of sterile rubber 
policemen. The cells were pelleted by centrifugation at 
2,9 0 0 cj for lmin and the PBS was removed. 200ul of TK Lysis 
Buffer was added to the cell pellets, which were resuspended 
by vortexing, placed at 4°C for 5min, and vortexed .once 
more. The lysed cell suspensions were then centrifuged at 
11,600^ for lmin. The pellet represented the nuclear 
fraction and the supernatant represented the cytoplasmic 
f raction.
The cytoplasmic fraction, in a solution of lOmM EDTA 
pK 7.5, lOOmM sodium chloride and in a final volume of 
500ul, was phenol:chloroform extracted and ethanol 
precipitated. RNA was degraded by treatment with RNAase A 
at lOOug/ml for 3h at 37°C.
Nuclei were incubated in 250ul of Nuclei Lysis 
Solution I containing 200ug/ml proteinase K for 16-20n at 
37°C, and phenol:chloroform extracted. Nucleic acids were 
precipitated in ethanol and dissolved in DW. RNA was 
degraded by RNAase A (lOOug/ml) treatment at 37°C for 3h.
3.19. Preparation of Whole Cell Fraction from which 
to Extract DNA
In this instance, the technique employed had to be 
such that the infectivity of viral particles in the 
preparation was not destroyed.
Cells were harvested by scraping (sterile rubber 
policemen) into 0.5ml of TBS. The preparation was frozen at 
-140°C and thawed at 37°C three times. For each sample, the 
presence of infectious viral particles was determined by 
titration of 20ul of cell lysate on BHK cells. 0.5ml of 
Nuclei Lysis Solution II containing 200ug/ml proteinase K 
was added and the sample was incubated at 3 7°C for 16-20h. 
Samples were phenol:chloroform extracted, nucleic acids were 
precipitated in ethanol and pellets were dissolved in DW. 
RNA was removed by treatment with lOOug/ml of RNAase A for 
3h at 37°C.
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3.20. Ultracentrifuqation of DNA in a Caesium Chloride 
Gradient
Separation (on the basis of density) of viral DNA
sequences of interest from the bulk of cellular DNA
sequences (with the exception of high G + C sequences)
was achieved by ultracentrifugation of DNA through a CsCl
gradient of RI 1.4 (density 1.707g/ml). Restriction
enzyme-digested, HSV-infected cellular DNA in aqueous
solution was mixed with a solution of CsCl to a final RI
of 1.4 (density 1.707g/ml), and a final volume of
approximately 18ml. The mixture was transferred to a TV865B
ultracentrifugation tube and topped up with liquid paraffin.
The tube was sealed by the use of a crimping apparatus. The
sample, and control balance sample, were centrifuged in a
TV865B vertical rotor at 128,618g[ for 18h at 15°C. The
sample was fractionated by piercing the bottom of the tube
with a syringe needle and collecting fractions of 10 drops.
The RI of these fractions was measured. Control experiments 
3with H-thymidme labelled HSV-2 infected cell DNA digested 
with the appropriate restriction enzyme, indicated that the 
HSV DNA was present in fractions of RI 1.4036 to 1.4002. 
Therefore, fractions of RI 1.4036 to 1.4002 were pooled and 
either, re-centrifuged, or, dialysed o/n in TE to remove 
CsCl. Fresh dialysis medium was added and dialysis was 
continued for a further 3h. The pooled, dialysed fractions 
were then concentrated to a volume of 1ml by agitation in 
butanol, followed by removal of the upper layer of butanol, 
and incubation at 65°C to evaporate the remaining butanol. 
The 1ml sample was divided equally into 2 parts and ethanol 
precipitated. The DNA pellet was redissolved in 40ul of DW.
3.21. DNA Blot Hybridisation
3.21.1. Transfer of DNA from Agarose to Membrane 
(Southern, 1975)
DNA fragments separated according to size by 
electrophoresis, were denatured, transferred to GeneScreen
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Plus Hybridisation Transfer Membrane (DuPont) and 
immobilised.
After electrophoresis, the agarose gel was pre-soaked 
for 30min in 0.25N HCl (partial depurination of the DNA) 
(Wahl et al., 19 79). The gel was placed in Gel Soak I for 
45min (cleavage and separation of DNA strands) and then in 
Gel Soak II for 45min (neutralisation). After each step the 
gel was rinsed briefly in DW.
The agarose gel, containing denatured DNA fragments, 
was laid upon Whatman's 3MM paper which had been pre-wet 
with transfer solution and arranged upon a horizontal 
support such that it formed a wick for the transfer solution 
within which the support was set. GeneScreen Plus membrane, 
cut to the same dimensions as the gel, was pre-soaked in 
transfer solution and placed, B-side down upon the agarose 
gel. The membrane was covered sequentially with 2 pieces of 
similarly sized Whatman's 3MM paper, a stack of paper 
towels, and a 1kg weight. DNA transfer was allowed to 
proceed for 16 to 18h.
Transfer was carried out in a 6xSSC solution. 
Following transfer the membrane was placed in 0.4N NaOH 
for lh, then soaked in a solution of 0.2M Tris-HCl pH 7.5 
- 2xSSC. The membrane was dried at RT for at least 2h.
An alternative method used to transfer DNA fragments 
to GeneScreen Plus is the Alkaline Transfer Method, which 
was described by Chomczynski and Qasba (1984). The agarose 
gel was presoaked for 30min in TS (alkaline denaturation). 
Transfer was carried out as described above, however, TS was 
substituted for 6xSSC. Following transfer the membrane was 
neutralised for 15min in NS, with occasional shaking, and 
dried at RT for at least 2h.
3.21.2. DNA-DNA Hybridisation
The GeneScreen Plus membrane (plus covalently-bound 
DNA) was incubated in 100ml of Pre-Hybridisation solution 
for >2h at 68°C with constant agitation. This solution was 
then removed and replaced by Hybridisation Solution plus 
denatured, 32P-labelled DNA probe in a final volume of 10ml. 
The hybridisation was carried out at 68°C, for 16 to 20h,
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with constant agitation of the membrane. The hybridisation 
solution was removed and the membrane was washed briefly in 
2xSSC at RT, 3 times in a solution of 2xSSC, 0.2% SDS at 
68 C for 3Omin with agitation, then twice in cold tap water 
for several seconds. The membrane was blotted onto tissue 
paper and laid on a plate, covered with a sheet of thin 
polythene, a sheet of X-Omat S photographic film, and an 
intensifier screen. The film was exposed at -70°C for 
appropriate periods.
3.22. Analysis of Polypeptides
3.22.1. Pulse-Labelling of Cells
Confluent monolayers of HFL cells in 15mm diameter
5
Linbro wells (2x10 cells per well), were mock-infected or
infected with 10 pfu of virus per cell in lOOul. Following
adsorption and penetration of the virus for lh at 37°C, the
infected cultures were overlaid with prewarmed EF5 (9 00ul)
and incubation was continued at the appropriate temperature.
Cultures incubated at 38.5°C or 42°C were pulse-labelled
at 5h pi, whereas, cultures incubated at 31°C were
pulse-labelled at 9.5h pi; monolayers were washed once in
prewarmed PBS prior to the addition of PBS containing 
3 5[ S]-methionine (50uCi/ml) and Actinomycin D (lug/ml). 
After 30min, the radio-labelled medium was removed, the 
monolayers were washed in 0.5ml of ice cold PBS, and then 
in 0.5ml of ice cold lOmM. Tris HCl, pH 7.6, 2.5mM EDTA.
The cells were harvested in 50ul of ice cold lOmM Tris HCl, 
pH 7.6, 2.5mM EDTA, transferred to a 1.5ml vial, mixed with 
25ul ESB, and heated at 100°C for 15min. Samples were stored 
at -70°C or analysed immediately.
3.22.2. SDS-Polyacrylamide Gel Electrophoresis
[^^S 3-methionine-labelied polypeptides were
electrophoresed in vertical SDS-polyacrylamide gels plus 
stacking gels (10% acrylamide/1% DATD) in Tank Buffer.
The gel solution consisted of 13.3ml of 30% 
acrylamide/3% DATD solution, 10ml of gel buffer, and 0.5ml
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of a 10% (w/v) ammonium persulphate solution (freshly
prepared) in a final volume of 40ml. 40ul of TEMED was mixed 
gently into the gel solution which was then poured into a 
sandwich of glass plates (2 60mmxl60mmxlmm) to fill 75% of 
the space. Using a Pasteur pipette, 20ml of a l/4xGel Buffer 
solution was immediately and carefully layered onto the 
surface of the gel solution, which was then left to set 
for >lh. The stacking gel solution consisted of 4ml 30%
acrylamide/3% DATD, 6ml of Stacking Gel Buffer, and 0.5ml
of 10% (w/v) ammonium persulphate solution in a final volume 
of 20ml. 25ul of TEMED was mixed into the solution and 
immediately, following removal of the l/4xGel Buffer 
solution, the surface of the gel was rinsed with 5ml of 
stacking gel solution, which was then removed. The remaining 
space between the glass plate sandwich was filled with 
stacking gel solution and a Teflon comb was inserted in the 
top. Approximately 5-15min later, when the stacking gel had 
polymerised, a small volume of Tank Buffer was layered 
gently along the top of the comb, which was then eased out 
of the stacking gel. The slots produced were washed twice 
with Tank Buffer. Samples were electrophoresed in Tank 
Buffer at 35mA, constant current, for 3-4h, or until the dye 
front had reached the base of the gel. The gel sandwich was 
removed from the kit, and the gel was separated from the
stacking gel and immersed in a 50:50 mix of Fix:Destain at 
RT for l-2h. The gel was heat-dried under vacuum, then 
exposed to Agfa film.
3.23. Determination of Thymidine Kinase (TK) Activity
Cells from 35mm diameter Petri dishes were harvested 
as described in section, except that the TK Lysis Buffer
contained 6.5mM beta-mercaptoethanol. The supernatants 
representing the cytoplasmic fractions were assayed for TK 
activity immediately or stored at -70°C.
20ul of the cytoplasmic fraction (1/10 of the total 
fraction) was analysed in a reaction solution of 50ul 
consisting of lOOmM sodium phosphate (pH 6.0), lOmM 
magnesium chloride, 5mM ATP, lOOuM dTTP and lOOuCi/ml 
[^H]-thymidine. The samples were incubated at 31 C for 3h.
9 5
The reaction was terminated by addition of 5ul of a solution 
of ImM thymidine, 5mM EDTA (pH 7.0), and incubation at 9 0°C 
for 3-4min. The solution was cooled on ice, and centrifuged 
at 11,600^ for 3-4min. 20ul samples of supernatant were 
spotted onto Whatmann DE81 discs which were then washed in 
a solution of 4mM ammonium formate, lOmM thymidine at 37°C 
for three lOmin periods. The discs were rinsed twice in 
absolute alcohol, dried under a heat lamp and placed into 
scintillation vials containing 3ml of EcoScint A (National 
Diagnostics). Radioactive counts were measured in a 
scintillation counter.
ESTIMATION OF DNA CONCENTRATION IN EXPERIMENTS
FROM SECTION A. 5 .
Approximate estimations of HSV DNA concentrations 
wpf’0 obtained bv d e n s i tomeiric* analysis of a.utora.d.iograpns
usinrr a Joyce-Loebl scanning densitometer. Areas beneath 
the peaks of the densitometric tracing were measured by the 
use of a pro ff ram me, DEN S, written by Dr# P. Ta.y3.or for a. DEC 
PDP 11/AA computer linked to a digitizing table.
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4. RESULTS AND DISCUSSION
4.1. OBJECTIVES
The ultimate aim of the research described in this 
thesis is to elucidate the molecular basis for HSV latency 
by the use of an in vitro latency system. The system was 
developed from preliminary work by Dr. C. Preston and Dr. E. 
Notarianni and is outlined schematically in Figure 3.1. and 
described in Section 3.6. Essentially, HFL cells are 
infected with HSV at low multiplicity, incubated at 42°C for 
6 days to convert HSV to a latent state, and then incubated 
at 37°C for 4 days, during which period the latent state is 
maintained. Experimental reactivation of latent HSV is 
induced by superinfection with HSV or HCMV.
There were four major objectives of the project: 
characterisation of an in vitro latency system for HSV; 
identification of the viral factors involved in 
establishment of latency; identification of the viral 
factors involved in reactivation of HSV from its latent 
state; determination of the physical nature of the latent 
HSV genome.
4.2. CHARACTERISATION OF AN IN VITRO LATENCY SYSTEM FOR HSV
4.2.1. Introduction
The in vitro latency system described below relies 
upon the use of supraoptimal temperatures to convert HSV to 
a latent state. It is well-established that HSV, especially 
HSV-2, cannot replicate in tissue culture cells at 
temperatures of 41°C to 4 2°C and there have been several 
reports of non-productive interactions of HSV with host 
cells induced by incubation of infected cells at these 
supraoptimal temperatures (Crouch and Rapp, 19 72; Darai and 
Munk, 1973; Marcon and Kucera, 1976; Levine et al., 1980; 
Notarianni, 19 76). Abortive HSV-2 infections of permissive
■ * —  O  p
human and rat cells have been induced by incubation at 42 C 
for 8 days; HSV DNA synthesis and infectious virus
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production were not detectable at 42°C. The surviving cell 
populations contained HSV information, as shown by the 
appearance of virus specific antigens and the rare 
production of infectious virus during subsequent incubation 
at 37°C. It was noted that some of the surviving cells 
acquired properties characteristic of transformed cells,
such as resistance to HSV superinfection and altered
morphology, and certain of the transformed rat cells were 
tumorigenic for neonatal rats (Darai and Munk, 1973; Marcon 
and Kucera, 1980). Notarianni (1986) reported that 
incubation at 41.5-42°C of human embryo lung cells infected 
at low m.o.i. with HSV resulted in the production of a 
non-infectious state for HSV-2 which could be maintained at 
the permissive temperature of 37°C for 12 to 17 days; the 
latent virus could be reactivated by inter-typic
superinfection. Only a small proportion of the cells 
containing HSV genetic information acquired some properties 
associated with transformation; the ability to grow in soft 
agar and/or altered morphologies. Since, in the vast 
majority of infected cells the HSV-2 genome was harboured in 
a non-infectious state from which it could be induced to 
reactivate, it was of interest to examine the virus-cell 
interaction in the context of latency.
4.2.2. Conversion of HSV to a Non-Infectious State in
Cultured Cells
Confluent monolayers of HFL cells, in 35mm diameter 
Petri dishes (approximately 10 cells/plate), were infected 
with wt HSV-2 strain HG52 at 0.003 pfu/cell, and following 
adsorption and penetration of virus, the cultures were 
incubated at 42°C for 6 days and then at 37°C for 4 days. 
Throughout the latter incubation at 37°C, and a further 2 
day incubation at 38.5°C, (both temperatures are permissive 
for HSV replication), cultures were tested for the presence 
of infectious virus.
Sample monolayers were scraped into the culture 
medium, sonicated thoroughly, and subjected to plaque assay 
analysis on BHK cells at 37°C. The results indicated that 
infectious virus was rarely detected. On the occasions when
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infectious virus was detected in a latently infected 
monolayer at 37°C, it appeared to arise from 1 or 2 plaques. 
These plaques presumably resulted from HSV-2 infection of an 
HFL cell in which the virus had not stabilised in a 
non-infectious state and was therefore able to replicate 
when the cells were shifted to the permissive temperature of 
37°C. In all experiments, therefore, it was important to 
maintain untreated, latently infected cultures as controls 
to assess the level of 'spontaneous' reactivation.
In 468 control cultures from 12 experiments, 4 
monolayers (arising from 2 experiments) showed spontaneous 
reactivation of 1 or 2 plaques after incubation for 6 days 
at 42°C followed by 4 days at 37°C. Furthermore, after a 
further 2 days at 38.5°C, 3 monolayers (arising from 1 
experiment) out of 81 control cultures spontaneously 
reactivated virus. Infectious virus was never detected in 
cell sonicates from monolayers which showed no evidence of 
HSV-2 cytopathic effect. Thus, over a 6 day period at 
temperatures permissive for HSV-2, infectious virus was 
undetectable in 9 out of 12 experiments, and was not 
reactivated at significant levels, compared with the 
efficiency obtained by experimental reactivation (see later) 
in the other 3.
The vast majority of infectious HSV-2 particles 
initially applied to the HFL cells was therefore rendered 
non-infectious by incubation at 42°C, and since, as 
described in Section 4.2.4., it is possible to 
experimentally reactivate HSV-2 from these cultures, the 
virus-cell interaction is considered here to be latency.
4.2.3. Permissiveness of Virus, Cells and Growth Medium
Following 42— C Treatment
The absence of detectable HSV-2, after incubation of 
HFL cells latently infected with HSV-2 (0.003 pfu/cell) at 
temperatures permissive for HSV, could have been due to 
stable alterations of the virus and/or of the cell, induced 
by 42°C-treatment, resulting in a non-permissive system.
To test this possibility, the growth of wt HSV-2, 
spontaneously reactivated virus, or, an experimentally
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reactivated virus (see below) from plaque isolate material, 
was compared in normal HFL cells and cells which had been 
incubated for 6 days at 4 2°C followed by 4 days at 3 7°C 
(Table 4.1.). The results show that wt HSV-2, the 
spontaneously reactivated virus and the experimentally 
reactivated virus grew equally well in both cell systems.
Therefore, non-permissiveness of cells or changes in 
the properties of the virus did not account for the failure 
to detect HSV-2 in latently infected cultures at 37°C.
A further possibility was that, during incubation of 
HSV-2 infected cultures at 42°C, an inhibitor of HSV growth 
might be produced by the cells or by the virus, which was 
needed only transiently to convert HSV to a latent state. 
This was tested by assay of the inhibitory effects of growth 
medium, from mock and latently infected cultures, upon the 
infectivity of a sample of HSV-2.
HFL cell monolayers were mock-infected or infected 
with HSV-2 at 0.003 pfu/cell and, following adsorption at 
37°C, the cultures were incubated at 42°C. At 1 day 
post-infection fresh growth medium (EF5) was added to the 
cultures and, subsequently, aspirated after 1 or 2 days in 
contact with the cell cultures at 42°C. 2ml samples of this 
growth medium were added to 5 00 pfu of HSV-2 and incubated 
at 37°C for lh. The inoculum was then used to infect BHK 
cell monolayers at 37°C, and plaques produced were counted 2 
days post-infection.
The results in Table 4.2. seem to indicate an 
inhibitory effect of growth medium from mock infected and 
latently infected cultures on the infectivity of HSV-2. 
However, control samples of growth medium incubated at 4 2°C 
in the absence of mock- or latently-infected cultures 
produced an identical effect (Table 4.2.).
Therefore, it would appear that incubation of growth 
medium at 42°C resulted in an alteration of the medium such 
that it was unable to support the replication of HSV-2. It 
is possible that this property of 42°C-treated medium, in 
combination with incubation of HSV-infected cells at 42 C 
for 6 days, might be involved in the conversion of HSV to a 
latent state.
Table 4.1. PERMISSIVENESS OF HEAT-TREATED AND NORMAL 
UNTREATED HFL CELLS TO INFECTION WITH WT 
AND REACTIVATED HSV-2
TREATMENT
TIME
POST-INFECTION WT
P.F.U./ml
REACTIVATED ftSffcXVOfflED
OF CELLS (h) HSV-2 HSV-2 V&V-X
HEAT-TREATED 16 1.8xl05 1.5x105 \ . 5  *  \ 0 *
24 6.3xl06 1.0x107
48 1.7xl08 1.3x108 * VO*
NORMAL, 16 1.5x105 1.5x105 \.S  X VO5
UNTREATED 24 8.4xl06 7.5xl06 5.*5 x vO
48 2.5x108 1.6x108 \ . 5  x VO*
Normal untreated or heat-treated (pre-incubated at 42°C 
for 6 days followed by 4 days at 37°C) HFL cells were 
infected with 0.003 pfu/cell of wt HSV-2 or with virus 
isolated by superinfection of latently infected cultures 
with jtsKsyn (reactivated virus). After various periods of 
incubation at 3 7°C, cell monolayers plus growth medium 
were harvested, sonicated and titrated on BHK cells.
Table 4.2. EFFECTS OF 42°C-TREATED MEDIA ON THE INFECTIVITY 
OF HSV-2a
SOURCE OF MEDIUM
VOLUME
OF
MEDIUM
(MLS)
MOCK-INFECTED
CELLSb
HSV-2 INFECTED 
CELLS5
MEDIUM
ONLYC
ld 2 1 2 1 2
2.00 1 -7<2 f17 v 0 14 V 0 30 s 0
1.50 40 s 12 V 43 s 20 s 34 s 4 V
1.00 75 s 40 s 70 s 58 s 95 n 29 s
0.50 102 n 105 n 136 n 165 n 126 n 105 n
0.25 189 n 128 n 128 n 158 n 170 n 100 n
UNTREATED
MEDIUM
2.00 19 In
a The sample of medium to be tested was made up to a final
volume of 2ml with fresh EF5, incubated at 37°C for lh
with 500 pfu of HSV-2, then added to BHK cell monolayers. 
Plaques were counted after 2 days at 37°C. 
b EF5 incubated at 4 2°C on mock infected or HSV-2 infected
cell monolayers for 1 or 2 days,
c EF5 incubated at 42°C for 0, 1 or 2 days,
d Number of days incubation of medium at 4 2°C.
e Number of plaques of HSV-2.
f Plaque size: v, very small; s, small; n, normal.
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4.2.4. Experimental Reactivation Induced by Superinfection
For the virus-cell interaction of the system 
described here to be considered as latency, it was essential 
to demonstrate reactivation of HSV-2. It has previously been 
shown that latent HSV can be reactivated in culture by
superinfection with HSV ts mutants or with HCMV ts mutants
(Colberg-Poley et al., 19 79, 1981; Lewis et al., 1984;
Wigdahl et al., 1982a,b; Notarianni, 1986).
4.2.4.1. Superinfection of Latently-Infected Cultures by ts 
Mutants of HSV-1
Cell monolayers, latently infected with HSV-2 (0.003 
pfu/cell), which had been incubated for 6 days at 4 2°C and 4 
days at 37°C, were superinfected at 3 8.5°C with HSV-1 ts 
mutants tsKsyn or _tslsyn. Both of these mutants, in contrast 
to HSV-2 strain HG52, form syncytial plaques on HFL cells. 
The HSV-1 mutant tsK has a mutation in the coding sequences 
for Vmwl75 and synthesises only IE proteins at 38.5°C, 
whereas Jtslsyn is a late mutant which produces viral D N A  as 
well as most polypeptides at the NPT (Section 1.3.4.2.; 
Marsden et al., 1976; Preston, 1979a; Preston, 1981).
Cultures were superinfected with the ts mutants at 
multiplicities of 0.03, 0.1 or 0.3 pfu/cell, overlaid with 
growth medium containing neutralising human serum (EHu5), 
and plaques were counted after incubation for 2 days at 
38.5°C (Table 4.3.). Following superinfection with either 
mutant, cell monolayers contained plaques which were 
predominantly non-syncytial, resembling HSV-2. The number of 
plaques increased approximately in proportion to the amount 
of ts mutant, but it should be noted that m.o.i. values of 1 
or more gave reduced plaque numbers due to cell killing 
(Section 4.2 . 4 . 4 . ) .
4.2 .4 .2. Confirmation of the Identity of Reactivated Virus
To confirm that the non-syncytial, non-ts virus 
reactivated by superinfection with tsKsyn was HSV-2 rather 
than revertants or intertypic recombinants of tsKsyn, DNA
Table 4.3. REACTIVATION OF LATENT HSV-2 BY SUPERINFECTION
SUPERINFECTION
INITIAL
INFEC-
TION o • M tsKsyn*3 tslsyn HCMV Ad2 Ad5 U V t :
HSV-2 ° 0.03 d e 109 (3) 116 (1) 94 0 0 0
HSV-2 0.10 212 (3) 213 (0) 332 0 0 0
HSV-2 0.30 504 (4) TNTCf TNTC 0 0 0
MOCK 0.30 4 (4) 0 0 0 0 0
a Pfu per cell of superinfecting virus.
b Superinfecting virus; uvtsK is tsK which has been u.v.
5
irradiated to reduce the titre by a factor of 5x10 . 
c Initial m.o.i. was 0.003 pfu per cell, 
d Number of plaques per plate.
e Numbers in parentheses represent the number of syncytial 
plaques.
f TNTC, too numerous to count 0500 plaques).
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from reactivated virus plaque isolates was labelled in vivo
3 2  '
with [ P ]-orthophosphate and restricted with BamHI (Figure
4.1.), as described by Lonsdale (1979). All of the 8 virus
samples analysed contained DNA characteristic of HSV-2, with
no evidence for the presence of revertants or recombinants.
Size variation of fragments g, p, w and the band containing
y and z was observed, as previously reported in plaque
isolates of HSV-2 (Buchman et al., 1980; Davison and Wilkie,
19 81; Maitland et al., 19 82; Chaney et al., 19 83).
4.2.4.3. HCMV Superinfection of Latently-Infected Cultures
HFL cells infected with HSV-2 (0.003 pfu/cell) were 
incubated at 42°C for 6 days and 37°C for 4 days prior to 
superinfection with HCMV. Superinfection was at 0.03, 0.10 
and 0.30 pfu/cell. Following adsorption for 1.5h at 37°C, 
the cultures were incubated at 37°C for 2 days.
The results in Table 4.3. indicate that HCMV was as 
efficient as the HSV-1 ts mutants in its ability to 
reactivate latent HSV-2, in agreement with previous findings 
in a related in vitro latency system (Colberg-Poley et al., 
1979, 1981; Wigdahl et al., 1981); the virus produced was
identified as HSV-2 by its ability to form plaques on BHK 
cells, which are non-permissive for HCMV.
4.2.4.4. Cytotoxicity at Higher Superinfecting M.o.i.
Theoretically, superinfection of each latently 
infected cell with at least 1 infectious viral particle 
(under conditions non-permissive for growth of the 
superinfecting virus) should subsequently give rise to 
plaques, the number of which would directly reflect the 
number of cells harbouring latent HSV in reactivatable form.
Table 4.4. shows the results of an experiment in 
which cells were infected with HSV-2 at 0.003 pfu/cell and 
incubated at 42°C for 6 days and then at 37°C for 4 days, 
prior to superinfection with tsKsyn or HCMV at 0.03, 0.10, 
0.30, 1.0, or 3.0 pfu/cell. At 2 days post-superinfection,
the cells were harvested, sonicated and titrated on BHK 
cells. Superinfection of latently infected cultures with
Figure 4.1. DNA PROFILES OF REACTIVATED VIRUS
3 2Autoradiograph of P-labelled BamHI-digested DNA
from reactivated virus samples (lanes 3 to 10 [read left to
right]). Cells were infected with plaque isolates of virus
reactivated from latently infected cultures by
superinfection with ^tsKsyn. Control lanes contain DNA from
cells infected with Wt HSV-2 (HG52) (lane 2) or wt HSV-1
(17) (lanes 1 and 11). DNA samples were labelled in vivo 
32with [ P]-orthophosphate and restricted with BamHI. In vivo 
labelling, electrophoresis and autoradiography were 
performed by Dr. C.M. Preston. The fragments which vary in 
size are labelled.
HSV-2 REACTIVATED VIRUS
HSV-1 HSV-1
Siis-sess-!
g
p
Table 4.4. REDUCED YIELD OF REACTIVATED VIRUS AT
HIGHER SUPERINFECTING MULTIPLICITIES3
SUPERINFECTION
INITIAL
INFECTION M.O.I.b tsKsync HCMV
HSV-2d 0.03 6 0 2.9x10° 8.lxl0^
HSV-2 0.10 2.1xl06 7.5x105
HSV-2 0.30 6.lxlO5 2.6x105
HSV-2 1.00 3.4xl04 2.3xl05
HSV-2 3.00 3.8xl03 4.5x104
MOCK 3.00 0 0
a Latent infections were established with HSV-2 in HFL 
cells and reactivation was achieved by superinfection 
with _tsKsyn or HCMV. 2-3 days post super inf ection the 
cells were harvested into the 2ml of bathing medium 
per plate, sonicated and titrated on BHK cells, 
b Pfu per cell of superinfecting virus, 
c Superinfecting virus.
d Initial m.o.i. was 0.003 pfu per cell, 
e Pfu per ml of cell harvest material.
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tjsKsyn at m.o.i. values of 0t3or more, and with HCMV at
m.o.i. values of greater than 0$ gave reduced yields of
reactivated HSV-2.
This experiment illustrates the problem of cell 
killing which occurs at the higher superinfecting
multiplicities and which is probably due to a toxic effect 
on the cells of non-infectious viral particles in the 
inoculum. Therefore, at such multiplicities, the number of 
plaques formed would not accurately reflect the number of 
cells in which HSV was harboured in a latent and
reactivatable state.
4.2.5. High Efficiency of Experimental Reactivation
The number of plaques produced following 
superinfection at a specific m.o.i. can vary by at least 
3-fold. From the data presented in Table 4.3., it is clear 
that a high proportion of the infectious HSV-2 particles 
were reactivated by superinfection. For example, in cultures 
of 10^ cells initially infected with 3000 pfu of HSV-2, an 
average of 209 plaques were detected after superinfection 
with 0.1 pfu/cell of tsKsyn or tslsyn, and 332 were observed 
after superinfection with 0.1 pfu/cell of HCMV. This finding 
suggests that the efficiency of reactivation is very high, 
since only 10% of HFL cells harbouring HSV-2 had received a 
potentially infectious superinfecting virus particle. The 
data in Table 4.13. suggest an approximately 3-fold lower 
efficiency of reactivation of HSV-2 by superinfection with 
_tsKsyn for this experiment.
To further investigate the efficiency of 
reactivation, lower initial doses of HSV-2 were used (Table
4.5.). The results in Table 4.5. show that 15-34% of the 
initial infectious HSV-2 could be reactivated by 
superinfection with 0.3 pfu/cell of tsKsyn, and imply that a 
greater proportion (50-100%) could have been reactivated but 
for the problem of cytotoxicity at higher multiplicities of 
tsKsyn (Section 4.2.4.4.). This calculation could be 
affected by the presence of non-infectious HSV-2 or tsKsyn 
particles, as discussed in Section 4.2.9..
The calculation of reactivation efficiency depends
Table 4.5. EFFICIENCY OF REACTIVATION OF HSV-2 FROM LATENTLY
INFECTED CULTURES BY SUPERINFECTION WITH tsKsyn3
EXPT. ACTUAL PFU PLAQUES
NO. APPLIED TO PLATE REACTIVATED
1 61, 84 13, 12
1 210, 220 37, 27
2 42, 53 13, 14
2 103, 104 35, 34
% INITIAL 
HSV-2 REACTIVATED
18
15
29
34
a Latent infections were established in HFL cells
at low initial m.o.i.and reactivation was achieved 
by superinfection with tsKsyn at 0.3 pfu/cell.
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upon the well-established observation that replication and 
spread of HSV-2 to form new foci of infection does not occur 
at 42°C (Crouch and Rapp, 19 72; Darai and Munk, 19 73; Marcon 
and Kucera, 1976; Levine et al., 1980; Notarianni, 1986). 
Addition of neutralising rabbit anti-HSV serum (a gift of 
Dr. A. Cross) to the growth medium during the first 2 days 
of incubation at 4 2°C did not affect the number of plaques 
produced after superinfection with tsKsyn, suggesting that 
HSV-2 did not replicate and spread at 4 2°C in the system 
reported here (Table 4.6.). (It should be noted that spread 
of virus to adjacent cells would not be prevented by the 
presence of antiserum, but that such foci would yield only 1 
plaque upon superinfection).
The calculation of reactivation efficiency would also 
be affected by the replication and spread of HSV-2 to form 
new foci of infection at 37°C, a temperature permissive for 
HSV replication. The following experiment attempted to 
determine the level of replication and spread of the virus 
at 37°C. HFL cells were infected with HSV-2 at 0.003 
pfu/cell and incubated at 42°C for 6 days at 42oC and then 
at 37°C for 1, 2, 3 or 4 days. The cultures were 
superinfected with LsKsyn at a m.o.i. of 0.03 pfu/cell at 
the NPT. The results from Table 4.7. show that there is no 
significant difference in the numbers of plaques of virus 
reactivated by tsKsyn superinfection (0.03 pfu/cell) 
following 1, 2, 3 and 4 days incubation at 37°C, thus
implying that there is no spread of HSV-2 during the 3 7°C 
period to form new foci of infection. This correlates with 
the infrequency of detection of infectious virus during 37°C 
incubation (Section 4.2.2.).
Taken together, these results imply that a relatively 
high efficiency of experimental reactivation can be 
achieved.
4.2.6. Subculture of Latently Infected Cultures
To investigate whether alterations in cell growth 
state could reactivate HSV-2, latently infected HFL cells 
were subcultured by trypsinisation and replating on new 
Petri dishes at half the original cell density. Monolayers
Table 4.6. EFFICIENCY OF REACTIVATION FROM LATENTLY INFECTED 
CULTURES PRETREATED WITH NEUTRALISING ANTISERUMa
ANTISERUM DILUTION 
SUPERINFECTION M.O.I.b 0 1/100° 1/250
tsKsyn 0.03 40d (0)e 27 (1) 32 (1)
tsKsyn 0.10 116 (2) 98 (1) 100 (2)
MOCK 0.0 0 0 0 0
a Latent infections were established with 0.003 pfu/cell 
of wt HSV-2 in HFL cells. The cultures were overlaid with 
EF5 or with EF5 plus rabbit anti-HSV antiserum for the 
first 2 days postinfection at 42°C, and overlaid with EF5 
for a further 4 days at 42^C and 4 days at 37°C. The 
cultures were then superinfected with tsKsyn and plaques 
were counted after 2 days at 38.5°C. 
b Pfu per cell of superinfecting virus, 
c Antiserum dilutions. In control experiments: 1/100
dilution neutralised 90% of infectious HSV-2 and 1/250 
dilution neutralised 50% of infectious HSV-2. 
d Number of plaques per plate.
e Numbers in parentheses represent the number of syncytial 
plaques.
Table 4.7. SUPERINFECTION OF LATENTLY-INFECTED CULTURES 
AFTER 1, 2, 3, AND 4 DAYS INCUBATION AT 3 7°Ca
PLAQUES
DAYS, TEMP. PER PLATE
6,42°C and 1,37°C 100 (3)c
6,42°C and 2,37°C 168 (5)
6,42°C and 3,37°C 172 (5)
6,42°C and 4,37°C 110 (0)
a Cultures were infected with HSV-2 at 0.003 pfu/cell, 
incubated at 42°C for 6 days and 37°C for 1, 2, 3, or 4 
days, and then super inf ected with _tsKsyn at 0.03 pfu/cell 
at 3 8.5°C.
Plaques were counted after 2 days, 
b The number of days of incubation at 42°C and at 37°C 
prior to superinfection, 
c Numbers in parentheses represent the number of syncytial 
plaques.
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were grown to confluence and tested for the presence and 
reactivation of HSV-2.
HFL cell monolayers on 35mm Petri dishes, infected 
with HSV-2 at 0.003 pfu/cell, were incubated at 42°C for 6 
days followed by 37°C for 4 days, prior to subculture. 
Confluent monolayers of passaged cells were re-subcultured, 
or, superinfected with tsKsyn at 0.3 pfu/cell and incubated 
at 38.5°C for 2 days.
No infectious virus was recovered in the growth 
medium or after harvesting, sonication and titration of 
cells, but superinfection with tsKsyn was able to reactivate 
HSV-2 (Table 4.8.). The number of plaques produced per plate 
after superinfection with tsKsyn declined as cells were 
subcultured, although HSV-2 could still be reactivated after 
three passages.
This experiment shows that not only is HSV maintained 
in a non-infectious state in tissue culture cells for at 
least 13 days at a temperature permissive for HSV 
replication, but that this non-infectious state is not 
disrupted upon subculture of infected cell monolayers.
4.2.7. Chemical or Ultraviolet Light Treatment of Latently
Infected Cultures
Various other manipulations of latently infected 
cells were carried out to test the stability of the 
virus-cell interaction, including exposure to UV irradiation 
and to the chemical compounds 5-azacytidine or 
12-O-tetradecanoyl-phorbol-13-acetate (TPA).
UV irradiation has been shown to stimulate the 
reactivation of latent HSV-1 in vivo (Blyth et al., 1986), 
for example, in the mouse ear model, in which initial 
infection with HSV in the ear results in the establishment 
of a latent HSV infection in the cervical ganglia, exposure 
of the ear to UV irradiation results in the reappearance of 
infectious virus in the ganglia 1 to 5 days later (Harbour 
et al., 1983).
5-azacytidine induces the expression of genes by 
inhibiting the methylation of newly synthesised DNA (Jones,
19 84; Taylor et al., 19 84), and can not only induce the
Table 4.8. MAINTENANCE AND REACTIVATION OF HSV-2 AFTER
SUBCULTURE OF LATENTLY INFECTED CELLS3
Number of plaques /plate after superinfection 
with 0.3 pfu/cell of _tsKsyn or mock superinf ection
ORIGINAL PASS 1 PASS 2 PASS 3
EXPT. Mock tsK Mock tsK Mock jtsK Mock tsK
NO.
1 0 183 (9 )C 0 115 (7) NDd ND ND ND
2 0 307 (6) 0 240 (8) 0 95 (6) 0 23 (2)
3 0 244 (3) 0 125 (3) 0 31 (0) 0 23 (2)
a Latent infections were established with 0.003 pfu/cell 
of wt HSV-2 in HFL cells, 
b At each passage, cell monolayers were trypsinised and
reseeded at half the original density. Superinfection was 
carried out at 38.5°C when cell monolayers were confluent 
and plaques were counted after 2 days, 
c Numbers in parentheses represent the number of syncytial 
plaques. 
d ND, no data.
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reexpression of the HSV TK gene from mouse cells transformed 
with the viral information in an inactive state (Clough et 
al, 1982) but can also activate the EBV replicative cycle in 
latently infected human lymphoid cell lines (Ben-Sasson and 
Klein, 1981) .
TPA affects latent EBV by enhancing the expression of 
various transcripts and inducing the virus to enter the 
replicative cycle (zur Hausen et al., 1978; Jeang and 
Hayward, 1983; Faggioni et al., 1986; Boos et al., 1987).
HFL cells infected with HSV-2 (0.003 pfu/cell) were 
incubated at 42°C for 6 days and 37°C for 4 days, and then 
exposed to various chemicals or to ultraviolet irradiation. 
The concentrations and time periods of treatments to which 
latently infected cells were exposed, as well as other 
experimental details, are described in Table 4.9. It should 
be noted that since the ability of 5-azacytidine to 
demethylate DNA requires replication of DNA, the latently 
infected cells were passaged once during exposure to 
5-azacytidine.
None of the treatments tested were able to induce the 
reactivation of HSV-2 from its latent state in vitro, as 
discussed in Section 4.2.9.
4.2.8. Specificity of Virus-Cell Interaction
To determine whether establishment and maintenance of 
a latent state in vitro was exclusively a feature of an 
interaction between HFL cells and HSV-2 strain HG52, the 
cell type and virus strain were varied.
HSV-2 strain HG52 (0.003 pfu/cell) could be converted 
efficiently to a latent state in another cell line, human 
foreskin fibroblasts, upon incubation at 42°C for 6 days. 
Incubation was continued at 37°C for a further 4 days, 
during which time no plaques of reactivated virus were 
detectable. The presence of latent HSV-2 in these cells was 
demonstrated by superinfection of cultures with 0.03, 0.10 
or 0.30 pfu/cell tsKsyn and incubation at 38.5 C for 2 days, 
which resulted in the appearance of plaques of reactivated 
virus in the cell monolayers (Table 4.10.)
Three additional strains of HSV-2, strains 333, 186
Table 4.9. CHEMICAL AND PHYSICAL TREATMENTS APPLIED 
TO LATENTLY INFECTED CULTURES
TREATMENT EXPERIMENTAL DETAILS
UV-Irradiation 
(240 nm)
Distance = 200cm
Exposure = 30sec,
1,2,3 or 5 min
Energy output =
2
32erg/mm /sec
EF5 was aspirated from latently 
infected cell monolayers and 
replaced by warm PBS. Petri dish 
lids were removed and the cells 
exposed to UV light. EF5 was 
reapplied and cultures were 
incubated at 38.5°C for 2 days.
TPA
Concentration = 
200ng/ml
EF5 was removed from monolayers and 
replaced with TPA in warm PBS. EF5 
was reapplied and the cultures were 
incubated at 38.5°C for 2 days.
5-Azacytidine 
Concentrations = 
0.75,1.5,3.0 or 6.0uM
EF5 was removed from monolayers, 
replaced with 5-azacytidine in EF5 
and incubated at 3 7°C for 2 days. 
The cells were then trypsinised and 
replated at half the original cell 
density in EF5 plus 5-azacytidine. 
Monolayers were stained after a 
further 4 days at 37°C.
HFL cells were infected with HSV-2 at 0.003 pfu per cell 
and incubated in EF5 at 42°C for 6 days and then at 37 C 
for a further 4 days, prior to exposure to the various 
physical and chemical treatments outlined above.
Table 4.10. ESTABLISHMENT OF DIFFERENT STRAINS OF HSV-2 
IN A LATENT STATE IN HUMAN FIBROBLASTIC 
CELL LINES HFL AND HFFa
CELL LINE
HFF HFL
I
M.O.I. 'HSV-2 Strain11- - ----------1
Super-
Infection HG52 HG52 333 186 UW268
0.03 67C (ND)d 40 (2) 12 (1) 8 (1) 8 (1)
0.10 142 (ND) 127 (3) 52 (5) 23 (2) 16 (1)m
0.30 TNTC0 TNTC 133 (10) 44 (3) 89 (8)
a Cultures were infected with 0.003 pfu/cell of wt HSV-2 
virus strains, incubated at 42°C for 6 days and 37°C 
for 4 days. Superinfection of cultures with tsKsyn was 
carried out at 3 8.5°C; and plaques were counted after 
2 days.
b Pfu of superinfecting virus per cell.
c Number of plaques per plate.
d Numbers in parentheses represent the number of syncytial 
plaques.
e TNTC, too numerous to count.
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and UW268, were compared with HSV-2 strain HG52 for the
ability to establish a latent interaction with HFL cells.
HFL cells were infected with HSV (0.003 pfu/cell) and
incubated at 42°C for 6 days and then 37°C for 4 days. There
was no evidence of plaques of spontaneously reactivated
virus in the monolayers during the 37°C period. The presence
of latent virus in these cultures was demonstrated by the
appearance of plaques of reactivated HSV-2 following tsKsyn
superinfection at 0.03, 0.10, or 0.30 pfu/cell at 38.5°C.
All HSV strains tested became established in a latent state
in HFL cells and could be experimentally reactivated (Table
4.10.). Results in Table 4.12. show that HSV-1 strain 17 is
also able to establish a latent state in this system;
reactivation of latent HSV-1 was achieved by HCMV
superinfection at 0.02 pfu/cell.
0
4.2.9. Discussion
In the system described, HSV is efficiently converted 
to a non-productive state in human fibroblasts by incubation 
at 42°C, and can be maintained in this state at permissive 
temperatures for viral growth for at least 13 days; the 
level of spontaneous reactivation is low. The virus-cell 
interaction produced can be classified as latency since HSV 
is maintained in a non-infectious state under conditions 
permissive for virus replication and can be experimentally 
reactivated by superinfection.
In the use of HFL cells and supraoptimal temperatures 
to suppress virus replication, the system described 
(Notarianni, 1986; Russell and Preston, 1986) is similar to 
work published by O'Neill (1977), who has examined HFL cells 
after infection with HSV-2 at 39.5 to 40°C, but found that 
all cultures rapidly produced virus when downshifted to 
37°C. It is likely, therefore, that the higher temperature 
of 42°C may be important for establishment of the latent 
state. It is important to note that here the latent state is 
defined as the period, albeit short, at the permissive 
temperature of 37°C rather than 39.5 to 40.5°C used in 
inhibitor-treated repressed cells.
It is possible that conversion of HSV to a latent
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state by the use of supraoptimal temperature is a 
consequence of the cellular stress response, which is known 
to be induced in human embryo lung cells incubated at 4 2°C 
(Notarianni, 1986; Figure 4.2.). The stress response is 
manifested at the level of transcription and leads to 
repression of transcription of most cellular genes and the 
overexpression or positive induction of expression of a set 
of genes termed cellular stress (or heat shock) genes 
(Notarianni, 1986). A latent state might be achieved through 
the effect of alterations in cell metabolism brought about 
by the cellular stress response, or, as a direct result of 
the cellular stress response upon viral gene expression. The 
apparent inability of 42°C-treated growth medium to support 
an efficient lytic infection of HSV is another 
consideration, and further investigation of the properties 
o'f the 4 2°C-treated medium would be of some interest.
It has been argued that in vitro latency systems 
should involve neuronal cells, which are highly 
differentiated and non-dividing and which represent the 
predominant site of latency for HSV. However, since there is 
recent evidence to suggest that HSV establishes latency in 
non-neuronal cells (Clements and Jamieson, 1989; Clements 
and Subak-Sharpe, 1988; Al-Saadi et al., 1988) it may be the 
metabolic state of the neuron rather than its extreme 
differentiation per se that is of importance in producing 
the latent state. Therefore, the use of fibroblasts in the 
latency system described rather than neuronal cells may not 
be an important variable.
Production of a latent viral state might be a general 
feature of interaction between HSV and cells following 42°C 
treatment; HSV-2 established a latent state in both HFL and 
HFF cells, and HSV-1 established a latent state in HFL 
cells. The HFL and HFF cells utilised in the system were 
chosen partly because of their ability to survive incubation 
at the supraoptimal temperature of 42°C for 6 days. Cook and 
Brown (1986, 1987) have since reported that HSV-1 can be
maintained in a non-productive state in cultured rabbit 
corneal cells (epithelial cells, keratocytes and endothelial 
cells) during incubation of infected cultures at 41.5 C or 
42°c and for several days during the subsequent 37°c
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incubation period. Cook and Brown (1986, 1987) considered 
that HSV was latent during the period of incubation at 
41.5°C or 42°C, which are temperatures non-permissive for 
viral growth, rather than during the period at 37°C in which 
infectious virus was not detectable. Cellular stress 
proteins were induced in the rabbit corneal cells at 41. 5°C 
(Cook and Brown, 1986). Superinfection of infected-cultures 
with an HSV-1 deletion mutant, following 42°C treatment, 
resulted in the isolation of virus with the wild-type DNA 
structure, at least a proportion of which was assumed to be 
reactivated input virus; in addition recombinants between 
the HSV-1 genomes harboured in the corneal cells and the 
superinfecting HSV-1 genomes were isolated. The significance 
of the system of Cook and Brown (1986, 1987) is in the 
demonstration that incubation at supraoptimal temperatures
3
can convert HSV to a latent state in corneal cells in which, 
there is evidence to suggest, HSV can be harboured in a 
latent state in vivo (Shimeld et al., 1982; Tullo et al., 
1985; Cook et al., 1987).
The latent state produced is apparently very stable, 
inasmuch as it is not susceptible to disruption by the 
various chemical and physical manipulations described, the 
effects of which, in vitro, would be generally manifested in 
alterations of cellular or viral metabolism.
UV-irradiation of cells latently infected with HSV in 
vitro did not induce reactivation of HSV. The primary effect 
of ultraviolet irradiation on the DNA of cultured cells 
would be a photolytic action causing adjacent pyrimidine 
rings, particularly thymines, to coalesce in pairs, thereby 
weakening the bonds between the 2 strands of the double 
helix and leading to distortion of the helix and inhibition 
of replication and transcription of DNA. In vivo,
UV-irradiation at the periphery induces reactivation of HSV
from latently infected ganglia (Blyth et al., 1976),
It is unlikely that the effects
of direct UV-irradiation of cultured cells would be
equivalent to those produced in ganglionic cells following 
UV-irradiation at the periphery.
On the assumption that the 5-azacytidine treatment of
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latently infected cells demethylated the HSV genome, 
demethylation is apparently unable to induce sufficient HSV 
gene expression for progression from the latent to the lytic 
cycle, implying that the latent state of the HSV genome is 
not a result of extensive methylation of the genome. 
Although this does not correlate with the in vivo findings 
that 5-azacytidine and the demethylation agent HMBA induce 
reactivation of latent HSV from explants of neural and 
non-neural tissues (Bernstein and Kappes, 1988; 
Stephanopoulos et al., 1988), it is consistent with the
findings of Dressier et al. (1987) that latent HSV is not 
heavily methylated in vivo. The inability of TPA treatment 
to induce reactivation suggests that the mechanism of 
reactivation, and thus possibly the latent state, of HSV 
differs from that of EBV; the latent EBV genome is reported 
to be extensively methylated and may be reactivated by 
treatment with demethylation agents as well as with TPA.
HSV is not reactivated by passage of the latently 
infected cultures and it was noted that the proportion of 
cells harbouring a latent HSV genome decreased upon cell 
passage. This would seem to suggest that replication of the 
latent HSV genome does not occur concomitantly with cellular 
DNA replication. However, a decrease in the proportion of 
cells harbouring latent HSV DNA would also be observed if 
the cells latently infected with HSV were unable to divide, 
or if the cells and the latent virus were able to divide but 
death of a proportion of the latently infected cells 
occured. Consequently, the replicative nature of the latent 
HSV cannot be inferred from this experiment.
Reactivation of HSV from its latent state can be 
induced rapidly by intertypic superinfection, as previously 
shown by Notarianni (19 86) and as reported for other in 
vitro latency systems (Colberg-Poley, 1979, 1981; Wigdahl, 
1982a,b). In experiments reported here, superinfection, by 
viruses tsK or HCMV, of HSV-infected cells incubated at 42°C 
for 6 days and 37°C for a further 4 days, reactivated HSV-2 
rapidly and efficiently.
Although the efficiency of reactivation calculated 
suggests that both the establishment of latency and 
reactivation from latency of HSV occur with high frequency
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in the system described, involvement of non-infectious viral
particles present in initial infecting and in superinfecting
inoculums would affect this calculation. For instance, if
non-infectious HSV-2 particles were maintained in a latent
state and were reactivated by tjsKsyn superinfection,
complementation of the superinfecting virus by the
reactivated virus, and vice versa, would culminate in the
formation of a plaque. One argument against this occurrence
is that HCMV reactivates latent HSV-2 as efficiently as
tsKsyn. There is also an approximate correlation between HSV
genome copy number per cell and the number of infectious
HSV-2 particles (Section 4.5). Alternatively, should
non-infectious particles of _tsKsyn and of HCMV have been
able to supply the functions essential for triggering the
reactivation event, then a higher proportion of latently »
infected cells would have received a potentially 
reactivating viral particle than calculated according to the 
number of infectious viral particles. Assuming that the 
particle to pfu ratio of tsKsyn is between 10:1 and 100:1; 
if 0.3 pfu/cell is the superinfecting m.o.i. then each cell 
would receive 3 to 30 non-infectious particles per cell. 
Unless less than 1 of the non-infectious particles per cell 
is capable of producing functions required for reactivation, 
a 3-fold lower level of reactivation would not be expected 
at a 3-fold lower multiplicity of superinfection. Since a 2- 
to 3-fold lower level of reactivation is observed following 
superinfection of latently infected cells at 0.1 pfu/cell 
compared to superinfection at 0.3 pfu/cell, then it may be 
concluded that less than 1 out of 3, and possibly less than 
1 out of 30, non-infectious particles is capable of 
reactivating latent HSV. Complementation studies of Messer 
(1978) suggested that some non-infectious particles of HSV-2 
mutant viruses were effective in producing plaques if 
complemented by another HSV-2 mutant and were therefore 
capable of producing some viral functions. However, in HSV-1 
infections, the proportion of cells expressing IE gene 3, as 
determined by immunofluorescence studies, correlated 
approximately to the number of pfu initially applied to the 
cells (N.D. Stow, personal communication). IE-3 gene 
expression is positively regulated by the same mechanism as
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expression of the other IE genes, therefore it is unlikely 
that HSV-1 non-infectious viral particles express the IE 
genes. Since, from the results presented in this thesis 
(Section 4.4.) there is a requirement for at least one of 
the IE polypeptides in the reactivation of HSV from its 
latent state in vitro by superinfection with HSV-1 mutants, 
then it is unlikely that non-infectious particles of 
superinfecting HSV-1 mutants are capable of inducing 
reactivation.
Therefore, the implication of the results presented
is that there is a high efficiency of establishment and
reactivation in the latency system: 30-100% of input HSV-2
is able to establish a latent state from which reactivation
may be induced upon superinfection with the HSV-1 mutant
tsKsyn. In the system of Wigdahl and coworkers (19 81,
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1982a,b), HSV, converted to a latent state by the use of 
viral inhibitors and temperature elevation, can be induced 
to reactivate by temperature reduction or by intertypic
superinfection with ts mutants of HCMV or with HSV. However,
the percentage recovery of input virus following 
superinfection is relatively low, (1% to 3%), despite an
initial infecting m.o.i. of 2.5 pfu/cell and a
superinfecting m.o.i. of 1 pfu/cell, suggesting a low 
efficiency either of establishment of latency or of 
experimental induction of reactivation. It was shown that a 
significant proportion of the cells harboured HSV in a 
latent state not reactivatable by superinfection or 
temperature reduction, as judged by the presence of HSV 
antigens following superinfection or temperature reduction 
and the level of detection of HSV genomes in the cells 
(Wigdahl et al., 1982b, 1984a,b). Thus, the efficiency of 
conversion of HSV to a latent state and the efficiency with 
which latent HSV can be experimentally reactivated appear to 
be significantly lower in this system in comparison to the 
system described in this thesis.
In summary, the latency system described fulfills all 
of the criteria proposed by Levine et al. (1980) inasmuch 
as, infected cells survive and harbour the complete HSV 
genome in a non-infectious state, and infectious virus can 
be recovered following manipulation of the culture by
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superinfection. Although the system described is similar to, 
and indeed partly based on, previous studies by others, 
differences exist in the methodology used and results 
obtained. It is not clear whether these variations are a 
matter of degree or if the virus-cell interactions are 
fundamentally different; this will be discussed in later 
sections. The system has the advantages of simplicity, 
relying solely on the use of supraoptimal temperature to 
convert HSV to a latent state, as well as a high level of 
reproducibility and a high efficiency of establishment and 
reactivation. The following sections are concerned with 
analysis of the latent viral-cell interaction.
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4.3. VIRAL FACTORS INVOLVED IN ESTABLISHMENT OR
MAINTENANCE OF LATENCY
4.3.1. Introduction
The approaches taken in analysis of the viral factors 
involved in establishment or maintenance of latency in vitro 
are essentially equivalent to the approaches used in the in 
vivo experiments outlined in Section 1.3.4.2., namely, 
identification of the HSV genes required in latency via 
examination of the behaviour of HSV mutants in the latency 
system, and, analysis of HSV gene expression in latently 
infected cells.
In the former studies, the ability of a mutant to 
become established in a latent state in vitro was assessed 
by its capacity to maintain a non-infectious state, during 
incubation at a permissive temperature for HSV replication 
for at least 6 days, from which it could be induced to 
reactivate upon superinfection. The purpose of these studies 
was to elucidate viral factors non-essential for HSV 
latency, and thereby, by a process of elimination, to 
identify viral factors which might be involved in 
establishment or maintenance of the latent state.
Preliminary analysis of viral gene expression in 
latently infected cells involved the use of a sensitive 
enzyme assay to detect the presence of functional gene 
products from the HSV E TK gene.
4.3.2. Analysis of Latently Infected Cultures for Viral
TK Activity
Latent HSV gene expression was investigated by 
analysis of TK enzyme activity in latently infected cells. 
Since only a small proportion (0.3%) of HFL cells harbour a 
latent HSV genome in the system described, the initial 
m.o.i. of input HSV was increased 100-fold or 300-fold to 
give a higher proportion (30% or 100%) of cells containing 
latent HSV and, thereby, to increase the probability of 
detecting gene expression from the latent virus, should it
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occur. The viral TK assay is sensitive enough to detect the 
presence of the enzyme in cells initially infected at 0.01 
pfu per cell (C.I. Ace, personal communication). Therefore, 
TK assays were performed on HFL cell cultures infected with 
wt HSV-2 strain HG52 at 0.3 or 1.0 pfu/cell, which had been 
incubated at 42°C for 6 days.
The results (Table 4.11.) indicate that no viral 
thymidine kinase activity above background levels for mock 
infected cells was detectable in these latently infected 
cultures, suggesting that viral TK is not required for the 
maintenance of the latent state in vitro. This result also 
suggests that transcription, translation or processing of 
viral TK is inhibited in latently infected cells, or that 
the TK polypeptide is altered in such a way as to destroy 
its enzymatic activity. The HSV TK gene is a typical E HSV 
gene in terms of its promoter and regulatory regions, so, if 
there is a block in transcription of this gene in latently 
infected cells, it is probable that expression of other E 
HSV genes is similarly affected.
4.3.3. HSV-2 ts Mutants and Establishment of Latency
The HSV-2 mutants tested for the ability to establish 
latency in vitro were te3, ts5, ts9 and tsll. With respect 
to the properties of these mutants at the NPT: ts3 and ts5 
are DNA positive; ts9 and tsll are DNA negative; the best 
characterised are ts5, which is defective in a late function 
at the NPT (38.5°C), and ts9, which is defective in the 
uncoating process as well as in a late function at the NPT 
(39.5°C) (Messer, 1978; Marsden et al., 1976).
HFL cells were infected with ts3, ts5, ts9 or tsll at 
0.003 pfu/cell, and, following a lh adsorption period at the 
NPT, the cultures were incubated at 42°C for 6 days and then 
at 31°C for 4 days.
During the 31°C period, no plaques were observed in 
any of the cultures, demonstrating that replication of the 
mutants was repressed by incubation at 42°C, as described 
previously for the wt HSV-2 strains (Section 4.2.8.). 
Super inf ection of ts5- and ^ts9- infected cultures with HCMV 
at 31°C resulted in the appearance of plaques, indicating
Table 4.11. VIRAL THYMIDINE KINASE ASSAY OF LATENTLY 
INFECTED CULTURES3
INITIAL INFECTION TK ACTIVITY
Virus M.o.i. cpm/Cell
Mock 0 0.03
HSV-2 0.3 0.04
HSV-2 1.0 0.03
Positive Control*3 1.50
a, HFL cells were mock-infected or infected with HSV-2
at 0.3 or 1.0 pfu per cell and incubated in EF5 at 4 2°C 
for 6 days. Cultures were harvested and thymidine kinase 
assays were performed on 20ul of the cytoplasmic fraction 
from each sample. The results are shown in cpm/cell.
The data are from 1 experiment, 
b A positive control for the TK assay, a sample known to 
possess thymidine kinase activity.
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that reactivation of these mutants had occurred (Tab.l e
4.12.). There was, however, reduced recovery of the HSV-2 
mutant ts9 compared to recovery of wt HSV-2 and _ts5, as 
discussed in Section 4.3.6.. Virus was not recovered from 
the latently infected cultures upon HCMV superinfection at 
the non-pemissive temperature; titration of cell sonicates 
on BHK cells at 31°C and 3 8.5°C showed that the virus 
reactivated following HCMV superinfection at 31°C of the 
latently infected cultures was unable to form plaques on BHK 
cell monolayers at the NPT. Therefore, the reactivated virus 
was parental ts virus, rather than revertant virus. Those 
results indicate that both ts5 and ts9 were able to 
establish a latent infection in vitro.
HCMV superinfection at 31°C of ts3- and tsll- 
infected cultures did not result in the production of 
plaques in the cell monolayers (Table 4.12.). However, 
titration of cell sonicates, from the HCMV superinfected 
cultures, on BHK cell monolayers at 31°C resulted in the 
production of plaques of ts virus (plaques were not produced 
upon titration of cell sonicates at 38.5°C). One possible 
explanation of these findings is a decreased plaquing
efficiency of jts3 and tsll mutant viruses on HFL cells 
compared to BHK cells. Indeed, a comparison of the titres of 
the _ts3 and tsll mutant viruses on BHK cells and on HFJ.. 
cells revealed that the mutants produced 100-fold less
plaques on HFL cells. These findings suggest that both ts.3 
and t^ sll were converted to a latent state in this in vitro 
system, and were induced to reactivate by HCMV 
superinfection, but that plaques of reactivated virus were
not produced due to the reduced plaquing efficiency of these
mutants on HFL cells.
In conclusion, all of the HSV-2 ts mutants tested, in 
addition to wt HSV-2, were able to establish a latent 
infection in vitro. Therefore, assuming that these mutants 
are as restricted in their gene expression at 42°C as at the 
non-permissive temperature of 3 8.5°C, growth and spread of 
input virus is not a prerequisite for the interaction to 
occur.
Table 4.12. ESTABLISHMENT OF LATENCY BY HSV ts MUTANTS3
INITIAL INFECTION
SUPER­
INFECTION HSV-2 ts3 ts5 ts9 tsll
HCMV
MOCK
49 b(13)C 0 87 (25) 13 (5) 0
0 0 0
SUPER­
INFECTION
INITIAL INFECTION
HSV-1 tsKsyn tslsyn
HCMV
MOCK
62 (11) 31 (10) 95 (26)
0 0 0
a Monolayers were initially infected with 0.003 pfu/cell of 
wt HSV-1, wt HSV-2, or ts mutants of HSV, incubated at 
42°C for 6 days, 31°C for 4 days and superinfected with 
0.02 pfu/cell of HCMV or mock-superinfected. Plaques 
formed after incubation at 31°C for 3 days were counted, 
b Mean number of plaques per plate.
c Standard error of the means of at least 3 determinations.
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4.3.4. HSV-1 Ts Mutants and Establishment of Latency
The ability of wt HSV-1 to establish a latent 
infection in vitro was referred to in Section 4.2.8. (Table
4.12.). The HSV-1 ts mutants tested for the ability to 
establish latency were tslsyn and tsKsyn. The phenotypes of 
these mutants at the NPT have been described elsewhere 
(Sections 1.2.3.2., 1.3.4.2. and 4.2.4.1.).
4.3.4.1. Polypeptide Profile of tsK at 42— C.
To determine whether tsK produces the same 
polypeptide profile at 42°C as at 38.5°C, cultures of HFL 
cells were infected with tsKsyn at 10 pfu/cell and cultures 
were pulse-labelled after incubation at 42°C or 38.5°C for 
4h, or, after incubation at 31°C for 8h. Labelled, infected 
cell polypeptides were analysed by SDS-PAGE. The results 
shown in Figure 4.2. suggest that the polypeptide profiles 
of the mutant at 42°C and at the NPT of 38.5°C are similarly 
restricted.
4.3.4.2. Establishment of Latency by tsKsyn and tslsyn
HFL cells were infected with _tslsyn or tsKsyn at 
0.003pfu/cell and, following adsorption and penetration at 
38.5°C, the cultures were incubated at 42°C for 6 days and 
at 31°C for 4 days.
Plaques were not observed in any of the infected, 
42°C treated cultures during subsequent incubation at the 
permissive temperature of 31°C, demonstrating repression of 
replication of these mutants as a result of the 42°C 
incubation. In both cases, however, superinfection with HCMV 
at 31°C resulted in the production of plaques, indicating 
that reactivation of HSV had occurred (Table 4.12.). The 
reactivated virus from _tsl- and tsK-infected cultures was 
shown to have retained the ts phenotype when cell sonicates 
were titrated on BHK cells at 31°C and 38.5°C, and, as with 
the HSV-2 mutants, virus was not recovered from the latently 
infected cultures upon HCMV superinfection at the
Figure 4.2. VIRAL POLYPEPTIDE PROFILES AT 42°C
HFL cell monolayers were mock-infected (lanes 1,
2 and 3), or infected with jtsK (4, 5 and 6), inl411 (lanes 7 
and 8), dll403 (lanes 9 and 10) or wt HSV-1 (17) (lanes 11 
and 12). Cultures were pulse-labelled after incubation at 
38.5°C (lanes 2, 5, 7, 9 and 11) or 42°C (lanes 3, 6, 8, 10 
and 12) for 4h, or, at 31°C (lanes 1 and 4) for 8h. SP (— *) 
is a cellular stress protein. HSV early and late (— ) and 
immediate early polypeptides (^ >) are labelled.
M O C K t s K  iin141  1 1 d f l4 0 3 w tH S V -1
S 5 / 6 4
1 2 3 4 5 6  7 8 9 1 0 1 1 1 2
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non-permissive temperature.
Therefore, HSV-1 mutants _tsl and _tsK were able to 
establish a latent infection in vitro. These findings 
support the notion that growth and spread of input virus is 
not necessary for establishment and maintenance of latency 
in vitro. The results with tsKsyn also illustrate that 
little or no viral gene expression is required for 
establishment and maintenance, and suggest that, at most, 
only the early polypeptide Vmw 136 and the IE polypeptides 
are necessary, with the possible exception of IE Vinwl75 
which is produced by _tsK as an abnormal polypeptide at the 
non-permissive temperature (Preston, 1979). Further 
investigation was carried out by the use of mutants in!411 
and d!1403.
4.3.5. HSV-1 Insertion and Deletion Mutants
The phenotype of inl411 is similar to that of tsK (at 
the non-permissive temperature), since gene expression is 
limited to the IE polypeptides Vmwl2, Vmw6 3, Vmw68 and 
VhiwllO, plus Vftiwl36; the results in Figure 4.2. show 
polypeptide profiles for _inl411-infected HFL cells 4h post 
infection at temperatures of 38.5°C and at 42°C. Cultures 
were infected with in!411 (0.003 pfu/cell) and incubated at 
42°C for 6 days followed by downshift to 3 7°C for 4 days. 
After this period, it was not possible to demonstrate the 
presence of latent virus by superinfection with HCMV, but 
this result was probably due to the failure of in_1411 to 
form plaques since Vmwl75 is essential for virus growth. 
Latent i_nl411 could be reactivated, however, by 
super inf ection with ts;I or jts5 (Table 4.13.). In these 
cases, plaques presumably resulted from reciprocal 
complementation and, possibly, recombination between in!411 
and the superinfecting mutant ts^ I or _ts5. As expected, tsK 
failed to reactivate iril411 since complementation between 
these 2 viruses does not occur.
in!411 is, therefore, able to establish a latent 
infection in the in vitro system, and this result confirms 
that Vmwl75 is not required for establishment or maintenance 
of latent HSV-2 in vitro.
Table 4.13. ESTABLISHMENT OF LATENCY BY ijil411 AND d!1403a
SUPER­
INFECTION M.O. I
INITIAL INFECTION 
HSV-1 dll403 inl411 HSV-2 m o c :
HCMV 0.01 27 7 0 23 0
HCMV 0.03 98 19 0 47 0
tsKsyn 0.03 41 15 0 33 0
tsKsyn 0.10 NDC 108 0 83 0
tsKsyn 0.30 273 235 0 213 0
talsyn 0.03 19 34 25 48 0
tslsyn 0.10 77 113 81 146 0
tslsyn 0.30 ND 299 206 ND 0
ts5 0.03 38 44 18 40 0
ts5 0.10 230 180 107 152 0
ts5 0.30 >400 >400 >400 >400 0
MOCK 0.00 0 0 0 0 0
a Cultures were infected with 0.003 pfu/cell of wt HSV- 1,
wt HSV-2 or _inl411, or with 0.0003 pfu/cell of dll403 f
incubated at 42°C for 6 days and 37°C for 4 days.
Superinfection was carried out at 38.5°C; and plaques
were counted after 2 days, 
b Pfu of superinfecting virus per cell.
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The mutant dll403 is unable to produce IE polypeptide 
VimwllO, but otherwise produces a pattern of protein 
synthesis indistinguishable from that of wt HSV-1 (Stow and 
Stow, 1986) at temperatures of 38.5°C and 42°C (Figure
4.2.). To establish latency with dll403 it was necessary to 
use a tenfold lower input multiplicity than usual, as stocks 
of this virus have a higher number of particles which do not 
form plaques (Stow and Stow, 19 86) but cause cell death in 
vitro. HFL cells were therefore infected with d!14Q3 at 
0.0003 pfu/cell, and incubated at 42°C for 6 days and 37°C 
for 4 days. It was found that d!1403 was reactivated 
efficiently upon superinfection with HCMV, tsK, tsl or ts5 
and, surprisingly, that the number of plaques recovered was 
equivalent to that found in cultures initially infected with 
a tenfold higher multiplicity of wt HSV-1 (Table 4.13.). 
This was because in d!1403 stocks many of the particles 
which cannot form plaques per se can nevertheless produce 
plaques when complemented by another non-replicating virus 
(Stow and Stow, 19 89).
The major point to be made here is that the mutant 
d!1403 was able to establish a latent state in vitro and, 
therefore, that the absence of IE polypeptide VmwllO does 
not preclude the establishment of latency.
4.3.6. Discussion
Care must be taken in the interpretation of results 
from studies utilising HSV mutants in in vitro latency 
systems and in in vivo latency systems. It is recognised 
that mutants which are not detectable following induction of 
reactivation in in vivo model systems might lack the ability 
to replicate efficiently at the periphery of the host 
organism, the ability to be transported to the ganglion (or 
the site of latency), the ability to become established in a 
latent state, the ability to be reactivated upon 
explantation or cocultivation of latently infected tissue, 
or, the ability to replicate in the indicator cell 
monolayers; in in vitro latency systems such mutants might 
lack the ability to establish or maintain a latent state, 
the ability to grow efficiently in the tissue culture cells,
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or, the ability to be reactivated from the latent state. The 
main point is that, in latency studies of this sort, no 
conclusions can be drawn, concerning viral factors involved 
in establishment or maintenance of latency, simply on the 
basis of a failure to recover latent mutant viruses from the 
system. However, mutants which are able to establish a 
latent infection in vivo or in vitro, and to be reactivated 
from the latent state, obviously produce all the functions 
required for establishment and maintenance of a latent 
infection. Therefore, functions which such mutants are 
unable to produce are not essential for establishment or 
maintenance of latency. Where ts mutants are utilised, this 
approach is, of course, dependent upon retention of the 
restricted phenotype of the mutants, characterised in tissue 
culture at the appropriate NPT, in latency systems. In this 
respect, the in vitro latency system described here has an 
advantage over in vivo systems, because control experiments 
can indicate whether or not a ts mutant has the same 
phenotype in tissue culture at the supraoptimal temperature 
of 42°C and at the NPT for viral replication. More recent 
studies in vivo and in vitro have avoided such a problem by 
the use of genetically engineered HSV mutant viruses 
(Section 1.3.4.2.). In the studies described, the HSV-1 
mutants inl411 and dll403, constructed by Stow and Stow 
(1987, 1988; Russell et al., 1987), were utilised.
The ts mutants tested for their ability to establish 
a latent state in vitro were HSV-2 mutants ts3, ts5, ts9 and 
tsll, and HSV-1 mutants _ts^ K and tel. These mutants have 
previously been analysed for their ability to establish a 
latent infection in vivo in studies of the mouse footpad 
latency system; _ts3 and ts9 were recoverable only from the 
footpad, tsll was recovered only from the dorsal root 
ganglia, and ts5 was not recoverable from either the footpad 
or the dorsal root ganglia in initial studies (Al-Saadi et. 
al., 19 83) but recent work found that ts5 was recoverable
from explant material and therefore capable of becoming 
established in a latent state (S. Batra, personal 
communication); taK and _t£l were not recoverable in 
explanted material (Lofgren et al., 1977; Watson et al, 
1980; Al-Saadi et al., 1983). Although ts3 and tsll were not
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recoverable from explant material in vivo, evidence from the 
studies presented here suggests that ts3 and tsll are host 
range mutants in tissue culture, with plaquing efficiencies 
some 100-fold lower on HFL compared to BHK cells, and it is, 
therefore, possible that the inability to recover the
viruses from latently infected explant tissue was due to a 
restricted ability to replicate in certain cells following 
explant.
All of the ts mutants tested were able to become 
established in a latent state including the HSV-2 mutant 
ts9, which is defective in uncoating and has greatly
impaired gene expression at the NPT. It is, therefore,
possible that viral gene expression is not a requirement for 
establishment and maintenance of the latent state. However, 
there was a reduced recovery of ts9, compared to wt HSV-2, 
following HCMV superinfection of cultures latently infected 
with the mutant. Thus, the possibility arises that viral 
gene expression is advantageous, although clearly not 
essential, for establishment of latency. However, the effect 
of cellular factors on uncoated virus held for a prolonged 
period in the cell is not known, and it is possible that ts9 
may become uncoated within the HFL cells during incubation 
at 42°C and therefore produce some gene expression, albeit 
restricted due to the secondary late mutation. The levels of 
recovery of the mutant following HCMV superinfection could, 
then, be a reflection of the proportion of ts9 which had 
become uncoated in the HFL cells. Clearly, it is not 
possible to deduce the requirement for HSV viral gene 
expression in latency from the experiment utilising ts9. In 
the in vitro latency system described, the bulk of wt HSV-2 
DNA which likely includes latent HSV genomes, are localised 
to the nucleus and exist in an endless configuration during 
the 42°C incubation period (Section 4.5.), therefore, for 
ts9 to be harboured in an equivalent state, the mutant virus 
must become uncoated during 42°C incubation, prior to 
circularisation and localisation of the genome to the 
nucleus. A less probable alternative is that, HSV may be 
harboured in a non-productive state in cells in either of 
two different forms, as uncoated virus in the cytoplasm or 
as naked DNA in the nucleus, both forms of virus being
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efficiently reactivated by superinfection.
The most informative results were those obtained by 
the use of mutants tsKsyn, in!411 and d!14Q3. Taken 
together, these results suggest that little or no viral gene 
expression is required for establishment, since mutants 
expressing only IE genes and Vmwl36 are converted to a 
latent state, and furthermore that there is no requirement 
for expression of IE gene 3 (coding for Vmwl75) and IE gene 
1 (coding for VmwllO). These findings do not contradict the 
results of recent studies carried out in vivo which 
indicated several HSV genes which were not essential for 
establishment or reactivation of latency, including 
glycoproteins G and E, the viral protein kinase, thymidine 
kinase, and, significantly, the genes encoding IE Vtaw68 and 
IE Vtnwl2 (Meignier et al. , 1988; Sears et al. , 1985a,b). 
Furthermore, recent studies using the in vivo latency mouse 
footpad model system showed that the mutant d!1403 is 
capable of establishing a latent infection in vivo, 
demonstrating the lack of a requirement for IE VnwllO in 
latency (Clements and Stow, 19 89).
In vitro studies on expression of viral genes in 
latently infected cells are at a preliminary stage; the 
functional E TK enzyme is not detectable in cells infected 
with HSV-2 at low m.o.i. during 42°C incubation. Therefore, 
there is a block in the production of the functional E TK 
gene product which may occur at the level of transcription, 
RNA processing, translation or protein modification. This 
finding implies that production of other HSV gene products 
could be similarly affected. Furthermore, the E TK gene is, 
presumably, not required for the maintenance of the latent 
state. Although the inability to detect the functional E TK 
in cells at 42°C might appear to contradict the finding that 
HSV-infected cells had the same polypeptide profiles during 
incubation at 42°C as at 37°C, it should be noted that 
polypeptide analysis was carried out on cells infected with 
HSV at higher multiplicities (lOpfu/cell) and during the 
first 24h of incubation at 42°C, in contrast to the TK assay 
which was carried out on cells infected with HSV at m.o.i. 
of less than 1 pfu/cell and following 6 days at 42 C. It
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would seem, therefore, thatAan increase in the period of 
42°C incubation is correlated with a decrease in HSV 
transcription and/or, wt HSV behaves differently in high 
multiplicity infection of cells compared to low multiplicity 
infections during incubation at 42°C. In this respect it is 
worth noting that cultures infected at relatively high 
m.o.i. and incubated at 42°C exhibit higher levels of
spontaneous reactivation than cultures infected at low
m.o.i.. Perhaps then, there is a correlation between the 
m.o.i., the level of HSV gene expression and the amount of 
spontaneous reactivation. This will be discussed in the
context of in vivo latency in Section 5.0..
In vivo studies suggest that the majority of the
latent HSV genome remains transcriptionally inactive; only 
one’ region of the genome (LAT) is actively transcribed. 
Recent mutant studies have suggested that the LAT gene is 
not essential for establishment, maintenance or reactivation 
of HSV latency in vivo (Wagner et al., 1988a; Javier et al., 
1988; Steiner et al., 1989). Expression of LAT in the in 
vitro latency system has not yet been analysed, therefore, 
it is not known whether there is a role for LAT in HSV 
latency in vitro. LAT will be discussed further in Section 
5.0.
The findings of the above studies, utilising the in 
vitro latency system, suggest that the pattern of HSV gene 
expression during the 42°C incubation period is restricted 
and that little or no viral gene expression is required for 
establishment or maintenance of a latent state in vitro.
Suppression of viral gene expression could occur as a result
of inhibition by cellular or viral factors (including only 
IE proteins, E protein Vlmwl36, virion components or LAT) or,
the lack of essential factors involved in viral gene
expression; it is also possible that at least some of the 
viral genes are inaccessible for transcriptional activation 
by virtue of their association with chromatin, as discussed 
in Section 5.0.
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4.4. VIRAL FACTORS INVOLVED IN REACTIVATION
4.4.1. Introduction
The reactivation of HSV from its latent state in 
vivo, which has been discussed in Section 1.3.3. may be 
induced by many, seemingly unrelated, stimuli; the molecular 
mechanisms involved in reactivation have not yet been 
defined.
Reactivation of HSV from in vitro latency systems 
that rely upon infection of cells in the presence of 
inhibitors of virus replication for establishment, and 
incubation at supraoptimal temperatures for maintenance of 
latency (O'Neill et al., 1972; O'Neill, 1977; Wigdahl et 
al., 1981, 1982a, 1983), can be induced by superinfection
with HSV j^ s mutants, or HCMV ts mutants, which are unable to 
synthesise virus DNA and express only IE and E virus genes 
at the NPT (Colberg-Poley et al., 19 79, 19 81; Lewis et al., 
1984; Wigdahl et al., 1982a,b).
The latent virus-cell interaction described in this 
thesis is not susceptible to disruption by the chemical and 
physical treatments tested (Section 4.2.7.; Table 4.9.). 
However, as previously demonstrated by Notarianni (19 86), 
reactivation of HSV can be induced by infection with HSV 
mutants, including tsK which produces only the IE 
polypeptides at the NPT; HSV is efficiently reactivated from 
its latent state in vitro by intertypic superinfection with 
HSV-1 ts mutants tsK or t^ sl (Tables 4.3., 4.13.), the HSV-2 
ts mutant ts5 (Table 4.13.), or by superinfection with HCMV 
(Tables 4.3., 4.13.) (Section 4.3.). Therefore, reactivation 
can be induced by the physical processes of viral infection 
and/or the presence of HSV or HCMV virion components and/or 
the expression of HSV or HCMV genes; the presence of HSV IE 
proteins and/or virion components are sufficient for 
reactivation induced by HSV superinfection.
The approach taken to determine the viral factors 
involved in reactivation of HSV from its latent state was to 
examine the ability of various well-defined HSV mutants to 
induce reactivation. Cultures latently infected with wt
124
HSV-2 were superinfected with mutant viruses and the 
subsequent appearance of plaques of reactivated HSV-2 was 
taken to indicate that reactivation had occurred.
4.4.2. Reactivation of Latent HSV
To establish whether viral functions, or the physical 
processes of viral infection, were responsible for the 
disruption of the latent state which occurred upon 
superinfection of latently infected cultures, the ability of 
adenovirus or UVtsK to reactivate latent HSV was 
investigated.
Adenoviruses were chosen for this study, partly to 
determine whether the ability to induce reactivation of 
latent HSV in vitro might be specific to herpesviruses, and 
partly because early in infection adenoviruses produce 
polypeptide E1A which, like HSV IE Vmwl75, is a 
transactivator and involved in the temporal regulation of 
gene expression. UVtsK virus is tsK which has been 
irradiated with ultraviolet light to decrease the titre by a 
factor of 5x10 and to prevent^viral gene expression. The 
virion component of HSV, Vmw65, which is responsible for 
transactivation of IE gene expression, retains its function 
despite uv-irradiation (Preston et al., 1984).
Cultures infected with HSV-2 (0.003pfu/cell) and 
incubated for 6 days at 42°C and 4 days at 3 7°C, which 
therefore harboured latent HSV-2 genomes, were superinfected 
with adenoviruses 2 or 5, or UVtsK. Within the time course 
of these latency experiments plaques of adenovirus would not 
be formed. However, as previously documented (Table 4.3.) no 
plaques of reactivated virus (or superinfecting virus) were 
formed in the cultures after 2 to 3 days at 38.5°C.
The inability of the adenoviruses to induce the 
formation of plaques of reactivated virus indicates that no 
adenovirus function produced is capable of inducing 
reactivation of latent HSV. The finding that UVtsK was 
unable to reactivate latent HSV-2 shows that none of the 
virion components of HSV, including Vhiw65, are directly 
responsible for the reactivation of latent HSV-2 by HSV 
superinfection. Together these results indicate that
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expression, specifically, of HSV or HCMV genes, rather than 
the physical processes of viral adsorption and penetration 
or the activity of virion components, is necessary for the 
induction of reactivation.
These findings, in combination with the observation 
that tsK was able to reactivate HSV-2 at the non-permissive 
temperature as efficiently as the late mutant tsl (Table 
4.3), suggest that one or more of the polypeptides 
synthesised by tsK at the non-permissive temperature is 
responsible for the reactivation of latent HSV-2 induced by 
HSV superinfection. As previously described, tsK produces 
only the IE polypeptides and the E polypeptide Vftiwl36 at the 
non-permissive temperature. TsK transcribes the IE gene 3, 
coding for VHiwl75, but produces an abnormal Vmwl75 protein 
with altered electrophoretic mobility (Preston, 1979b), 
which, unlike wt Vmwl75, is unable to autoregulate 
transcription of IE gene 3, or stimulate transcription of 
the E and L genes of HSV (Preston, 1979a; Dixon and 
Schaffer, 1980; Watson and Clements, 1980). Therefore, the 
finding that teK superinfection reactivated latent HSV also 
suggests that the presence of functional Vmwl75 is not a 
prerequisite for reactivation.
To determine which of the IE gene products were 
involved in the reactivation of latent HSV it was initially 
proposed to transfect plasmids containing DNA encoding IE 
polypeptides into latently infected cells, followed by 
monitoring of the cell cultures for the presence of 
reactivated virus. In control experiments DNA was applied to 
cell monolayers in calcium chloride precipitates or in DEAE 
dextran and the cells were permeabilised by treatment with 
DMSO or glycerol to facilitate the entry of the DNA into the 
cell; protoplast fusion was also used in an attempt to 
transfect the HFL cells (a review of these techniques has 
been presented by Spandidos and Wilkie, 1984). However, it 
was found that HFL cells did not take up extracellular DNA 
by any of the transfection techniques employed. It is 
well-documented that transfer of DNA into human diploid 
cells by transfection procedures is very inefficient. 
Therefore, in an alternative approach, experiments examining 
the ability of HSV mutants to induce reactivation were
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extended to include the insertion mutant _inl411 and the 
deletion mutant dll403.
4.4.3. Reactivation Induced by Superinfection with in!411
The HSV-1 mutant in!411 was used in these studies to 
further investigate possible involvement of Vftiwl75 in the 
reactivation event, as inl411 is unable to produce IE 
Vtnwl 7 5.
Cultures latently infected with HSV-2 were 
superinfected with in!411 at various m.o.i. At 0.1 pfu/per 
cell, in_1411 formed a small number of plaques on 
mock-infected HFL cells due to the presence of revertants 
which probably arose by recombination with the resident gene 
in the helper cells, M65, used for propagation of in!411 (N. 
D. Stow and E. C. Stow, personal communication).
However, it is clear from the data in Table 4.14. 
that in!411 was able to reactivate latent HSV-2, confirming 
that IE polypeptide Vmwl75 is not required for reactivation. 
This finding also substantiates the possibility that one or 
more of the HSV-1 IE polypeptides, or the E polypeptide 
Vtnwl36, is involved in the reactivation event.
4.4.4. Superinfection of Latently Infected Cultures
with d!1403
The mutant dll403 is unable to produce IE polypeptide 
VtnwllO, and was therefore used in experiments to determine 
whether there was any involvement of VftiwllO in reactivation.
Mutant d!1403 forms plaques on HFL cells, albeit at 
lower efficiency than on BHK cells (Stow and Stow, 1986). 
When this virus was used for reactivation, no increase in 
plaque number was observed on cell cultures harbouring 
latent HSV-2 compared with mock-infected cell cultures which 
had been incubated at 42°C for 6 days and at 3 7°C for 4 days 
(Table 4.14.), and all plaques showed the characteristic 
morphology produced by d!1403 (Stow and Stow, 1986)/ with no 
evidence for replication of HSV-2. The ability of d!1403 to 
replicate means that the sensitivity of detection of 
reactivation is low. Thus by use of 0.001 pfu of d!1403 per
Table 4.14. REACTIVATION OF LATENT HSV-2 BY HSV-1 MUTANTSa
INITIAL INFECTION
SUPERINFECTION M.O.I. MOCK HSV-2
tsKsyn
tsKsyn
0.03
0.10
3(3)
3(3)
78(3)
231(3)
inl411
inl411
0.03
0.10
ND
14
231
>500
dll403 
dll4 03
0.0003
0.0010
79
176
70
169
a Cultures were mock-infected or infected with
0.003 pfu/cell (ts and iri mutants) or 0.03 pfu/cell 
(d!1403) of wt HSV-2 and incubated at 42°C for 6 days 
followed by 37°C for 4 days. Superinfection was carried 
out at 3 8.5°C and plaques were counted after 2 days, 
b Pfu of superinfecting virus per cell.
c Values in parentheses represent the number of syncytial 
plaques, 
d ND, no data.
Figure 4.3. THE GENOMIC LOCATIONS OF HSV-2 Hindlll L
AND CROSS-HYBRIDISING HSV-1 HindiII FRAGMENTS
The relative positions of the HSV-2 Hindlll L 
fragment and the HSV-1 Hindlll n, and g fragments,
which cross-hybridise with the HSV-2 Hindlll L probe, are 
illustrated. The scale in map units is shown above.
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Figure 4.4. DNA FROM SUPERINFECTED CULTURES
HFL cells were mock-infected (M) or infected with 
0.03 pfu of HSV-2 per cell (L), and incubated at 42°C for 6 
days followed by 3 7°C for 4 days. Cultures were 
superinfected with d!1403 (lanes 3 to 12), wt HSV-1 (lanes 
14 to 23), in!411 (lanes 24 and 25), or mock-superinfected 
(lane 13). Cytoplasmic DNA was extracted, cleaved with 
HindiII L and hybridised to radiolabelled HSV-2 Hindlll L. 
The multiplicity of superinfection was 0.0003 (lanes 14 and 
15), 0.001 (lanes 16, 17, 24 and 25), 0.003 (lanes 3, 4, 18 
and 19), 0.01 (lanes 5, 6, 20 and 21), 0.03 (lanes 7, 8, 22 
and 23), 0.1 (lanes 9 and 10) or 0.3 (lanes 11 and 12) pfu 
per cell. HSV-l-specific (t», HSV-2-specific (►) and a 
background cellular band (♦) are labelled.
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cell only 0.1% of the initial HSV-2, or 30 plaques, would be 
expected and this would be difficult to detect over a 
background of 176 plaques (Table 4.14.). The value of 30 
reactivated plaques represents a minimum estimate since, as 
shown in Table 4.13. and discussed above, many particles of 
d!1403 unable to form plaques alone could be complemented by 
reactivated HSV-2. On balance, the results shown in Table 
4.14. suggest that d!1403 fails to reactivate latent HSV-2.
4.4 .4.1. Analysis of Reactivation in Hybridisation Studies
The apparent inability of dll403 to reactivate latent 
HSV-2 was investigated by Southern hybridisation analysis.
HFL cells, mock-infected or infected with HSV-2 at 
0.03 pfu/cell and incubated for 6 days at 42°C and for 4 
days at 37°C, were then superinfected with dll403, ££11411 or 
wt HSV-1 at various m.o.i.. Cultures were harvested after 2 
to 3 days at 37°C, when extensive cytopathic effect was
observed, and DNA was extracted from the cytoplasmic
fractions and digested with Hindlll. DNA fragments were 
separated by electrophoresis and the presence of HSV-2 in 
these samples was determined by Southern hybridisation of 
the DNA using cloned HSV-2 Hindlll L fragment (Figure 4.3.), 
derived from U , as a probe. This fragment migrates 
differently upon electrophoresis from the HSV-1 Hindlll 
fragments B, E, G, and N (Figure 4.3.), with which it shares 
homology.
Figure 4.4. shows that HSV-2 DNA was present in
latently infected cultures subsequently superinfected with 
HSV-1 or iril411 but was not detected in cultures which had 
been superinfected with dll403. The presence of
cross-hybridising HSV-1 bands demonstrates that wt HSV-1 and 
dll403 replicated efficiently.
To ensure that the failure of d!1403 to reactivate
HSV-2 was due to the deletion in the coding sequences for
VfriwllO, virus isolates generated by rescue of d!1403 with a 
small DNA fragment derived entirely from the VmwllO gene
(Stow and Stow, 1986) were tested for the ability to
reactivate latent HSV. Cultures latently infected with HSV-2 
were superinfected with these revertants and incubated at
Figure 4.5. DNA FROM SUPERINFECTED CULTURES
HFL cells were mock-infected (M) or infected with 
0.03 pfu of HSV-2 per cell (L), and incubated at 42°C for 6 
days followed by 3 7°C for 4 days. Superinfection was with 4 
independent isolates of virus obtained by rescue of d!1403 
with a cloned DNA fragment, R1 (lanes 1 and 2), R2 (lanes 3 
and 4), R3 (lanes 5 and 6), R4 (lanes 7 and 8), or with 
d!1403 (lanes 9 to 12). Cytoplasmic DNA was extracted, 
cleaved with Hindlll and hybridised to radiolabelled HSV-2 
Hindlll L. The multiplicity of superinfection was 0.003 
(lanes 1 to 8), 0.03 (lanes 9 and 10) or 0.3 (lanes 11 and 
12) pfu per cell. HSV-1 ( »  and HSV-2 (►) bands are 
labelled.
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Figure 4.6. CO-REPLICATION OF HSV-2 AND d!1403
HFL cells were infected with 3 pfu of dll403 
(lanes 3 to 5) or rescued virus R4 (lanes 6 to 8) plus 
O.lpfu of HSV-2 per cell. Cytoplasmic DNA was extracted 
after incubation of cultures at 37°C for 2h (lanes 3 and 6) 
8h (lanes 4 and 7) or 18h (lanes 5 and 8), cleaved with 
Hindlll, and hybridised to radiolabelled HSV-2 Hindlll L. 
HSV-2 DNA (lane 1) or HSV-1 DNA (lane 2) were also analysed 
HSV-1 (t>) and HSV-2 (►) bands are labelled.
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37°C for 2 days. Southern blot analysis, using as a probe 
32
[ P]-labelled HSV-2 fragment Hindlll L, of Hindlll-digested 
DNA derived from the cytoplasmic extracts of these cultures, 
showed that the four independently isolated revertants 
reactivated HSV-2 efficiently (Figure 4.5.).
Therefore, the deletion in the gene encoding VmwllO 
is responsible for the failure of dll403 to reactivate 
HSV-2. It should be noted that the deletion in dll403 also 
affects the 3' end of- the LAT gene, and this will be 
discussed below.
The possibility remained that dll403 superinfection 
was able to reactivate HSV-2 from latently infected cells, 
but that the presence of dll403 inhibited the replication of 
reactivated HSV-2, which was therefore undetectable.
Although it is clear from the presence of
HSV-l-specific fragments that dll403 replicated in HFL cells 
infected at less than 1 pfu/cell (Figures 4.4., 4.5.), it 
was possible that d!1403 inhibited the replication of HSV-2 
when both viruses were present in the same cell. HFL cell 
cultures were coinfected with 3 pfu of d!1403 or rescued 
virus plus 0.1 pfu of HSV-2 per cell, and the virus was 
allowed to adsorb to and penetrate the cells for lh at 3 7°C. 
Incubation was continued at 3 7°C. The cultures were
harvested at 2h, 8h, and 20h post-infection. Southern blot 
analysis was performed on Hindi!I-digested DNA derived from 
the cytoplasmic extracts of these cultures. The probe was 
[ ^ P]-labelled Hindlll L of HSV-2.
The results in Figure 4.6. show that HSV-2 replicated 
in both cases, showing that interference with HSV-2 
replication by d!1403 did not account for the failure to 
reactivate latent virus. As expected from previous studies, 
d!1403 replicated less efficiently, or more slowly, than 
rescued virus in HFL cells, and HSV-2 was affected in the 
same way (Stow and Stow, 1986; Sacks and Schaffer, 1987)
4.4.5. Discussion
The results presented suggest that reactivation
induced by superinfection with HSV involves only the HSV IE 
genes and/or virion components. By contrast, the results of
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Scheck et al. (1987), utilising a system in which HSV is
converted to a repressed state by treatment of infected 
cultures with chemical inhibitors followed by incubation at 
elevated temperatures, suggested that early, as well as 
immediate early, HSV-1 genes were required for reactivation 
of HSV-2 by HSV-1 superinfection in this system. Therefore, 
it is apparent that the non-productive state of HSV produced 
in latency systems utilising inhibitors and elevated 
temperatures differs from that produced in systems which 
rely solely on the use of supraoptimal temperatures to 
achieve a latent state for HSV, at least in terms of 
requirements for reactivation.
The finding that, in contrast to wt HSV-1 or tsK, 
d!1403 did not reactivate HSV indicates that the region of 
the genome affected by the deletion, which includes most of 
the coding sequences for VmwllO (Figure 4.7.), is essential 
for reactivation induced by HSV-1 superinfection. Therefore, 
the results strongly suggest that VmwllO is required for 
reactivation.
It is not clear from the results whether VmwllO acts
alone or in conjunction with one or more of the virion
components and/or the other HSV IE polypeptides, although,
from the results of superinfection with in_1411, there is no
requirement for at least IE polypeptide Vmwl75 in
reactivation. In order to resolve the issue, it was
necessary to introduce the gene encoding VmwllO into
latently infected cells and determine the ability of VmwllO
to stimulate reactivation. Transfection of DNA into HFL
cells was unsuccessful by the techniques employed (Section
4.4.2.), therefore, construction of a virus vector
expressing VmwllO was desirable. Since wt Ad5 superinfection
does not induce HSV reactivation, the virus vector selected
was an Ad5 mutant dlEl,3, which is deleted for the El and E3
regions (Haj-Ahmad and Graham, 1986), kindly supplied by Dr.
F. Graham. Unfortunately, insertion of the IE-1 gene
sequences into dlEl,3 was not completed within the time
limits of the project. However, adenovirus vectors
expressing VmwllO under the control of the IE-1 promoter
(Orm^”0) or the adenovirus major late promoter (MLP-O) have PKU
been constructed by Zhu et al. (1988), and recent studies by
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R.A. Harris and C.M. Preston utilising 0 - 0  and MLP-0 havePRO
indicated that both viruses are capable of reactivating 
latent HSV, suggesting that VmwllO can trigger the 
reactivation event in the absence of the other IE
polypeptides (Harris et al., 1989).
Since the deletion in dll403 extends through the IE-1
gene to the LAT gene (Figure 4.7.), it was possible that LAT
was also required for reactivation. Evidence that LAT 
production by the superinfecting virus is not a requirement 
for the reactivation event has been provided by Harris et 
al. (1989): reactivation of HSV was induced by 
superinfection of latently infected cultures with adenovirus 
recombinants, which expressed VmwllO but which did not 
produce LAT due to deletions in the promoter and the 5 1 
portions of the coding sequences for the LAT gene, and with 
HSV-1 mutant D14 (Figure 4.7.), which contains a deletion in 
the LAT gene such that 41 amino acids are missing from the 
carboxy terminus of the longer potential reading frame in 
LAT; reactivation was not achieved by superinfection with an 
HSV-1 mutant incapable of expressing VmwllO due to deletions 
which did not affect the LAT gene. Therefore, the presence 
of VmwllO alone is sufficient to stimulate reactivation of 
HSV from latently infected cultures (Harris et al., 1989).
The ability of VmwllO to stimulate expression, 
presumably at the level of transcription, from a variety of 
HSV promoters and heterologous promoters introduced into 
cells by transfection, has been demonstrated. The degree of 
trans-activation can be increased in the presence of Vmwl75, 
but to date there are no examples of eukaryotic or animal 
genes which fail to respond to VmwllO; there appears to be a 
general lack of sequence specificity in the promoters 
activated by VmwllO during transfection assays (Everett, 
1983, 1984a,b). Evidence for the importance of a region
containing a potential metal-binding domain in the 
transactivation function of VmwllO and in viral growth was 
recently provided by Everett (1988, 1989) (Section
1.2.3.2. ) . R.A. Harris and C.M. Preston have analysed the 
ability of HSV-1 mutant FXE (Figure 4.7.), which lacks the 
region containing the potential metal-binding site (Everett, 
19 89; Section I.2.3.2.), to reactivate HSV in the in vitro
Figure 4.7. POSITIONS OF DELETIONS IN HSV-1 MUTANTS d!1403, 
FXE AND D14 IN RELATION TO LAT AND TO THE 
IE VtowllO GENE
The locations of VmwllO mRNA and LAT are shown in
relation to the positions of deletions in HSV-1 mutants
dll403, FXE and D14. Spliced regions are shown as raised
sections; all copies of LAT are spliced. The exact
position of the 3' end of LAT is not known. Filled boxes and
dashed lines represent deleted regions. Numbering of
nucleotides begins at the IR junction ’a 1 sequence (Perry
Li
et al., 1986).
This figure was kindly provided by Ruth Harris.
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latency system. Superinfection of latently infected cultures 
with FXE did not reactivate HSV, which, therefore, implies 
that VmwllO reactivates HSV via its ability to stimulate 
gene expression (Harris et al., 1989).
HCMV superinfection was also able to induce HSV 
reactivation; if reactivation by HCMV and HSV superinfection 
occur via similar mechanisms, the HCMV gene function 
involved in reactivation would be expected to share some 
properties with the HSV IE VmwllO polypeptide. Interestingly 
then, HCMV, but not UV-irradiated HCMV, is capable of 
complementing low multiplicity infections of the d!1403 
mutant. Therefore, HCMV produces a function, which is not a 
virion component, capable of substituting for the VmwllO 
function in HSV-1 infections (Stow and Stow, 1989). It seems 
probable that the HCMV function involved in reactivation and 
the HCMV function which substitutes for VmwllO function in 
complementation of dll403 are one and the same. Although 
there are no obvious amino acid sequence homologies between 
HCMV IE gene products and VmwllO, the HCMV IE gene products 
are likely candidates for the complementation of d!1403, 
since complementation can occur in cells in which HCMV 
infection is blocked at an early stage and the major IE 
polypeptide accumulates (Stow and Stow, 1989). Furthermore, 
like VmwllO, the HCMV IE gene products stimulate gene 
expression in a manner that is not specific to promoter 
sequences (Everett, 1984a,b). It would, therefore, be of 
interest to determine the ability of individual HCMV IE gene 
products to induce reactivation of HSV from the in vitro 
latency system.
It should be noted the VZV possesses the potential to 
complement dll403 infections, implying that VZV encodes a 
polypeptide which substitutes for VmwllO functions, possibly 
the VZV 61 gene product which shares some amino acid 
homology with VmwllO (Davison and Scott, 1986; Perry et al., 
1986), and it is, therefore, possible that superinfection of 
latently infected cultures with VZV would also result in 
induction of the reactivation event (Stow and Stow, 19 89).
Since superinfection of latently infected cultures 
with dll403, which does not produce VmwllO but which 
otherwise has a polypeptide profile similar to that of wt
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HSV, failed to reactivate HSV, it may be concluded that the 
HSV transcriptional trans-activators Vmwl75, Vmw63 and Vmw65 
were unable to trigger the reactivation event. Stimulation 
of reactivation by HSV superinfection is therefore due to a 
specific effect of VmwllO. Due to the lack of target 
sequence specificity of stimulation, it has been suggested 
by Harris et al. (1989) that VmwllO functions either, by
increasing template availability in a relatively 
non-specific manner, perhaps by displacing other bound 
proteins from a latent genome that is maintained in a state 
resembling inactive chromatin, or, by activating gene 
expression at a post-transcriptional stage, perhaps acting 
on a specific viral or cellular transcript to trigger 
reactivation.
Latency in vivo is characterised by episodes of 
reactivation of HSV, and the in vitro latency system also 
exhibits a low level of 'spontaneous1 reactivation (Section
4.2.2.; Russell and Preston, 1986). Active VmwllO is not the 
trigger for reactivation in such situations since it is 
presumably not present before these events occur and is not 
introduced extrinsically. Therefore, 'spontaneous' 
reactivation must be induced either by the formation of 
active VmwllO, which could occur as a result of modification 
of the polypeptide or its transcript or stimulation of 
transcription, or by cellular processes which substitute for 
the VmwllO trans-activation function. Support for the latter 
possibility comes from the observation that latent d!1403 
can be reactivated by HCMV (Section 4.2.4.3.), since no 
VmwllO is present under these circumstances.
The ability of a transactivator protein to reactivate 
HSV from its latent state indicates a possible block in 
viral gene expression of the HSV genome. The inability of 
d!1403 superinfection of latently infected cultures to 
stimulate reactivation of HSV from the latency system 
suggests that functional VmwllO (or the HSV-2 equivalent, 
Vimwll8) is not being produced in HSV-1 (HSV-2) latently 
infected cells. Furthermore, the failure of d!1403 
superinfection to reactivate HSV suggests the possibility 
that the gene encoding Vmwll8, the HSV-2 functional 
equivalent and homologue of VmwllO, is not accessible to
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activation by Vmw65, Vtnwl75 and Vmw6 3 which stimulate 
expression from IE-1 in transfection studies (Mackem and 
Roizman, 1982; O'Hare and Goding, 1988; Ace et al., 1989) 
and that, therefore, in the latent DNA the IE-1 gene, and 
possibly the other IE genes, is maintained in a 
transcriptionally inactive state. However, it is also 
possible that these transactivators stimulate IE-1 
transcription but that functional VmwllO is unable to be 
expressed.
The implication is that HSV is maintained in a latent 
state due to suppression of viral gene expression which may 
be the cause or effect of conversion of HSV to a latent 
state, and can be reactivated by induction of viral gene 
expression, in this case by the introduction of VhiwllO or 
its functional equivalent in HCMV.
134
4.5. THE STATE OF THE LATENT HSV GENOME
4.5.1. Introduction
The physical nature of the latent HSV-1 genome has 
been determined by Southern hybridisation analysis of DNA 
from animal model systems and from human tissue, using DNA 
probes which span the joint and terminal regions of the 
genome (Rock and Fraser, 1983; Efstathiou et al., 1985). The 
reported state of latent HSV-1 DNA in vivo is 'endless', as 
indicated by a predominance of joint fragments, at a 2:1 
molar ratio compared to unique HSV sequences, and a 
corresponding underrepresentation of the terminal fragments. 
The latent HSV DNA is, therefore, circular, concatemeric or 
integrated via regions of the genome other than the termini 
(Figure 1.7. ) .
A similar strategy has been employed in analysis of 
the state of the HSV genome in the in vitro latency system. 
This analysis presented problems due to the low number of 
latent HSV genomes per cell genome equivalent. Therefore, 
the relative proportion of HSV DNA was increased in two 
ways. First, the initial input m.o.i. of HSV to the system 
was increased 10-fold or 30-fold. Superinfection of the 
cultures, following incubation at 42°C for 6 days and 37°C 
for 4 days showed that the number of latent HSV genomes was 
increased proportionally (Table 4.15.), although at higher 
m.o.i. the level of spontaneous reactivation was such that 
it occurred in most cultures and therefore interfered with 
detection of latent genomes. Even at the multiplicities used 
a relatively high proportion of cultures had to be discarded 
due to the presence of spontaneously reactivated virus (for 
example, see Table 4.16.). Secondly, since HSV DNA has a 
high G+C content and therefore a greater buoyant density 
than most cellular DNA sequences, HSV DNA was separated from 
the bulk of cellular DNA sequences in infected 42°C-treated 
cultures by equilibrium centrifugation in CsCl gradients. To 
facilitate separation, DNA from 42°C-treated cultures was 
cleaved with BamHI prior to centrifugation.
The state of the latent HSV genome in the in vitro
Table 4.15. REACTIVATION OF LATENT HSV-2 FROM CULTURES
INITIALLY INFECTED AT 0.03 PFU/CELLa
EXPERIMENT NUMBER 
(Relates to data 
in Figure Number)
2. (Figure 4 . ^  . )
3.
SUPERINFECTION 
Virus M.o.i.
HCMV
tsKsyn
tsKsyn
0.001
0.03
0.003
REACTIVATED VIRUS 
PLAQUE NUMBER 
Actual Expected^
28
660
72
30
900
90
a HFL cell monolayers were infected with HSV-2 at 0.03
pfu/cell and incubated in EF5 at 4 2°C for 6 days and then 
at 37°C for 4 days. The cultures were then superinfected 
with HCMV or tsK at various multiplicities and overlaid 
with EHu5. After 2 days at 38.5°C, the cultures were 
stained with Giemsa stain and plaques were counted, 
b Expected plaque numbers were calculated on the assumption 
that 100% of input virus is able to establish a latent 
infection and be induced to reactivate upon 
superinfection with HCMV or tsKsyn.
Table 4.16. SPONTANEOUS REACTIVATION IN LATENTLY
INFECTED CULTURES MONITORED BY PLAQUE ASSAY 
OF CELL LYSATES
TREATMENT OF CELLS 
PRIOR TO HARVESTING 
(Days,Temperature)
6, 4 2°C + 2, 37°C
6, 4 2°C + 4, 3 7°C
6, 4 2°C + 6, 3 7°C
HFL cells were infected with HSV-2 at 0.03 pfu/cell and 
incubated in EF5 at 42°C for 6 days and then at 37°C for 
2, 4, or 6 days at 37°C. The cultures were then harvested 
and frozen and thawed 3 times. 20ul samples of cell 
lysates were titrated on BHK cells in EF5 and cultures 
were scored as positive or negative for spontaneously 
reactivated virus. The data are from 1 experiment.
NUMBER OF CULTURES 
CONTAINING SPONTANEOUSLY 
REACTIVATED VIRUS
3 out of 18
6 out of 2 2
7 out of 18
Figure 4.8. THE GENOMIC LOCATIONS OF HSV-2 FRAGMENTS 
BamHI g f BamHI u, BamHI v AND BamHI d.
The HSV-2 BamHI fragments illustrated are the
terminal fragments u and v, the joint fragment g (g=u+v),
and fragment d which is located in U . The scale in map
Jj
units is shown above.
oo
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latency system was investigated for two reasons. Primarily, 
it might elucidate some of the molecular mechanisms involved 
in the latent viral-cell interaction, but, it is also 
necessary to determine whether the physical nature of the 
latent genome is identical in vitro and in vivo and, 
therefore, whether the viral-cell interaction in vitro is 
comparable to that in vivo.
4.5.2. Detection of HSV DNA Joint Fragments in HSV-2
Infected HFL Cells Incubated at 42— C for 4 Days
The state of the HSV genome was analysed in HFL cell
cultures which had been infected with HSV-2 at 0.03 or 0.1 
pfu/cell and incubated at 4 2°C for 4 days. Nuclear DNA 
extracted from these cultures was digested with BamHI and 
density-gradient banded in caesium chloride to remove the 
bulk of the cellular DNA sequences from DNA fragments of 
densities ranging from 1.709 to 1.746, which include HSV 
DNA. DNA fragments of such densities were separated on the
basis of electrophoretic mobility and analysed by Southern
. . . . . 32hybridisation, utilising [ P]-labelled (by nick
translation) plasmid pBamg DNA as a probe. Plasmid pBamg 
consists of the HSV-2 fragment BamHI g, derived from the
joint region of the HSV-2 genome (Figure 4.8.), cloned into
pAT153. In control experiments, hybridisation, to 
BamHI-digested cellular DNA plus linear HSV-2 DNA, of the 
pBamg probe and of HSV-2 fragment BamHI g was compared. The 
results in Figures 4.9.(b) and 4.9.(c) indicate that both 
the probes hybridised to the HSV-2 BamHI g (joint) fragments 
(g=v+u) and the HSV-2 BamHI v (terminal) and BamHI u 
(terminal) fragments (note that the terminal BamHI u and v 
fragments are approximately the same size and often 
comigrate), and that, in addition, the pBamg probe 
hybridised to certain cellular DNA sequences.
Figure 4.9.(a) shows that DNA samples, from HSV-2 
infected HFL cells incubated at 42°C for 4 days, contain DNA 
which hybridises to pBamg, has the same electrophoretic 
mobility as HSV-2 BamHI g, and which is not present in 
mock-infected HFL cells incubated at 42°C for 4 days. There 
were no detectable sequences hybridising to pBamg of the
Figure 4.9. DETECTION OF HSV JOINT FRAGMENTS IN HFL CELLS 
INFECTED WITH HSV-2 AND INCOBATED AT 42°C 
FOR 4 DAYS
7 7(a) Lanes 1, 2, 3, and 4 contain 4.5x10 , 1.5x10 ,
fi fi4.5x10 , 1.5x10 BamHI-digested HSV-2 genomes, respectively.
7
Lane 10 contains 4.5x10 copies of BamHI-digested 
pBamg plasmid DNA (HSV-2 BamHI g plus vector sequences).
Lanes 5 to 9 contain BamHI-digested nuclear DNA 
of densities 1.709 to 1.746, from cell cultures which had 
been incubated at 42°C for 4 days. In lanes 5 and 7, the DNA 
is from 3x10^ HFL cells infected with HSV-2 at 0.03 or 0.1 
pfu/cell respectively; in lanes 6 and 8, the DNA is from
7
3x10 mock-infected HFL cells; in lane 9, the DNA is from
7
3x10 mock-infected cells, plus HSV-2 infected cells from a
lytic infection.
Southern hybridisation of DNA fragments separated
3 2by electrophoresis used, as a probe, P-labelled pBamg 
plasmid DNA.
Bands representing HSV-2 BamHI g (•), u and v (0) 
are marked. The band depicted by (■) represents the vector 
sequences of plasmid pBamg.
(b) Experimental details of samples in lanes 1 and 2 
are as for lanes 9 and 10, respectively, of Figure 4.9.(a).
(c) Experimental details are as for Figure 4.9.(b),
32except that the P-labelled probe used in Southern 
hybridisation analysis was the HSV-2 fragment BamHI g.
(a)
1 2  3 4
L M L M
5 6 7 8 9 10
g
V t
(b)
9 10
(c)
9 10
g
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same electrophoretic mobility as the HSV-2 BamHI v and u 
fragments in DNA from mock- or HSV-2- infected HFL cells
incubated at 42 C for 4 days. A control sample containing
mock-infected DNA plus linear HSV-2 genomes, which had also 
been BamHI-digested and density-gradient banded, contained 
DNA fragments representing HSV-2 BamHI fragments g, v and u, 
illustrating that BamHI fragments v and u were not lost 
during processing of DNA samples.
It seems, therefore, that HSV-2 infected cultures
incubated at 42°C for 4 days contain HSV-2 DNA joint
fragments but do not contain detectable HSV-2 terminal
fragments. It is, therefore, possible that the HSV-2 genome
persists in an endless configuration. Alternatively, the HSV
DNA could persist as unit length, linear molecules,
integrated into the cellular genome via the repeat regions
of the HSV DNA, although there was no detection of the
novel—sized terminal fragments which would be so generated.
It is likely, therefore, that the HSV-2 genome is in an
'endless' configuration in these cultures and is therefore
either circular, concatemeric or integrated via regions of
the genome other than the termini.
Reconstructions showed that in a DNA sample derived 
7
from 3x10 HFL cells initially infected with 0.1 pfu/cell of 
HSV-2, the HSV-2 joint fragments were present at 
approximately 5x10 copies. Assuming 100% of the pfu applied 
to the cells becomes established in a latent state, at least 
3x10 HSV-2 genomes would be present in the latently 
infected sample. If the latent HSV-2 DNA is endless, 6xl06 
copies of the joint fragment and no terminal fragments would 
be expected. Since the level of HSV joint fragments detected 
in infected 42°C-treated cultures is approximately the same 
as the level predicted, the DNA detected is likely to be the 
DNA which establishes a latent state.
4.5.3. Determination of the Molar Ratio of HSV Joint
Sequences to HSV Unique Sequences in HSV-2 Infected 
Cells Incubated at 42— C for 4 days
Further evidence was sought for the presence of HSV-2 
DNA in an endless configuration in HSV-2 infected cells
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which had been incubated at 42°C for 4 days. The molar ratio 
of HSV-2 joint sequences to HSV-2 unique sequences was 
determined by Southern hybridisation analysis of the DNA 
using, as probes, the HSV-2 BamHI g fragment representing 
the joint sequences, plus the cloned HSV-2 BamHI d fragment, 
derived from the UL region of the HSV-2 genome and therefore 
representing a unique HSV-2 sequence (Figure 4.8.).
Nuclear DNA was extracted from HFL cells infected 
with HSV-2 at 0.03 pfu/cell which had been incubated for 4 
days at 42°C. DNA from such cultures was digested with BamHI 
and density-gradient banded in caesium chloride. DNA 
fragments of densities ranging from 1.709 to 1.746, were 
electrophoresed in agarose gels and Southern hybridisation 
was performed.
Figure 4.10.(a) shows the results of a DNA analysis, 
with probe BamHI g, indicating that, as in Figure 4.9.(a), 
HSV-2 joint fragments, but not termini, are present in HSV-2 
infected cultures following incubation at 42°C for 4 days. 
The initial m.o.i. was 0.03 pfu/cell and therefore the 
expected number of HSV-2 genomes was at least 10^. If the 
HSV-2 molecules were endless the number of joint fragments
C.
present would be 2x10 , compared to the detected level in N 
Figure 4.10. (a) of 10 copies of joint fragments^. Therefore, 
5-fold more joint fragments were detected than predicted. 
The factors affecting the calculations made to determine 
levels of latent DNA are discussed below (Section 4.5.6.).
The membrane autoradiographed and photographed for
Figure 4.10. (a) was stripped of the BamHI g probe and
3 2reprobed with a mixture of P-labelled BamHI g and BamHI d 
fragments, in equal concentrations and at approximately 
equal specific activities. Bands representing BamHI g and 
BamHI d are present in the lane containing DNA from HSV-2 
infected 42°C treated cells. Densitometric analysis of these 
bands indicates that the molar ratio of bands representing 
BamHI g to bands representing BamHI d is between 1.1:1.0 and 
1.5:1.0. The molar ratio of these bands in reconstruction 
samples is 0.8:1.0. Therefore, the calculated ratio of BamHI 
g to BamHI d sequences is between 1.4:1.0 and 1.9:1.0. A 
more accurate estimate of the molar ratio of joint to unique 
sequences cannot be obtained due to the close proximity of
Figure 4.10. DETERMINATION OF THE MOLAR RATIO OF HSV JOINT 
FRAGMENTS TO HSV UNIQUE FRAGMENTS IN HSV-2 
INFECTED HFL CELLS INCUBATED AT 42°C FOR 4 DAYS
7 6(a) Lanes 1, 2 and 3 contain 1.5x10 , 4.5x10 , and 
1.5x10^ BamHI-digested HSV-2 genomes, respectively.
7
Lane 6 contains 1.5x10 copies of BamHI-digested
plasmid pBamg (HSV-2 BamHI g plus vector sequences).
Lanes 4, 5 and 7 contain BamHI-digested nuclear
DNA of densities 1.709 to 1.746, from cell cultures which
had been incubated at 42°C for 4 days. In lane5 , the DNA is 
7from 3x10 mock-infected HFL cells; m  lane I* , the DNA is 
from 3x10^ HFL cells infected with HSV-2 at 0.03 pfu/cell;
7
in lane 7, the DNA is from 3x10 mock-infected cells, plus
HSV-2 infected cells from a lytic infection.
Southern hybridisation of DNA fragments separated 
32by electrophoresis used P-labelled HSV-2 fragment BamHI g 
as a probe.
Bands representing HSV-2 BamHI fragments g (•), u 
and v (®) are labelled.
(b) Experimental details are the same as for Figure
4.10.(a) except that Southern hybridisation analysis 
32utilised P-labelled HSV-2 fragments BamHI g and BamHI d.
Bands representing HSV-2 BamHI fragments d (■), g 
(•), u and v (@) are identified.
(a)
1 2
(b)
1 2
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the BamHI g and BamHI d bands and a cross-hybridising 
cellular band and due to the diffuseness of the bands. 
Therefore, HSV-2 joint fragments are present in higher molar 
ratios than HSV unique sequences, at best approaching 
bimolarity compared to unique HSV-2 sequences. It is, 
therefore, likely that viral genomes from HSV-2 infected HFL 
cells incubated at 42°C for 4 days are in an 'endless' 
configuration and are not unit length, linear molecules 
integrated into the cellular genome via the repeat regions 
of the genome. No distinction can be made between circular, 
concatemeric or integrated states from this data.
4.5.4. Analysis of HSV DNA Sequences in HFL Cells Latently
Infected with HSV-2
Although the HSV-2 genome was analysed following 
incubation of infected cells for 4 days at 42°C, in the in 
vitro latency system HSV is considered to be latent during 
the 37°C period, within which infectious virus is not 
usually detectable even though 37°C is a permissive 
temperature for HSV replication.
Therefore, to determine the state of the latent HSV
genome in vitro, DNA was extracted from cytoplasmic and
nuclear fractions of HSV-2 infected cultures which had been
incubated at 42°C for 6 days and then at 37°C for a further
4 days. To check for spontaneous reactivation, DNA from the
cytoplasmic fraction of each culture was analysed for the
presence of HSV-2 DNA by digestion with BamHI and Southern
hybridisation analysis using the HSV-2 fragment BamHI g as a
3 2probe (the probe was P-labelled by hexanucleotide random 
priming to increase specific activity and incorporation of 
label and thereby increase the sensitivity of detection of 
fragments hybridising to BamHI g). Lane 6 in Figure 4.11.(a) 
shows the presence of HSV-2 DNA, and therefore the 
corresponding nuclear fraction was discarded. Nuclear DNA, 
from several cultures of cells in which the presence of 
spontaneously reactivated virus was not apparent by Southern 
hybridisation analysis of the corresponding cytoplasmic 
fractions, was digested with BamHI. The latent HSV genomes 
were concentrated and separated from the bulk of the
Figure 4.11. DETECTION OF HSV DNA SEQUENCES IN HFL CELLS 
LATENTLY INFECTED WITH HSV-2
7 6(a) Lanes 1, 2 and 21 contain 1.5x10 , 4.5x10 and
7
1.5x10 BamHI-digested HSV-2 genomes, respectively.
Lanes 11 and 13 contain BamHI-digested plasmid
7
pBamg (HSV-2 BamHI g plus vector sequences) at 1.5x10 
copies.
Lanes 3 to 10 and 14 to 20 contain BamHI-digested
6DNA from the cytoplasmic fractions of 3x10 HFL cells
infected with HSV-2 at 0.03 pfu/cell and incubated at 42°C
for 6 days and at 37°C for a further 4 days.
Lane 12 contains BamHI-digested DNA from the
cytoplasmic fractions of 3x10^ mock-infected HFL cells.
Southern hybridisation of DNA fragments separated
3 2by electrophoresis utilised P-labelled HSV-2 fragment
BamHI g as a probe.
Bands representing HSV-2 BamHI fragments g (■), u 
and v (A) are indicated.
(b) Lanes 1, 2 and 3 contain BamHI-digested HSV-2
7 6 6genomes at 1.5x10 , 4.5x10 and 1.5x10 copies,
respectively.
Lane 6 contains BamHI-digested plasmid pBamg
7
(HSV-2 BamHI g plus vector sequences) at 1.5x10 copies.
Lanes 4, 5 and 7 contain BamHI-digested nuclear 
DNA of densities 1.709 to 1.746, from cell cultures which 
had been incubated at 42°C for 6 days and at 37°C for a
7
further 4 days. In lanes5 andV , the DNA is from 4.2x10 
HFL cells mock-infected or infected with HSV-2 at 0.03
7
pfu/cell, respectively; in lane 7, the DNA is from 4.2x10 
mock-infected HFL cells, plus HSV-2 infected cells from a 
lytic infection.
Southern hybridisation analysis of DNA used the
32 P-labelled HSV-2 fragment BamHI g as a probe.
Bands representing HSV-2 BamHI g (■), u and v (A)
are marked.
( a)  1 2 3 4  5 6 7 8 9 1 0 1 1 1 2
4
13 14 15 16 17 18 19 2 0 2 1
CALCULATION
Bv densitometric analysis there are approximately:
3.6x10 Joint fragments and 3-0x10 Terminal fragments 
in the latently infected sample.
Assumption: Each terminal fragment is from a unit length 
linear molecule.
Note: Terminal fragments are blmolar in this experiment 
since BamHI v is approximately the same size as BamHI u. 
Therefore, there are 1,Sx^0^unit length linear genomes 
with a total of 1.5x10^ joint fragments. This leaves 
2 .1x10^ joint fragments (ie. 3*6x10^ minus 1.5x10 ).
Assumption: Each of the 2.1x10 joint fragmentsis from 
an Endless HSV genome.
Therefore, there are 1.1x10 endless HSV genomes, 
cttvL a total of 2.6x10^ (ie. 1.5x10  ^plus 
1.1x10^ ) HSV genomes in the latently infected sample.
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cellular D N A  sequences by ultracentrifugation twice in a 
caesium chloride gradient. Southern hybridisation analysis 
of the D N A  was carried out using the BamHI g fragment of 
HSV-2 as a probe.
Figure 4.11.(b) indicated that HSV-2 was present in
the latently infected samples and that both joint and
terminal HSV-2 sequences were represented. Since joint
fragments were present at 3.6x10^ copies and terminal
fragments were present at 3.0xl06 copies, 2.6xl06 HSV-2
molecules were present in the latently infected samples
(compared to the predicted number of 1.3x10^ molecules), of 
6 .which 1.5x10 were unit, length and linear and 1.1x10 were 
endless. The possibility that the HSV-2 genomes detected 
were representative of a small amount of spontaneously
reactivated HSV-2 could not be dismissed. The level of 
detection of spontaneously reactivated virus in DNA from 
cytoplasmic fractions was approximately 4.5x10 copies of 
HSV-2. Therefore, if DNA from reactivated virus was present 
in less than half of the cytoplasmic fractions of the 
cultures m  this experiment at less than or equal to 4.5X10 
copies it might have escaped detection but could have 
accounted for the 2.6x10 copies of HSV-2 detected in the 
latently infected cultures.
To overcome this difficulty, a more sensitive assay 
for the level of spontaneous reactivation was required. 
Therefore, HSV-2 infected (0.03 pfu/cell) cultures, which 
had been incubated at 42°C for 6 days and then at 3 7°C for a 
further 2, 4 or 6 days, were harvested, frozen and thawed 3 
times, and a sample of the lysate was titrated on BHK cells 
at 37°C. Control reconstruction experiments implied that 60% 
of infectious virus present in the latently infected 
cultures would be detected. The number of cultures, from 
this experiment, in which spontaneous reactivation was 
detected by titration of cell lysates is shown in Table 
4.16.; it should be noted that the level of spontaneous 
reactivation in these cultures is higher than expected from 
previous data (Section 4.2.2.), which might be an anomaly of 
the particular experiment or might be due to the increased 
sensitivity of detection of spontaneous reactivation by the 
method employed. Total cellular DNA from cultures in which
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spontaneously reactivated virus was not detectable was
pooled, BamHI digested, ultracentrifuged twice on caesium
chloride gradients and analysed by Southern hybridisation
using the HSV-2 fragment BamHI g as a probe.
Figure 4.12. shows that no HSV-2 DNA was detectable
in these cultures despite a sensitivity of detection of at 
5
least 4.5x10 copies of HSV DNA and expected copy numbers 
for latent HSV-2 of 1.4x10^ (lane 5), 7.2x10^ (lane 6) and 
10 (lane7). Bimolar joint fragments would have been present 
at 2.7x10^, 1.4x10^ and 2x10^ copies, respectively.
This suggests that the HSV DNA sequences detected in 
the experiment shown in Figure 4.11. were representative of 
spontaneously reactivated virus.
Therefore, the approach taken did not permit the 
detection of latent HSV-2 during incubation at 3 7°C in the 
in vitro latency system. To detect latent HSV, either the 
proportion of latent HSV genomes per cell genome equivalent 
must be increased, or the sensitivity of detection of the 
Southern hybridisation technique employed must be increased.
4.5.5. The Fate of the HSV Genome in HFL Cells during 
Incubation at 42— C
From the data discussed so far, it appeared that the 
concentration of HSV-2 genomes was much decreased in 
cultures that had been incubated at 4 2°C for 6 days and then 
at 3 7°C for 2, 4 or 6 days in comparison with cultures that 
had only been incubated at 4 2°C for 4 days. Therefore, to 
determine the fate of the HSV DNA detectable during the 4 2°C 
period, a time course analysis was performed. DNA was 
extracted from the nuclear fractions of HSV-2 infected 
cultures which had been incubated for 1, 2, 3, 4, 5 or 6 
days at 42°C. The DNA from 42°C treated cultures was 
BamHI-digested, centrifuged in CsCl gradients, 
electrophoresed, and Southern hybridisation was performed 
with the "^P-labelled HSV-2 BamHI g probe.
Analysis of DNA from the cytoplasmic fractions showed 
that no HSV-2 DNA was detectable in these fractions and, 
therefore, the majority of the HSV DNA present in cultures 
at 42°C was confined to the nucleus. Figure 4.13. indicates
Figure 4.12. ANALYSIS OF DNA FROM HFL CELLS LATENTLY
INFECTED WITH HSV-2 AND SCREENED FOR THE PRESENCE 
OF SPONTANEOUSLY REACTIVATED VIRUS BY PLAQUE ASSAY
Lanes 1, 2 and 3 contain BamHI-digested HSV-2
7 6 6genomes at 1.5x10 , 4.5x10 and 1.5x10 copies,
respectively.
Lane 8 contains BamHI-digested plasmid pBamg
7
(HSV-2 BamHI g plus vector sequences) at 1.5x10 copies.
Lanes 4 to 7 contain BamHI-digested whole cell 
DNA of densities 1.709 to 1.746. In lane 4, the DNA is from 
4.5xl07 mock-infected HFL cells incubated at 42°C for 6 days 
and at 3 7°C for 4 days; in lanes 5, 6 and 7, the DNA is from 
4.5xl07 , 2.4xl07 and 3.3xl07 HFL cells, respectively, 
infected with HSV-2 at 0.03 pfu/cell and incubated at 42°C 
for 6 days and then at 37°C for 2, 4 or 6 days, 
respectively; in lane 9, the DNA is from mock-infected HFL 
cells incubated at 42°C for 6 days and at 3 7°C for 4 days, 
plus HSV-2 infected HFL cells from a lytic infection.
Southern hybridisation analysis of DNA used the
32 P-labelled HSV-2 fragment BamHI g as a probe.
Bands representing HSV-2 BamHI g (•), u and v (A) 
are indicated.

Figure 4.13. DETECTION OF THE HSV GENOME IN HFL CELLS 
DURING INCUBATION AT 42°C
Lane 1 contains BamHI-digested HSV-2 genomes at
7
1.5x10 copies.
Lane 9 contains BamHI-digested plasmid pBamg
7
(HSV-2 BamHI g plus vector sequences) at 1.5x10 copies.
Lanes 2 to 8 contain BamHI-digested nuclear DNA 
of densities 1.709 to 1.746. In lane 2, the DNA is from 
mock-infected HFL cells incubated at 4 2°C for 6 days. In
7
lanes 3 to 8 the DNA is from 1.8x10 HFL cells infected with 
HSV-2 at 0.03 pfu/cell and incubated at 42°C for 1, 2, 3, 4, 
5 and 6 days respectively.
Southern hybridisation analysis of DNA used
32
P-labelled HSV-2 fragment BamHI g as a probe.
Bands representing HSV-2 BamHI g (•), u and v (A) 
are labelled.
M  L1 L2 L3 L4 L5 L6
i c
o
CALCULATION
Estimations of DNA concentrations were obtained by 
densitometric analysis. The values for the number 
of unit length, linear HSV genomes, the number of 
'endless'' genomes and the number of HSV genomes present 
in total were derived in the same way as outlined on 
the page facing p1 3 9 «
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a change in the conformation of HSV-2 genomes during 
incubation at 42°C. The DNA from HSV-2 infected cells
incubated at 42°C for 1 day contained both joint fragments
5 5(at 6.3x10 copies) and terminal fragments (at 4.7x10
copies) of HSV-2 D N A ;  a total of 4.3xl05 HSV-2 genomes were
present, of which approximately 50% were unit length and
linear (2.3x10^ molecules) and 50% (2.0x10^) were endless.
Similarly, the D N A  from HSV-2 infected cells incubated at
O  5 S42 C for 2 days contained 6x10 copies of joint and 4.4x10 
copies of terminal fragments, and therefore a total of 4.1
5
HSV-2 genomes of which 2.2x10 were unit length and linear, 
while 1.9x10 were endless. After the third day, DNA from 
HSV-2 infected cells incubated at 42°C contained 
approximately 3-fold greater levels of HSV-2 joint fragments 
(2:5*10“ ) and there was a marked decrease of terminal 
fragments. No terminal HSV-2 fragments were detectable in 
DNA from HSV-2 infected cells incubated at 42°C for 4 or 5 
days. These findings imply a change in the state of the 
HSV-2 DNA from linear to 'endless' during the first 4 days 
of incubation at 42°C. There was a gradual reduction in the 
level of HSV-2 joint fragments, relative to the level of the 
cross-hybridising cellular fragments, in DNA from HSV-2 
infected cells during incubation at 42°C; from 2.5x10^ on 
day 3, to 1.1x10^ on day 4, to 0.7x10^ on day 5 and to 
0.25x10 on day 6. It would therefore seem that the number 
of HSV-2 DNA molecules decreases during 42°C incubation and 
this could partially account for the inability to detect 
latent HSV-2 DNA during the 3 7°C period.
In summary, HSV-2 DNA from cells incubated at 42°C 
for 1 to 6 days is found predominantly in the nucleus. The 
HSV-2 DNA appears to change from unit length linear genomes 
into endless molecules during a 3 day incubation at 42°C; 
after 6 days of incubation at 42°C, the level of (endless) 
molecules of HSV-2 in infected cells appears to be 
decreased.
4.5.6. Discussion
Incubation of HSV-infected cells at the supraoptimal 
temperature of 42°c results in conversion of the HSV genome
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to an 'endless' molecule. The results presented suggest that 
the proportion of genomes converted to an endless state 
increases with the number of days of incubation of infected 
cultures at 42°C, until by the 4th day at 42°C all the HSV 
DNA appears to be endless. The level of spontaneous 
reactivation following downshift, to a permissive 
temperature for HSV, of infected cultures decreases with an 
increasing number of days (up to six) incubation of infected 
cultures at 42°C (C.M. Preston, personal communication; 
Notarianni, 1986). Therefore, there is a temporal 
correlation between achievement of a stable latent state for 
HSV and the conversion of HSV DNA to an endless 
conformation.
It is likely that circularisation of HSV-2 occurs 
during incubation of infected cultures at 42°C in view of 
the fact that, circularisation would be the first step both 
in integration into the cellular genome of HSV DNA via 
regions of the viral genome other than the termini and in 
the production of concatemers by a rolling circle mechanism. 
It is not possible to distinguish between circular, 
concatemeric or integrated states in these experiments. 
However, since the molar ratio of joint fragments (BamHI g) 
to unique fragments (BamHI d) tends to 2:1, following 4 days 
incubation of HSV-2 infected cultures at 42°C, this argues 
against a model in which a copy of the viral genome 
integrates into cellular DNA via the joint regions to form 
novel-sized junction fragments. It is known from mutant 
studies that replication is not essential for establishment 
of latency in the system described (Section 4.3.) and, since 
there is a reasonable correlation between the numbers of 
genomes detected and the expected numbers of genomes 
present, it is unlikely that replicative concatemeric 
structures account for the presence of endless molecules of 
HSV.
The results from superinfection of latently infected 
cultures (initial m.o.i. 0.003 pfu/cell) suggested that at 
least 30% and up to 100% of the pfu applied to the cells was 
able to become established in a latent state from which 
reactivation was inducible by superinfection (Section
4.2.5.). Superinfection of control cultures, from
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experiments in which HSV-2 at an initial multiplicity of 
0.03 pfu/cell was converted to a latent state in HFL cells 
by incubation at 42°C (Table 4.15.), indicated that the 
number of plaques of reactivated virus increased in 
proportion to the increased amount of input virus. The copy 
numbers of HSV-2 genomes detected in infected cultures 
incubated at 42°C were compared with predicted copy numbers 
of HSV-2 genomes. In the experiments described in Sections 
4.5.2. (DNA from cultures incubated for 4 days at 42°C) and
4.5.5. (1,2 and 4 days at 42°C) there was a good correlation 
between detected and predicted copy numbers of HSV-2 
genomes; in the experiments described in Sections 4.5.4. (4 
days at 42°C), 4.5.5. (3 days at 42°C) and 4.5.3. (4 days at 
42°C) detected copy numbers of HSV-2 genomes were 2-fold, 
2.4-fold and 5-fold, respectively, higher than predicted 
copy numbers; while, in the experiments described in Section
4.5.5. (5 days at 42oC) and Sections 4.5.5. (6 days at 42°C) 
detected HSV-2 genome copy numbers were 0.6-fold and 
0.2-fold, respectively, lower than predicted copy numbers. 
The presence in some experiments of higher HSV-2 genome copy 
numbers than predicted could be due to inaccuracies in the 
measurement of HSV DNA concentrations for reconstruction 
samples and/or of input virus titres. Replication of HSV 
during 42°C incubation in culture is also a possibility, 
although there is evidence from several sources that 
replication of HSV at 42°C is unlikely to occur (Crouch and 
Rapp, 1972; Darai and Munk, 1973; Marcon and Kucera, 1976; 
Notarianni, 1986). It could be argued that the higher copy 
number of HSV molecules detected was not a result of HSV 
replication if a correlation was observed between the levels 
and states of viral DNA detected in wt HSV infected cultures 
incubated at 42°C, viral DNA from cultures infected with a 
ts replication defective mutant and incubated at 42°C, viral 
DNA from wt HSV infected cultures treated with inhibitors of 
replication (for example, phosphonoacetic acid) and 
incubated at 42°C, and, viral DNA from wt HSV infected 
cultures harvested early during incubation at 42°C. Another 
explanation for the detection of higher levels of HSV 
genomes than predicted would be the presence of molecules of 
virus which are not capable of forming plaques during a
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lytic infection of cultured cells but which are capable of 
establishing a latent state from which, however, 
reactivation cannot be induced by HSV superinfection. It is 
noteworthy that cells latently infected with HSV in vivo 
apparently contain rather high numbers of viral genomes 
(Section I.3.4.I.). Therefore, in both in vivo and in vitro 
latency systems, the DNA detected may or may not represent 
latent HSV genomes potentially capable of being induced to 
reactivate.
There is an apparent decrease in the copy number of 
HSV-2 genomes during the latter period of incubation at 
42°C. The latent HSV DNA is undetectable during the period 
at 37°C. This could be explained if a proportion of the 
HSV-2 fragments detected during 42°C incubation was 
accounted for by the presence of non-infectious or defective 
HSV DNA, unable to establish a latent state and degraded 
during incubation at the supraoptimal temperature. This 
explanation does not account for the inability to detect the 
predicted level (on the basis of initial infecting pfu and 
reactivation efficiencies) of latent HSV-2 DNA during 37°C 
incubation. A low recovery of HSV DNA following the 
manipulations required to concentrate sufficient quantities 
of the DNA was a possibility, although control experiments 
suggested that the efficiency of recovery was relatively 
high. Despite the inability to detect HSV DNA at 37°C, on 
the basis of the evidence presented above, particularly from 
the time course experiment, it is not unreasonable to 
propose that the state of the HSV genome remains endless 
during the latent period at 3 7°C, although this has yet to 
be confirmed.
Wigdahl et al. (1982b), utilising an in vitro latency 
system which relies upon treatment with viral inhibitors and 
elevated temperatures to establish and maintain a latent 
state for HSV, detected unit length and linear HSV DNA 
molecules, suggesting a difference between the 
non-productive states of HSV produced by treatment with 
inhibitors and with elevated temperatures and by treatment 
with elevated temperatures alone. Differences in the 
efficiency of and requirements for reactivation by 
superinfection between the systems have been mentioned in
145
the preceding results sections. It is thought that 
differences in the m.o.i. utilised in the systems could be 
an important parameter. In the in vitro latency system 
described here, low m.o.i.'s were used and, there was a 
reasonable correlation between the amount of HSV-2 D N A  
detected (during 42°C incubation), the amount of virus 
reactivated by superinfection and the amount of pfu 
initially used to infect the cultures. In the system 
described by Wigdahl et al. (1982b), high m.o.i. was used,
as reflected by the amount of D N A  detected, but the 
reactivation efficency was comparatively low. Supposing that 
the latent HSV genomes are those which can be induced to 
reactivate in the system of Wigdahl et al. (19 82b) and are 
therefore present at relatively low copy number, perhaps, 
then, the state of the latent HSV D N A  is endless but is 
masked by the presence of unit, length linear HSV molecules 
not involved in latency.
It is widely accepted that the latent HSV genome 
resides in a endless state in vivo and the detection of HSV 
genomes in an endless configuration is regarded as a 
criterieofor the classification of HSV as latent in in vitro 
systems. The evidence presented indicates that the state of 
the latent genome in the in vitro latency system described 
in this thesis might be endless. There is recent evidence to 
suggest that in vivo the latent HSV-1 genome is 
extrachromosomal (Mellerick and Fraser, 19 87) and, 
furthermore, has a nucleosomal structure similar to that of 
cellular chromatin, as determined by micrococcal nuclease 
digestion (Deshmane and Fraser, 1989). Since in vivo and in 
vitro transcription of latent HSV genomes is restricted, it 
is possible that the latent genome may be associated with 
transcriptionally inactive chromatin structures. This will 
be discussed further in Section 5.
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5.0. FINAL DISCUSSION
HSV latency, both in vivo and in the in vitro latency 
system described in this thesis, appears to involve a 
relationship between the virus and its host cell such that 
the virus exists in a non-replicative state and exhibits a 
restricted pattern of gene expression; the latent HSV genome 
resides in an endless configuration in vivo, associated with 
nucleosomes, and probably also resides in an endless state 
in vitro.
The observations that the latent HSV genome does not 
express the full repertoire of genes involved in lytic 
infection (Stevens et al., 19 87; Section 4.) and that the 
HSV VmwllO trans-activator protein is capable of stimulating 
the reactivation event in vitro (Russell et al., 1987a; 
Harris et al., 1989), suggest that latency is controlled at 
the level of gene expression. The following discussion 
considers the possibility of control of HSV latency at the 
level of IE gene expression since these proteins are the 
first to be produced during lytic infection and since the IE 
proteins Vftiwl75, VmwllO and Vmw6 3 are involved in control of 
HSV gene expression in trans. The possible importance of 
levels of VmwllO and Vmwl75 gene expression in the 
lysis/latency decision of HSV was proposed by O'Hare and 
Hayward (1985b).
The properties of the IE proteins are detailed in 
Section 1.2.3.2.: only the salient points are reiterated
here. IE polypeptide Vmwl75, which has the capacity to 
stimulate E and L transcription and is involved in the 
negative regulation of IE gene expression (Everett, 19 84a, 
1986; Quinlan and Knipe, 19 85; O'Hare and Hayward, 1985a,b; 
Gelman and Silverstein, 1986), is essential for the 
transition from IE to later phases of HSV gene expression 
that occurs during lytic infection (Preston, 1979b). IE 
polypeptides Vmw63 and VmwllO are also transactivators of 
gene expression (Everett, 1984a; Mavromara-Nazos et al., 
1986; Quinlan and Knipe, 1985; Rice and Knipe, 1988; 
Everett, 1986; Sekulovich et al., 1988) and Vmw63 appears to 
be essential for modulation of E and L gene transcription 
(McCarthy et al., 1989). VmwllO is not absolutely essential
147
for virus growth in tissue culture since, at relatively high 
ra.o.i., replication of the HSV-1 mutant d!1403, which does 
not express VmwllO, is similar to that of wt HSV-1. However, 
in low multiplicity d!1403 infections the efficiency of 
plaque formation is severely reduced in a cell-dependent 
manner (Stow and Stow, 1986). A similar phenotype is 
exhibited by HSV-1 mutant in!814, which is defective in 
transinduction of IE transcription as a result of a 12bp 
insertion in the gene encoding the transinducing factor 
Vftiw65. In comparison to IE RNA levels in wt HSV-l-infected 
cells, in J1nl814-infected cells the accumulation of IE-1 and 
IE-2 RNA was reduced 4 to 5 fold, whereas the level of IE-4 
RNA was reduced only 2-fold and IE-3 RNA was unaffected (Ace 
et al., 1989). Ace et al. (1989) suggested that the
inability of in!814 to replicate at low m.o.i. could result 
from failure to produce sufficient levels of IE proteins for 
initiation of lytic infection and that Vmw65 functions to 
ensure that such 'threshold' levels are attained. In view of 
this, it may be significant that IE genes are not expressed 
at detectable levels by latent HSV in vivo (Stevens et al., 
19 87), that functional HSV-1 IE VmwllO (or HSV-2 Vmwll8) is 
not, apparently, present in latently'infected cells in 
vitro, and that IE VtnwllO, which is not essential for the 
establishment of latency, can stimulate reactivation of 
latent HSV in vitro (Russell et al., 1987; this thesis; 
Harris et al., 1989). It is particularly intriguing that in 
low multiplicity infections of both in!814 and d!1403, as 
well as in low multiplicity infections of wt HSV following 
incubation at 42°C, virus can be maintained in a 
non-productive state for several days at 3 7°C and then 
reactivated to form plaques by superinfection with HCMV 
(Stow and Stow, 19 89; Ace, Harris and Preston, personal 
communication; Notarianni, 1986; Russell and Preston, 1986; 
Russell et al., 19 87; this thesis). Complementation of
inl814 by VtnwllO has also been demonstrated (Ace et al. ,
19 89). Both the levels of spontaneous reactivation in the in 
vitro latency system and the plaquing efficiencies of the 
mutants d!1403 and in!814 increase relative to the initial 
m.o.i.. Therefore, it is plausible that incubation of cells 
at the supraoptimal temperature of 42°C renders HSV DNA
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incapable of synthesising sufficient levels of IE proteins 
required for progression to the lytic cycle, and that the 
presence of VmwllO, or its proposed cellular, HCMV or VZV 
functional counterpart (see Section 4.4.5.), initiates the 
lytic cycle and/or restores the ability of the latent HSV 
genome to synthesise the appropriate amounts of IE 
polypeptides (perhaps by a mechanism similar to VmwllO 
complementation of in!814 [Ace et al., 19 89]).
Leib et al. (19 89), recently reported the results of 
an investigation into the roles of the IE proteins Vmwl75, 
VmwllO and Vmw63 in the establishment and reactivation of 
ganglionic latency in a mouse ocular model. Viruses with 
deletion or nonsense mutations in the genes encoding Vmwl75 
and Vmw6 3 were unable to establish a latent state, probably 
due to the inability of the viruses to replicate at the site 
of inoculation. Virus mutants dlx3.1 and dlx0.7, with 
deletions in the coding and non-coding sequences of VmwllO, 
were able to become established in a latent state but were 
deficient in reactivation. In vivo studies with d!1403 have 
indicated that there is no absolute requirement for VmwllO 
in establishment or reactivation, although there was a 
reduced level of recovery of d!1403 compared to wt virus in 
vivo (Leib et al., 1989; Clements and Stow, 1989). The
trigger for reactivation in vivo may be functionally 
equivalent to VmwllO or could act at the level of IE gene 
expression resulting in the production of 'threshold' 
quantities of IE proteins, including VmwllO, for progression 
into the lytic cycle.
Roizman and Sears (19 87) proposed a model, based on 
the apparent presence of the HSV genome in multiple copies 
in each neuron that harbors latent virus (Cabrera et al., 
1980; Puga et al., 1978; Rock and Fraser, 1983; Rock and 
Fraser, 19 85; Efstathiou et al., 19 86), in which the balance 
between the latent state and viral gene expression, leading 
to lytic replication, depends upon the copy number of viral 
genomes per cell. The authors suggested that the effect of 
reactivation stimuli on neuronal cells is to amplify latent 
viral genomes and that viral gene expression ensues when the 
copy number of genomes in individual cells reaches a 
specific level at which point the lytic cycle proceeds. The
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most obvious mechanism for the proposed activation of the 
lytic cycle by the accumulation of high genome numbers, with 
respect to the evidence discussed above, assumes low levels 
of, at least, IE expression from each genome and a 
cumulative effect of the gene products. A model in which 
reactivation is dependent upon genome copy is not 
inconsistent with the observations that spontaneous 
reactivation from the in vitro latency system described 
occurs at increased levels when cells are initially infected 
at high m.o.i. and that the plaque forming defects of d!1403 
and in!814 can be overcome at high m.o.i.. A mechanism for 
controlled amplification of the viral genome involving a 
host polymerase and a specific origin of DNA replication was 
postulated by Roizman and Sears (19 87), based on findings 
from EBV latency in which replication of the latent genome 
involves a viral origin of replication (oriP), the EBNA-1 
protein and cellular DNA polymerase (Yates et al., 1985; 
Reisman et al., 1985; Rawlins et al., 1985; Summers and
Klein, 1976; Colby et al., 1980). It is important to note 
that latent EBV multiplies in tandem with replication of the 
B lymphocyte (Adams, 19 87) and since neuronal cells do not 
divide the mechanism for proposed amplification of latent 
HSV would differ, at least in this respect, from the
mechanism for multiplication of latent EBV DNA.
Control of latency at the level of IE gene expression 
would require suppression of IE gene expression at 
transcriptional or post-transcriptional levels.
The theory that absence of Vmw65 and the consequent 
suppression of IE gene transcription results in the 
establishment of a latent state was proposed by Kristie and 
Roizman (19 88) and has been supported by Ace et al. (19 89) 
on the basis of evidence from analysis of mutant in!814, 
including the ability of in!814 to reside in a state
resembling latency in infections at low m.o.i.. It was
originally suggested that in neuronal cells the loss or 
inactivation of Vtnw65 could occur during transport of the 
HSV nucleocapsid over the comparatively great distance from 
the neuronal cell surface to the neuronal nucleus (Kristie 
and Roizman, 19 88). However, an alternative mechanism for 
loss or inactivation of Vmw65 must be postulated since there
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is convincing evidence that HSV can exist in a latent state 
in cells other than neuronal cells both in vivo (Clements 
and Subak-Sharpe, 1988; Al-Saadi et al., 1988; Clements and 
Jamieson, 1989) and in vitro (Section 1.3.6.; Notarianni, 
1986; Section 4.0. ).
A possible role for LAT in the control of latency at 
the level of IE gene expression was suggested by the 
findings that the LAT gene was the only region of the genome 
expressed in latently infected cells and that the LAT RNA 
was antisense to the mRNA of the IE VnwllO protein (Stevens 
et al., 1987; Rock et al., 1987a) which has the potential
for trans-activation of gene expression and which 
reactivates HSV from its latent state in vitro. A negative 
effect of LAT on VmwllO production might result in the 
establishment of HSV in a latent state; possible mechanisms 
for such an effect by LAT were outlined in Section 1.3.4.2.. 
However, recent experiments utilising HSV mutants which 
express VmwllO but which fail to produce detectable levels 
of LAT, due to deletions in the region 5' to the LAT 
template, have suggested that there is no prerequisite for 
LAT in the establishment, or reactivation, of HSV latency 
(Steiner et al., 1989). It is nonetheless interesting that 
LAT is the only transcript detectable in cells latently 
infected with HSV and the selective expression of the LAT 
gene may occur via the presence of distinct cis-acting 
upstream transcriptional control elements and differences in 
methylation patterns or chromatin structure.
Another possible mechanism for control of latency at 
the level of HSV IE gene expression is DNA methylation. EBV 
has been shown to be extensively methylated and can be 
reactivated by treatment with demethylation agents 
(Bensasson and Klein, 1981; Szyf et al., 1985). Although 
there is evidence to suggest that HSV DNA is not extensively 
methylated in vivo (Dressier et al., 19 87), demethylation 
agents stimulate reactivation of HSV from its latent state 
(Bernstein and Kappes, 1988; Stephanopoulos et al., 1988). 
It is therefore conceivable that only specific regions of 
the HSV genome involved in control of expression, perhaps 
including the promoter regions of IE genes, are methylated 
and that demethylation results in activation of these genes
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and, thereby, in initiation of the lytic cycle.
There is recent evidence that most latent HSV-1 DNA, 
including the transcriptionally active LAT region, has a 
nucleosomal structure similar to that of cellular chromatin 
and that, in contrast, during acute infection of mice the 
majority of viral DNA is not associated with nucleosomes 
(Deshmane and Fraser, 19 89). It is noteworthy that the 
latent EBV is predominantly nucleosome-associated, whereas, 
in producer line P3HR-1, the majority of EBV DNA is 
nonnucleosomal (Shaw et al., 19 79; Dyson and Farrell, 19 85). 
It is possible that the transcriptional inactivity of the 
majority of the latent HSV genome is a consequence of 
formation of a particular chromatin structure. A correlation 
exists between transcriptionally active regions of DNA and 
regions which are DNase-hypersensitive (Gross and Garrard, 
1988); the analysis of DNase hypersensitive sites within 
HSV-1 latent DNA is reported to be underway (Deshmane and 
Fraser, 1989).
In conclusion, evidence to date is consistent with a 
mechanism for control of latency at the level of IE gene 
expression. Suppression of IE gene expression from the 
latent HSV genome could be the result of absence or loss of 
the IE trans-inducing factor Vmw6 5, the presence of a 
cellular/viral repressor, selective DNA methylation or the 
association of the latent HSV genome with chromatin in a 
transcriptionally inactive state. Reactivation could be 
induced upon attainment of sufficient levels of IE gene 
expression, which could be achieved by activation of, or 
substitution for, IE gene expression by cellular factors, 
removal of repressor activities or an increase in genome 
copy number.
Experiments utilising the in vitro latency system 
described in this thesis and considered to be of importance 
for further investigation of the molecular basis for HSV 
latency encompass three main areas: analysis of the 
mechanism by which VhiwllO stimulates reactivation of HSV 
from its latent state, analysis of the pattern and control 
of gene expression from the latent HSV genome, and 
determination of the state of the latent HSV genome.
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The probability of VmwllO action at the level of 
viral gene expression has been discussed in Section 4.4.5.. 
Vinwl 10-mediated stimulation of expression from the HSV 
genome present in latently infected cells could occur 
directly or, indirectly via the effect of VmwllO on cellular 
gene expression. To distinguish between the possibilities, 
RNA species produced in latently infected cell cultures 
could be analysed, in a time course experiment following the 
introduction of the VmwllO gene into latently infected cells 
and utilising protein synthesis inhibitor treatment or, 
following direct introduction of the VmwllO protein into the 
latently infected cells in the presence of a protein 
synthesis inhibitor. Also, due to similarities between the 
in vitro latency system and low multiplicity infections of 
mutants d!1403 and in.1814, it would be of interest to 
determine the mechanism for 'reactivation' of the mutants. 
Since in!814 can be complemented by VmwllO, investigation of 
the mechanism of complementation could yield information 
concerning the properties of VmwllO. Identification of the 
genes activated by VmwllO during stimulation of reactivation 
might suggest mechanisms for the prevention of reactivation 
of HSV.
Since the levels of IE gene expression might be 
crucial in the lysis/latency decision of HSV in vitro and in 
vivo, an investigation of the levels of IE transcripts or IE 
gene products in cells latently infected with HSV would be 
appropriate. The production of LAT may be a criterion for 
the classification of wt HSV as latent in vitro. The 
expression of the LAT gene and the possible role of LAT in 
establishment and maintenance of latency in vitro, should, 
therefore, be analysed; the results of Harris et al. (19 89) 
indicate that LAT gene expression is not essential in the 
reactivation event. There appear to be differences in viral 
gene expression between high multiplicity and low 
multiplicity HSV infections at 42°C; analysis of viral gene 
expression in cells infected at low m.o.i. might be more 
relevant because conversion of HSV to a latent state in the 
in vitro latency system described apparently relies upon low 
m.o.i.. IE gene expression and the production of LAT in 
latently infected cells could be analysed by Northern blot
153
or in situ hybridisation or, by the DNA polymerase chain 
reaction method.
Confirmation of the state of the latent HSV genome in 
the in vitro latency system described is essential because, 
like LAT production, the presence of HSV DNA in an endless 
configuration could be considered as a criterion for a 
virus-cell interaction in vitro equivalent to that of the 
HSV latent interaction in vivo. Since HSV DNA is not 
detectable in cells during the 3 7°C period following 
incubation at 4 2°C for 6 days, the amount of HSV genomes per 
cell must be increased in order to determine the state of 
the latent HSV genome; perhaps this could be achieved, 
without affecting the levels of spontaneous reactivation, by 
utilising mutant viruses for the initial infection. 
Furthermore, investigation of the association of the latent 
HSV genomes with chromatin, by micrococcal nuclease 
digestion, and analysis of regions of DNase hypersensitivity 
and of CpG methylation, by digestion with MspI and Hpall 
restriction enzymes, might provide information regarding the 
transcriptional status of the latent HSV genome in vitro.
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